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ABSTRACT

Sayer, Richard D. Ph.D., Purdue University, December 2015. Dietary and Exercise
Effects on Neural Responses to Visual Food Stimuli in Overweight and Obese Adults.
Major Professor: Wayne Campbell.

Results from human neuroimaging studies consistently demonstrate that obesity is
associated with altered neural reward processing of food-relevant cues. These
observations have caused some investigators to question whether behavioral interventions
such as dietary manipulations or physical activity might modulate processing of food
cues in reward-related brain regions. The use of functional magnetic resonance imaging
(fMRI) to measure neural responses to visual food stimuli is a commonly utilized
paradigm for assessing neural reward responses relating to ingestive behavior of foods in
humans. Using this study design, limited evidence suggests that increases in dietary
protein and participation in acute and chronic aerobic exercise may modulate rewardrelated neural responses to visual food stimuli. However, data regarding the reliability of
this fMRI-based paradigm to produce consistent results on multiple testing days and time
course of responses following a meal have not been systematically studied. These data
are critically important for the proper interpretation of existing literature and for the
design of future intervention studies using this paradigm.
Therefore, the purpose of Study 1(Chapter 2) was to 1) assess the test-retest
reliability of fasting-state neural responses to visual food stimuli and 2) document
potential meal-induced changes in neural responses up to 4.5 hours after the consumption
of a meal in overweight and obese adults. We hypothesized that fasting-state neural
responses would demonstrate good to excellent test-retest reliability and that neural
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responses to visual food stimuli would be suppressed following meal consumption and
then would return to fasting-state levels of activation by 4.5 hours after the meal. Our
results indicate that visual food stimuli elicits relatively consistent mean or group-level
neural activation in reward-associated brain regions including the insula, amygdala,
orbitofrontal cortex, caudate, and putamen. However, contrary to our hypotheses, the testretest reliabilities of these responses were generally poor (high degree of within-subject
variability) and responses were relatively unaffected by meal consumption. These results
have important implications relating to the design of future studies including observable
correlations among study outcomes, sample size determination, and statistical modeling.
Being cognizant of these considerations, the purpose of the two randomized
crossover trials within this document were to assess the effects of dietary protein and
fiber (Study 2, Chapter 3) and dietary protein and acute aerobic exercise (Study 3,
Chapter 4) on neural responses to visual food stimuli and appetite in overweight (Study 2)
and obese (Study 3) adults. For Study 2, we hypothesized that higher intakes of protein
and fiber at breakfast would independently and additively increase fullness and decrease
hunger, desire to eat, neural responses to visual food stimuli, and ad libitum energy intake
at lunch. For Study 3, we hypothesized that higher protein consumption at dinner would
increase fullness and decrease hunger, desire to eat, and neural responses to visual food
stimuli similar to our hypotheses in Study 2. We further hypothesized that acute aerobic
exercise would decrease fullness and increase hunger, desire to eat, and neural responses
to visual food stimuli only when performed prior to the consumption of a normal protein
dinner.
Higher protein breakfasts in Study 2 transiently decreased desire to eat compared
to normal protein breakfasts, and hunger was increased on exercise compared to rest in
Study 3. Appetite and neural responses to visual food stimuli were otherwise not
influenced by the interventions in either study. Collectively, the results of these
intervention studies do not support higher intakes of dietary protein and fiber or acute
aerobic exercise as significant modulators of neural reward-based ingestive behavior in
overweight and obese adults.

1

CHAPTER 1. REVIEW OF LITERATURE

1.1

Adult Overweight and Obesity in the United States

Results from the National Health and Nutrition Examination Survey (NHANES)
indicate that the prevalence of obesity (BMI ≥ 30 kg/m2) more than doubled between
1976-1980 and 2009-2010 (Figure 1.1 and Figure 1.2) (1). Adult obesity rates in 20032004 were 34.9%, and overall obesity prevalence rates were unchanged from the
NHANES 2003-2004 to 2011-2012 (2). While the prevalence of obesity has risen rapidly
since the mid-1970s, the prevalence of overweight (BMI: 25.0-29.9 kg/m2) has remained
remarkably stable at approximately one-third of the total adult population over this period
(1, 3). These data suggest that a systematic increase in BMI across all weight categories
has occurred in the previous 4 decades with normal weight individuals (BMI: 18.5-24.9
kg/m2) moving into the overweight category to “replace” those who have progressed
from an overweight to an obese BMI. However, weight gain appears to be most prevalent
in those at the higher end of the BMI distribution (4). This model is further supported by
longitudinal data demonstrating a high risk for overweight individuals to gain weight and
progress to obesity (5-7). The continued and rapid rise in morbid obesity (BMI ≥ 40.0
kg/m2) is especially troubling. Estimates from the Behavioral Risk Factor Surveillance
System indicate that morbid obesity prevalence increased 70% between 2000 and 2010
and that approximately 15.5 million Americans or 6.6% of the adult population had a
BMI ≥ 40.0 kg/m2 in 2010 (8). These data underscore the critical importance of
preventative and treatment strategies to curb the substantial medical (9) and financial (10)
burdens attributable to obesity.
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Figure 1.1.Trends in overweight, obesity, and extreme obesity among men aged 20-74
years: United States, 1960-1962 through 2009-2010 (1)

Figure 1.2.Trends in overweight, obesity, and extreme obesity among women aged 20-74
years: United States, 1960-1962 through 2009-2010 (1)
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1.2
1.2.1

Health Consequences of Obesity

Medical Expenditures Attributable to Excess Weight
Estimated obesity-related medical expenditures were $147 billion in 2008, and

obese individuals spent, on average, $1429 or 42% more on medical care than normal
weight individuals in 2006 (10). A significant portion of these costs are incurred by those
with BMIs ≥ 35.0 kg/m2 compared to those with class I obesity (BMI: 30.0-34.9 kg/m2).
In 2000, 7.9% of the U.S. adult population had a BMI ≥ 35.0 kg/m2, yet they were
responsible for nearly 40% of medical expenditures attributable to excess weight at that
time. The healthcare costs for those with a BMI ≥ 40.0 kg/m2 are even greater. While 2.8%
of the population had a BMI ≥ 40.0 kg/m2 in 2000, they were responsible for ~20% of
healthcare expenditures related to excess weight. Comparatively, the prevalence of class I
obesity was approximately 5 times higher than morbid obesity (14.7% vs. 2.8%), but this
group accounted for only 30% of expenditures related to excess weight (11). The
increased healthcare costs attributable to excess weight are the result of well-documented
increased risk of chronic morbidity with obesity, including type 2 diabetes (T2D),
cardiovascular diseases (CVD), respiratory diseases, gastrointestinal problems,
osteoarthritis, and certain cancers (9). Subsequent sections will consider the relationships
between obesity and T2D and CVD in more detail. For a detailed review of the medical
complications of obesity, the reader is referred to the review by Malnick and Knobler (9).
1.2.2

Obesity and Chronic Low-Grade Inflammation
Obesity is associated with a state of chronic low-grade inflammation, which at

least partially mediates the relationships between obesity and chronic disease risk (12).
Adipose tissue distribution appears to have a significant influence on its inflammatory
properties. For instance, central obesity (measured by waist-to-hip ratio) was more
strongly associated with markers of inflammation than BMI. Specifically, central obesity
was associated with increased concentrations of C-reactive protein, tumor necrosis factoralpha (TNFα), amyloid A, interleukin-6, and white blood cell counts (13). Excess
accumulation of adipose tissue in other ectopic sites including intermuscular (14), hepatic
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(15), and epicardial fat (16) results in a locally increased inflammatory state and
compromises the metabolic health of skeletal muscle, liver, and the heart, respectively.
Adipose tissue, especially visceral and other ectopic fat depots, secretes a number
of cytokines, termed adipokines, which are known to influence metabolic processes.
Depending on the functional state of the adipocytes within the tissue, these adipokines
can result in either a net pro- or anti-inflammatory state (17). Metabolically normal
adipose tissue secretes adipokines such as adiponectin, which are decreased in obese
individuals, have anti-inflammatory properties, and are protective against obesity-related
metabolic disease (17). As obesity develops, adipose tissue mass expands both through
hyperplasia and hypertrophy of adipocytes. However, a limited ability to expand adipose
tissue volume through adipocyte hyperplasia ultimately causes adipocyte hypertrophy to
dominate the expansion process. These hypertrophied adipocytes become fat-laden and
hypoxic, and eventually can undergo necrotic and/or apoptotic cell death, which recruits
other pro-inflammatory cell types including macrophages to the adipose tissue.
Collectively, the adipocytes and associated macrophages secrete pro-inflammatory
cytokines such as TNFα, leptin, interleukin-6, resistin, and others that may have both
paracrine and endocrine effects on metabolism (17).
TNFα in particular is likely to be a major contributor to obesity-related
disruptions in metabolism. For example, TNFα impairs insulin signaling by jun-Kterminal kinase 1-mediated serine phosphorylation of insulin receptor substrate-1 (18).
When adipocytes become resistant to insulin, the release of non-esterified fatty acids
(NEFA) continues unabated in the postprandial state. Increased NEFA concentrations can
overwhelm the ability of other tissues, such as skeletal muscle, to completely metabolize
them. This can lead to the build-up of intramyocellular lipids and their by-products
diacylglycerol and ceramide, which impair insulin signaling (18). TNFα also contributes
to the pathogenesis of hepatic insulin resistance and enhances the expression of vascular
adhesion molecules, which further increases the risk of developing T2D and CVD,
respectively (17, 18). Many other pro-inflammatory cytokines are mechanistically linked
to the etiology of chronic metabolic diseases, and the reader is referred to a number of
excellent reviews on the topic (12, 17, 18).
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1.2.3

Obesity and Type 2 Diabetes
Obesity and weight gain are widely accepted as major contributing factors to the

development of T2D in men and women, and these relationships are almost certainly
mediated in part through the inflammatory processes described above. Data from the
Health Professionals Follow-Up Study (a long-term, prospective study of over 50,000
U.S. male health professionals) indicated that men aged 40-75 years with a BMI ≥ 35.0
kg/m2 had a multivariate-adjusted relative risk of 42.1 for developing T2D after 5 years
of follow-up compared to similarly aged men with a BMI < 23.0 kg/m2 (19). The Nurses’
Health Study (a long-term prospective study of over 100,000 female registered nurses)
found similarly strong relationships between obesity and weight gain and incident
diabetes in women. Over 14 years of follow-up, those who attained a BMI of ≥ 35.0
kg/m2 had a relative risk of 93.2 for developing T2D compared to women with a BMI <
22.0 kg/m2. When weight gain was statistically controlled for, the relative risk of
developing T2D for women with a BMI of ≥ 35.0 kg/m2 at age 18 was reduced to 13.5
compared to women with a BMI < 22.0 kg/m2. While this still represents a dramatically
increased risk of T2D, the attenuation of the relative risk by controlling weight gain
highlights the importance of preventing weight gain in the development of T2D. On the
other hand, those who lost > 5.0 kg during the follow-up period reduced their risk of T2D
by more than 50% (20).
The positive influence of behavioral interventions on incident diabetes was
reinforced by the results of the Diabetes Prevention Program (21), which compared the
effectiveness of a high intensity lifestyle intervention and daily metformin to prevent or
delay the development of diabetes in nondiabetic adults with impaired glucose tolerance.
Over a mean follow-up of 2.8 years, both the lifestyle intervention and metformin
reduced the incidence of T2D compared to placebo, but the lifestyle intervention was
more effective than metformin (58% vs. 31% reduction in risk) (21).
1.2.4

Obesity and Cardiovascular Diseases
Evidence from the Framingham Heart Study demonstrated that overweight status

was associated with an approximately 20% increased risk of CVD for both men and
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women. Obesity was associated with a 46% and 64% increased risk in men and women,
respectively (22). Unlike T2D, results from a 2011 meta-analysis indicate that the
measurement of waist circumference or waist-to-hip ratio does not improve the prediction
of CVD risk compared to BMI (23). Although results from the EPIC study did conclude
that waist-to-hip ratio was a better predictor of myocardial infarction than BMI (24). A
more recent meta-analysis confirmed the relationships between BMI and coronary heart
disease (relative risk: 1.27 for each 5kg/m2 higher BMI) and stroke (relative risk: 1.18).
However, it was determined that elevated blood pressure and concentrations of
cholesterol and glucose accounted for approximately 50% of the association between
BMI and CVD. Elevated blood pressure was the most important mediator of BMIassociated risk and accounted for 31% of the excess risk of coronary heart disease and 65%
of the excess risk for stroke. However, it is important to note that increased BMI was still
positively associated with coronary artery disease and stroke risk even after accounting
for the mediating effects of blood pressure, cholesterol, and glucose (25).
Weight loss improves CVD risk factors including blood pressure (26, 27), lipid
profile (28, 29), and markers of chronic low-grade inflammation (30-33). However, the
role of weight loss in modulating CVD morbidity and mortality are less well-defined. For
example, the Look AHEAD trial was designed to investigate the effects of an intensive
lifestyle intervention that promoted weight loss on CVD events in overweight or obese
patients with T2D. After a median follow-up of 9.6 years, the intervention was successful
in producing 6.0% weight loss, but the study was ended prematurely because CVD
morbidity was not different between the intervention and control groups (34). However,
data from the Swedish Obese Subjects study (a non-randomized prospective study)
indicated that bariatric surgery reduced the risk of CVD events compared to controls who
received usual care within the Swedish medical system (35, 36). Regarding the risk of
mortality, some meta-analytical findings suggest that weight loss is associated with
increased all-cause mortality, but the authors concluded that this seemingly paradoxical
relationship was likely confounded by unintentional weight loss (37). Intentional weight
loss, on the other hand, decreases the risk of all-cause (38) and CVD mortality (39).
Collectively, these data support the beneficial role of intentional weight loss on CVD risk
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factors in overweight and obese individuals, and purposeful long-term weight loss
maintenance is likely to reduce the risk of CVD events and CVD-related mortality.
However, longer-term randomized controlled trials are necessary to confirm this assertion,
although the logistical feasibility (e.g. cost, duration) of conducting such research needs
to be considered.
1.2.5

The Metabolically Healthy Obese Phenotype
While a substantial body of evidence supports a causal role of excess weight on

the development of T2D and CVD risk factors, others have noted the existence of a subgroup of approximately 30% of obese individuals who, despite excess adiposity, maintain
a healthy metabolic profile. This phenotype has been termed “metabolically healthy
obese” (MHO) and these individuals are characterized by normal insulin sensitivity, lipid
profiles, blood pressure, and inflammatory status (40). Studies have indicated that MHO
is associated with decreased ectopic fat storage (40) and higher adiponectin
concentrations (41) compared to metabolically unhealthy obese individuals, which may
provide some mechanistic insight into the origins of the MHO phenotype. Some
investigators, most prominently Steven Blair and his colleagues, have argued that the
relationships between obesity and metabolic disease and mortality risk is virtually
abolished when the investigators account for the influence of cardiorespiratory fitness
(42-44). However, others have found that high levels of physical activity do not fully
protect obese individuals from the risk of developing T2D and CVD risk factors (45).
Meta-analytical data also demonstrate that individuals with the MHO phenotype are at
high-risk of developing T2D, especially in studies with follow-up periods of ≥ 10 years
(46, 47). Furthermore, obesity is strongly associated with non-metabolic conditions such
as osteoarthritis and obstructive sleep apnea regardless of metabolic profile (40). These
data collectively suggest that weight loss should be encouraged in obese individuals,
regardless of their current metabolic profile or level of cardiovascular fitness.
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1.3

Obesity Treatment Options

Individuals who have decided to engage in purposeful weight loss are faced with
myriad options for achieving their goals, and the benefits, limitations, and risks of each
approach are not always readily apparent. In the following section, approaches for weight
loss will be broadly grouped as behavioral/lifestyle, pharmacological, and surgical for the
sake of comparison. However, it is important to recognize that a variety of approaches to
weight loss are available within each of these broad categories (e.g. energy restriction vs.
exercise vs. combination therapies, types of weight loss drugs, Roux-en-Y vs. sleeve
gastrectomy vs. gastric banding) and also that these approaches are often used in
conjunction with one another (e.g. energy restriction plus pharmacological). While a
comprehensive review and comparison of available obesity treatment options is beyond
the scope of this review, numerous meta-analyses and systematic reviews have been
published on the topic (referenced below).
1.3.1

Behavioral Approaches for Weight Loss
Behavioral or lifestyle interventions for the treatment of obesity are comprised of

dietary energy restriction, increased physical activity/exercise, and cognitive behavioral
therapy either alone or in some combination of these three strategies. Regarding dietary
energy restriction, much research has been focused on whether the macronutrient content
of the diet alters weight loss outcomes. For studies lasting 12 weeks on average, a higher
protein diet is associated with greater weight loss, fat loss, and reducing fat-free mass loss
compared to standard protein diets (48). However, these beneficial effects of a high
protein diet may not be maintained in studies lasting ≥ 12 months (49). Some evidence
suggests that the low-carbohydrate Atkins diet may result in greater weight loss
compared to other commercial diets (50) and a low-fat diet (51) that persists up to 1 year.
However, a meta-analysis of the effects of “named diets” (such as the Atkins, Zone,
South Beach, Weight Watchers, and Ornish diets) on weight loss demonstrated that
overall differences in weight loss after 6 and 12 months among diets were small (52).
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Similarly, results from the POUNDS LOST study demonstrated that subjects
assigned to a low fat/average protein, low fat/high protein, high fat/average protein, and
high fat/high protein diets achieved similar weight loss over the 2 year study period (53).
However, it is important to note that none of the groups in the POUNDS LOST study
were able to achieve the dietary goals of their respective diets, and by 2 years the
percentage of energy from protein was similar in all 4 groups (range: 19.6 – 21.2%
protein) (53). Due of the lack of long-term studies with sufficient dietary controls and
adherence, it is not possible to conclude whether the apparent lack of differential effects
on weight loss among diets is the result of a true equivalence of the diets or simply a
result of poor dietary adherence. Long-term studies with strict dietary control and
intensive counseling are necessary to definitively characterize the importance of
macronutrient content on weight loss and metabolic health, but such studies may be
hindered by cost, feasibility, and, therefore, a lack of translational potential to widespread
clinical practice.
As such, current guidelines for the management of overweight and obesity in
adults simply state that an energy deficit is required to achieve weight loss and that a
variety of dietary approaches can be utilized to achieve the deficit (54). Of course, an
energy deficit can also be achieved by increasing energy expenditure via increased
physical activity, but most evidence to-date suggests that exercise alone is only modestly
effective at reducing measures of adiposity (55). However, combination interventions that
include dietary energy restriction and increased physical activity are more effective for
achieving long-term weight loss than either diet- or physical activity-only interventions
(56, 57). The addition of intensive behavioral therapy/counseling further improves weight
loss outcomes (57) and a reduced-calorie diet, increased physical activity, and the use of
behavioral strategies to improve dietary and physical activity adherence are considered to
be necessary components of comprehensive lifestyle interventions for weight loss (54).
Historically, the cost of such high-intensity lifestyle interventions and lack of
insurance coverage for intensive behavioral therapy for obesity have limited the clinical
utilization of such interventions (58). However, the Center for Medicare & Medicaid
Services recently began offering intensive behavioral therapy for Medicare beneficiaries.
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The intensive behavioral therapy model allows for a total of 22 visits per year (59), which
is similar to that of the Diabetes Prevention Program (21) and is congruent with the
American College of Cardiology/American Heart Association guidelines for the
management of overweight and obesity in adults (54). Future research utilizing this
model for the behavioral treatment of obesity should be encouraged to determine whether
this model is effective and economically viable more broadly in clinical practice.
1.3.2

Pharmacological Approaches for Weight Loss
It is generally recommended that overweight or obese individuals attempt weight

loss through behavioral modification(s) prior to utilizing pharmacological (60) or surgical
means (54). Even when these more invasive approaches are employed, dietary and
physical activity advice is still provided to research subjects and patients. For
pharmacological interventions, both the treatment and control (placebo) groups are
provided with lifestyle modification advice. Therefore, these trials are testing whether the
medications provide additional benefit relative to lifestyle modification and are
recommended as adjunctive treatments to lifestyle interventions rather than stand-alone
treatments (60).
As of December 2014, there are 7 FDA-approved drugs for weight management
with various mechanisms of action (Figure 1.3). Most of these medications ultimately
influence anorexigenic or orexigenic signaling and are thought to help improve adherence
to lifestyle intervention programs. One drug (orlistat) blocks the absorption of the dietary
fat (60).Two of the FDA-approved drugs (phentermine resin and diethylpropion) are
approved for short-term (3 months) use and were found to result in approximately 3 kg of
additional weight loss compared to placebo. The remaining 5 drugs are approved for
chronic weight management. Administration of orlistat and lorcaserin were both found to
result in approximately 3 kg of additional weight loss at 1 year, while liraglutide (an
injectable glucagon-like peptide-1 [GLP-1] agonist) and Qsymia (a combination of
phentermine and topiramate) resulted in approximately 6 kg of additional weight loss
after 1 year. Contrave (a combination of naltrexone and bupropion) reduced body weight
by an additional 4.8% compared to placebo at 1 year (60). It is acknowledged that weight
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gain is likely to occur when the use of these drugs are discontinued. However, the lack of
persistent action after medication discontinuation is common among many drug classes
(e.g. anti-hypertensive medications) and weight loss medications are therefore
recommended as an adjunctive therapy to lifestyle interventions for long-term weight
management in obese individuals as well as those with a BMI ≥ 27 kg/m2 with at least 1
existing comorbidity (e.g. hypertension, dyslipidemia, T2D, sleep apnea) who have been
unsuccessful with lifestyle-only approaches (60).

Figure 1.3. Antiobesity agents and their mechanism of action (60)

1.3.3

Surgical Approaches for Weight Loss
Individuals with a BMI ≥ 40 kg/m2 and those with a BMI ≥ 35 kg/m2 with

existing obesity-related comorbidities are likely candidates for bariatric surgery if
previous behavioral and/or pharmacological weight loss interventions were unsuccessful.
A number of bariatric surgeries are currently in use and they all have associated benefits,
limitations, and risks. Broadly speaking, bariatric surgeries cause weight loss by
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restricting the amount of food that can be eaten at a given eating occasion and/or altering
the ability of the body to absorb nutrients and energy in the ingested foods (61, 62).
Laparoscopic Roux-en-Y gastric bypass is the most commonly performed bariatric
surgery procedure and induces weight loss through both restrictive and malabsorptive
mechanisms. In this procedure the stomach is reduced to a 15 – 30 mL pouch (restrictive)
and the small intestine is attached to the newly created pouch distal to the duodenum
(malabsorptive) (62). The sleeve gastrectomy and adjustable gastric banding are
examples of surgical bariatric procedures that leave the entire small intact and in-place
and thus cause weight loss by restrictive mechanisms. In the case of the sleeve
gastrectomy, the greater curvature of the stomach is removed to create a tubular section
of stomach (62). Adjustable gastric banding leaves the entire gastrointestinal system
intact, but the amount of food that can be consumed by the patient is limited by creating a
30mL pouch by placing an adjustable collar or band 1-2 cm below gastroesophageal
junction (62). Biliopancreatic diversion is another bariatric surgery procedure that is often
performed with a sleeve gastrectomy (biliopancreatic bypass with duodenal switch). Like
Roux-en-Y gastric bypass, this procedure produces weight loss through both
malabsorptive and restrictive mechanisms (62).
Regardless of the type of bariatric surgery utilized, weight loss is substantially
greater and more persistent compared to all non-surgical weight loss approaches. In a
2013 meta-analysis, Gloy et al. (63) reported 26 kg greater weight loss with surgical vs.
non-surgical treatment for severe obesity. However, an earlier meta-analysis (64) found
that weight loss varied considerably among procedures. Across all techniques, patients
lost an average of 61.2% of their excess body weight after bariatric surgery, but patients
who underwent gastric banding lost 47.5% of their excess weight, gastric bypass
procedures resulted in the loss of 61.6% of excess weight, and 70.1% of excess weight
was lost following biliopancreatic diversion or duodenal switch procedures (64).
Furthermore, diabetes remission rates and metabolic syndrome components were
improved to a greater extent following the malabsorptive and restrictive plus
malabsorptive procedures compared to the restrictive-only procedures (64).
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Overall mortality within 30 days of the procedure was low, but did demonstrate
procedure-specific differences. Mortality was lowest for the purely restrictive procedures
(0.1%), 0.5% for gastric bypass patients, and highest (1.1%) in those undergoing
biliopancreatic diversion or duodenal switch procedures (64). The systematic review
completed as part of the American College of Cardiology/American Heart Association
guidelines for the management of overweight and obesity confirmed the results of the
previous meta-analysis and recommended that patients who were previously unsuccessful
with behavioral and/or pharmacological approaches for weight loss be advised that
bariatric surgery may be an appropriate option for weight loss and health improvement
(54). The expert panel also acknowledged that the choice of bariatric procedure may be
affected by a number of factors including age, severity of obesity, presence of comorbid
conditions, etc. that need to be considered by the potential patient and his/her medical
team (54).
1.3.4

Weight Regain
Weight regain is widely prevalent following weight loss regardless of which

technique(s) was/were employed to achieve the initial weight loss (60, 65, 66). Data from
high-intensity long-term dietary intervention studies suggest that the degree of weight
loss peaks around 6 months and then weight is gradually regained over the next 18
months (50, 53). A systematic review of diet and diet plus aerobic exercise studies with
long-term follow-up measurements concluded that participants regain approximately 55%
of the initial weight lost during the active weight loss phase of trials (65). A number of
physiological mechanisms have been proposed to explain the reasons for weight regain in
overweight and obese adults. Broadly, MacLean et al. (67) describe 4 systems
influencing body weight regulation; homeostatic or biological systems, behavioral
choices by the individual, the environment, and the individuals unique genetic
background (Figure 1.4). In this model, biology does not strongly defend against weight
gain and allows a gradual upward drift in “steady-state” body weight. However, weight
loss through behavioral and/or environmental modifications prompts the homeostatic
system to adapt to these perturbations in an attempt to maintain a “steady-state.” During
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weight loss maintenance, the individual must adhere to and possibly intensify behavioral
and/or environmental weight loss/maintenance strategies to counteract these homeostatic
adaptations (67). Biological adaptations that promote weight regain ultimately act
through either suppressing energy expenditure (e.g. decreased resting metabolic rate and
drive to be physically active) or increasing energy intake (e.g. enhanced appetite and
sensitivity to environmental food cues) (67, 68). These adaptations are at least partially
mediated through weight loss-induced changes in circulating hormones (e.g. leptin,
insulin, ghrelin) that are interpreted by regions of the brain associated with homeostatic
regulation (e.g. hypothalamus and hindbrain) and reward and motivation (e.g. striatum,
amygdala, insula, orbitofrontal cortex) (67, 68).

Figure 1.4. Biology’s influence during obesity development, treatment, and relapse (67)
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1.4

Homeostatic Model of Ingestive Behavior and Energy Balance

The study of ingestive behavior and regulation of energy balance has evolved
greatly over time, especially in the last 40 years (as reviewed by Stephen Woods (69)).
An intuitive homeostatic model of energy balance regulation was popularized in the late
1990s and early 2000s whereby the hypothalamus interprets a complex system of
metabolic signals to match energy intake and expenditure and prevent weight gain or loss
(70). However, the role of the hypothalamus in the homeostatic regulation of energy
balance has been investigated since at least the early 1940s (71) and remains a central
player in the field today (72). The arcuate nucleus of the hypothalamus in particular
appears to be of critical importance for interpreting metabolic signals of both long- and
short-term indicators of energy balance, which ultimately influence behavior to adjust
food intake and/or energy expenditure up or down as needed. Two major classes of
neurons are present within the arcuate nucleus of the hypothalamus and they have
opposing functions as regards the central regulation of energy balance. Proopiomelanocortin (POMC) neurons decrease food intake while neuropeptide Y/agoutirelated protein (NPY/AgRP) neurons enhance food intake (72-74). POMC and
NPY/AgRP neurons are both sensitive to circulating metabolic signals representing acute
(75) and long-term (72, 74) energy balance and form a complex and interactive system
for the maintenance of energy homeostasis (Figure 1.5).
1.4.1

Long-Term Indicators of Energy Balance
Insulin and leptin have been described as long-term indicators of energy balance

because both hormones circulate in proportion to the degree of adiposity during periods
of energy balance and weight stability. However, plasma insulin and leptin
concentrations are hypersensitive to acute changes in energy balance and body weight,
and display greater-than-predicted increases with overfeeding and weight gain and,
conversely, decreases with energy restriction and weight loss (67, 72). Receptors for
insulin and leptin are present in high densities in the arcuate nucleus of the hypothalamus
where they have complimentary effects on the suppression of energy intake and increase
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in energy expenditure (72-74). Insulin and leptin reduce energy intake by the dual actions
of receptor-mediated inhibition of the NPY/AgRP neurons and stimulation of the POMC
neurons (72-74).

Figure 1.5. Neuroanatomical model of pathways by which adiposity signals, leptin, and
insulin interact with central autonomic circuits regulating meal size (70)

Positive energy balance and weight gain – specifically fat mass gain – cause
insulin and leptin concentrations to increase, which should act to decrease energy intake,
increase energy expenditure, and prevent continued weight gain and promote weight loss.
These actions are achieved by stimulation of POMC neurons by insulin and leptin.
POMC is a precursor to α-melanocyte stimulating hormone, which binds to melanocortin
receptors in anorexigenic hypothalamic regions including the paraventricular nucleus.
Insulin and leptin also inhibit NPY/AgRP neurons, which stimulate food intake both by
inhibiting the anorexigenic actions of POMC neurons and by stimulating orexigenic
neurons in lateral hypothalamus (72-74). Therefore, insulin and leptin suppress food
intake by directly enhancing the anorexigenic actions of POMC neurons and suppressing
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orexigenic actions of NPY/ApRP and indirectly by diminishing NPY/AgRP-mediated
inhibition of POMC neurons. Not surprisingly, there was substantial interest in the
potential for leptin as a potential therapeutic agent for weight loss. However, it soon
became apparent that obesity is associated with a state of leptin resistance – similar to
insulin resistance – whereby circulating levels of leptin increase with obesity but the
physiological responses to leptin are blunted (67).
Conversely, negative energy balance or weight/fat loss decrease circulating
concentrations of insulin and leptin and increase ghrelin concentrations (discussed later).
The result is a relative increase in the of activity of NPY/AgRP neurons relative to
POMC neurons, which increases orexigenic drive, suppresses resting energy expenditure,
and even appears to dampen the drive to engage in volitional physical activity (67).
Ultimately, these biological responses to weight loss undermine the individual’s ability to
maintain weight loss and encourage weight regain. Due to the aforementioned
hyperleptinemia and leptin resistance associated with obesity, leptin therapy is not
effective for initiating weight loss in humans. However, leptin therapy may be useful for
helping individuals maintain a lower body weight after the active phase of weight loss. In
the hypoleptinemic state induced by weight loss, exogenous leptin administration may
prevent the reduction in energy expenditure and increase in energy intake that are
typically observed during the weight loss maintenance period (76).
1.4.2

Short-Term Indicators of Energy Balance
While insulin and leptin are primarily considered to be long-term indicators of

energy balance, a number of gut-derived peptides are thought to reflect short-term or
meal-to-meal variations in energy balance (75, 77, 78). To date, ghrelin is the only
identified gut-derived peptide that acts as a “hunger signal” and initiates feeding (77).
Most of these peptides are putative “satiety signals”, meaning that they are thought to
cause meal termination and/or delay the onset of the next eating occasion (75, 78).
Ghrelin is produced by the enteroendocrine cells of the stomach and upper small
intestine. Ghrelin concentrations rise prior to meal initiation and fall rapidly upon food
intake (77, 78). Like insulin and leptin, ghrelin binds to its receptors on NPY/AgRP
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neurons in the arcuate nucleus of the hypothalamus, but has opposing effects on ingestive
behavior and energy expenditure. Ghrelin stimulates NPY/AgRP neurons which
subsequently inhibits insulin/leptin activation of POMC neurons and stimulates
orexigenic neurons in the lateral hypothalamus to reduce energy expenditure and enhance
energy intake (79).
While ghrelin is most often associated with within-day modulation of ingestive
behavior, ghrelin concentrations have also been shown to be decreased with obesity and
increase upon weight loss (80). These broad shifts in ghrelin concentrations with weight
change are therefore likely partially mediating the biological responses to increase or
decrease weight to defend weight stability. However, weight loss-induced elevations in
ghrelin may be modulated by the manner in which the weight was lost. In a group of 13
obese subjects, a 6-month diet-induced weight loss of 17% of initial body weight resulted
in a 24% increase in 24-hour ghrelin area under the curve. However, gastric bypass
resulted in weight loss of 36% of initial body weight and ghrelin 24-hour area under the
curve was greatly suppressed even relative to normal-weight controls and did not
demonstrate the typical meal-induced oscillations seen in normal weight and obese
individuals (81). However, the degree of ghrelin suppression following gastric bypass
displays some between subject variability and a greater suppression of ghrelin is
associated with better long-term weight maintenance (66). This effect on ghrelin
concentrations, presumably caused by the resection of the majority of the stomach, may
be partially responsible for the observed improvement in long-term weight loss
maintenance observed following gastric bypass (82) vs. lifestyle interventions (65).
While ghrelin is the only known gut-derived signal to stimulate feeding, a
number of peptides including cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1),
peptide tyrosine tyrosine (PYY), pancreatic polypeptide, amylin, and glucagon have
purported roles in suppressing food intake (75, 78). CCK is released from endocrine Icells in the upper small intestine via stimulation by ingested amino acids and long-chain
(≥ 11 carbon) free fatty acids. The anorectic effects of CCK are most commonly
associated with satiation (termination of meals) rather than between meal satiety (78).
The exact mechanism by which CCK exerts its effects on energy intake are not fully
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understood, but may be related to its role in slowing gastric emptying. However, CCK
receptors have been identified in many peripheral sites (e.g. vagus nerve, pancreas, gall
bladder, stomach) and within brainstem and hypothalamus that likely contribute its
anorectic effects. In particular, CCK’s interaction with the vagal nerve appears to be
critically important because the ability of peripheral CCK to suppress food intake is
virtually abolished by vagotomy (75, 78). Amylin and glucagon also appear to only affect
food intake through satiation or meal termination as intake at subsequent meals is not
affected by these signals. Like CCK, glucagon’s anorectic effects are dependent upon an
intact vagal nerve. However, vagotomy does not influence the ability of amylin to induce
satiation and it can cross the blood brain barrier, which suggests its effects on food intake
are centrally mediated (78).
Unlike CCK, amylin, and glucagon, concentrations of PYY and GLP-1 do not
peak until after meal termination and remain elevated for several hours into the
postprandial period. Both PYY and GLP-1 are released by L-cells in the distal small
intestine (78). PYY circulates in 2 forms; the full-length PYY1-36 and truncated PYY3-36.
The truncated version of PYY represents the major circulating form and is thought to be
responsible for the anorectic effects of PYY. The mechanism(s) by which PYY reduces
food intake are not fully understood, but are likely to involve both peripheral and central
actions. PYY has long been recognized for its role in nutrient sensing in the distal small
intestine and activation of the “ileal brake.” However, PYY may be able to cross the
blood brain barrier at the median eminence of the hypothalamus where it could act upon
NPY/AgRP neurons within the arcuate nucleus to decrease food intake (75). GLP-1 also
has been shown to promote a feeling of fullness between meals, but also is known to have
insulinotrophic effects on pancreatic β cells (83). Similar to PYY, GLP-1 is likely to
influence food intake through via peripheral and central sites. GLP-1 can bind its receptor
at the stomach to slow gastric emptying, but GLP-1 receptors have also been identified
within the satiety centers of the hypothalamus which have been previously described in
this review (83).
Importantly, administration of exogenous CCK, PYY, and GLP-1 or their analogs
reduces food intake in lean and obese individuals (75, 83). In fact, one of the FDA-
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approved weight loss drugs, liraglutide, is a long-lasting GLP-1 analog (60, 83). These
observations suggest that obesity is unlikely to result from a disruption of the actions of
these gut derived peptides, and that the homeostatic model may be insufficient for
describing the totality of factors influencing energy balance regulation. It is now clear
that a number of non-homeostatic factors contribute substantially to energy balance
regulation, or dysregulation, especially in the obese-state (84).
1.5

Nonhomeostatic Modulation of Ingestive Behavior and Energy Balance

Stanley Schachter was one of the first scientists to study the impact of the external
environment on eating behavior. He observed differences in ingestive behavior between
lean and obese individuals with regard to eating in the absence of hunger and the
influence of external factors. Under the guise of a taste-testing experiment, Schachter first
noted that, as would be expected, lean individual consumed less food in the “full stomach”
compared to “empty stomach” condition. However, obese individuals ate the same
amount in both conditions. Second, the influence of fear on food intake was investigated
by telling the subjects they were assessing the impact of electrical shock on taste
perceptions. Lean individuals markedly reduced their intake in the “high fear” compared
to “low fear” condition, but obese individuals ate slightly more in the “high fear”
condition (85). The results of this now classic experiment clearly demonstrated the
importance of the external environment on eating behavior and suggested that obese
individuals may be affected differently than lean individuals.
Schachter’s observations are still highly relevant in the modern food environment,
which is fraught with contradictory messages regarding what, when, and how much to eat.
The multi-billion dollar weight loss industry is evidence of the desire for weight loss, but
these efforts are hindered by an environment with a plethora of widely available energydense and palatable foods that promote overeating and weight gain. The physical
properties of these foods (e.g. appearance, smell, taste) are received and interpreted by
brain regions associated with reward processing and motivated behavior that influence
food intake (84).
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1.5.1

Overview of Reward Processing
Broadly speaking, a “reward” is anything that is perceived as being pleasurable.

The perception of reward, however, can be further divided into interrelated, yet
experimentally distinguishable, components – ‘liking,’ ‘wanting,’ and learning – that
influence behavior through physiologically distinct mechanisms (86). For a complete
experience of reward, an action or stimulus must be both ‘liked’ and ‘wanted.’ ‘Liking’
without ‘wanting’ is simply a positive affective state, and ‘wanting’ without ‘liking’
constitutes a desire to obtain a stimulus but devoid of sensory pleasure. ‘Wanting’ adds a
component of desire and motivation to obtain the ‘liked’ stimulus (87). Reward learning
occurs over time such that the organism learns to predict the delivery of a reward and can
elicit motivation to obtain the reward.
Under normal circumstances, ‘liking’ is the earliest experienced component of
reward (88). ‘Liking’ of a substance can be difficult to measure, especially in animals,
due to its highly subjective nature. Fortunately, in addition to subjective feelings and
ratings, ‘liking’ can be assessed objectively by evaluating highly conserved ‘likingdisliking’ facial reactions to sweet and bitter tastes. Sweet tastes produce positive ‘liking’
orofacial reactions such as rhythmic tongue protrusions while bitter tastes produce
negative ‘disliking’ reactions such as mouth gapes (89-91). These facial reactions are
similar in human infants and many other animals including non-human primates, mice,
and rats and are therefore likely to be mediated by highly conserved brain circuits (87).
Kent Berridge and his research group have made great use of these facial reactions along
with sophisticated research techniques to identify small “hedonic hotspots” in the nucleus
accumbens shell (92) and ventral pallidum (93), which are causally related to ‘liking.’
In Sprague-Dawley rats, microinjection of µ-opioid agonists such as morphine (92)
or D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO) (94) or anandamide, an
endogenous endocannabinoid (95), into an approximately 1 cubic millimeter sized
subregion of the medial caudal region of the nucleus accumbens shell increased the
number of positive hedonic facial reactions to sucrose and subsequently increased
palatable food intake compared to vehicle injection. A second “hedonic hotspot” has also
been identified in the ventral pallidum, which lies adjacent to the nucleus accumbens
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shell and receives a large limbic system projection from the nucleus accumbens.
DAMGO microinjection into the posterior ventral pallidum increased hedonic ‘liking’
reactions to sucrose and increased palatable food intake by nearly 2-fold compared to
vehicle injection (93). Further evidence for the role of the ventral pallidum in ‘liking’ has
been demonstrated by excitotoxic lesion of the region. Quinolinate lesions to the ventral
pallidum caused rats to exhibit aversive, rather than positive, facial reactions to tasting a
sucrose solution (96). To summarize, these data indicate that opioid and/or
endocannabinoid signaling in specific sites in the medial nucleus accumbens shell and
posterior ventral pallidum are implicated in mediating the ‘liking’ component of reward.
‘Wanting’ is a term for the psychological process of incentive salience. The
incentive salience hypothesis was developed by Kent Berridge and Terry Robinson, and
posits that ‘wanting’ or incentive salience is a motivational state attributed to either an
unconditioned reward (e.g. sweet taste) or to a conditioned stimulus that predicts reward
(88). Accumulating evidence suggests that ‘wanting’ is the reward component mediated
by dopamine action in mesocorticolimbic brain structures (87, 88). However, substantial
debate regarding dopamine’s specific role in reward continues. This section of the review
will focus on dopamine’s role in ‘wanting’ or incentive salience. Alternative hypotheses
for dopamine’s role in reward – such as ‘liking’ and learning – are discussed in numerous
reviews to which the reader is referred for additional information (88, 97-100).
Evidence from both rodent and human models support the theory that dopamine
signaling increases ‘wanting’ for food and drug rewards without altering ‘liking’ or
learning processes. While ‘liking’ for sweet taste seems to be facilitated by specific sites
on the nucleus accumbens shell and ventral pallidum, administration of µ-opioid agonists
such as morphine and DAMGO to the entire nucleus accumbens shell and even regions
outside the nucleus accumbens including the amygdala and neostriatum will increase
dopamine release and subsequently stimulate ‘wanting’ for food and robustly increase
food intake (87). Genetic manipulation of dopamine homeostasis also alters reward
processing and ‘wanting’ for rewards. For example, mice with a dopamine transporter
(DAT) knockdown mutation exhibit synaptic dopamine levels 70% higher than wild-type
mice. These hyperdopaminergic DAT knockdown mice demonstrate heightened ‘wanting’
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for sweet reward as measured via incentive runway performance (decreased time to leave
the start box, decreased pauses on the runway, and resistance to distractions) (101). DAT
knockdown mice also display enhanced motivation to obtain a food reward (chocolate
flavored pellets) as indicated by a higher breakpoint for lever pressing when tested under
a PR7 schedule of reinforcement (102). Importantly, positive hedonic facial reactions to
sucrose (‘liking’) (101) and learning about food reward (102) were unaffected by the
hyperdopaminergic state in DAT knockdown mice.
As regards data in humans, Leyton et al (103) administered an amino acid mixture
deficient in phenylalanine and tyrosine (APTD method) to cause dopamine depletion in a
group of regular cocaine users. APTD decreased both cue and cocaine-induced cravings,
but had no effect on euphoria or ‘liking’ for cocaine once it was administered (103).
Human functional neuroimaging studies provide further evidence for the role of
dopamine in ‘wanting’ for reward. Positron emission tomography (PET) imaging utilizes
radio-labeled tracers to make inferences about neural activity in specific brain regions.
Specifically for dopamine research, [11C]raclopride binds to dopamine type-2 receptors
(D2R) but with a lower affinity than dopamine. Due to the differences in binding affinity,
changes in synaptic dopamine levels can be inferred based on the displacement of
[11C]raclopride from the D2R. Exposure to a cocaine-related video depicting the
acquisition and use of cocaine was shown to cause significant displacement of
[11C]raclopride (increase in synaptic dopamine) within the dorsal striatum in two
independent PET imaging studies. Importantly, the magnitude of the decrease in
[11C]raclopride binding was inversely related to the intensity of cocaine craving in both
studies (104, 105). Functional Magnetic Resonance Imaging (fMRI) is another commonly
used neuroimaging technique. Numerous fMRI studies evaluating the relationship
between the fMRI-measured responses to various drug-related cues and subjective ratings
of craving have been conducted, and the results are generally consistent. Heightened
responses in mesocorticolimbic and other reward-related structures to cues related to
heroin (106, 107), cocaine (108-110), nicotine (111), marijuana (112), and alcohol (113)
have been shown to be positively related to subjective craving scores for the respective
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drug amongst current users. Collectively, data from animal models and human clinical
studies support a role of dopamine in ‘wanting’ component of reward processing.
The third component of reward is learning, which occurs over time as the
individual (human or animal) begins to learn and predict the timing of a reward based on
the cues that precede it. Pavlov observed this phenomenon in his classic salivating dog
experiment. The dogs began salivating upon ringing of the bell once the dogs learned that
the ringing bell predicted the delivery of food (114). Contemporary neuroscience
supports Pavlov’s observations and suggests that dopamine may play a role in reward
learning. As learning takes place, the peak in phasic dopamine release shifts from the
time of reward receipt to the time of the cue that predicts the delivery of the reward.
Furthermore, dopamine release is suppressed at the expected time of reward receipt if a
reward-predictive cue is presented but no reward is delivered (115). It is worth repeating
and emphasizing that ‘liking,’ ’wanting,’ and learning are experimentally distinguishable
components of reward processing, but that they are highly interrelated. An alteration to
one reward component undoubtedly influences the other 2 components and ultimately the
perception of reward. For example, a learned cue that predicts reward delivery will be
more powerful when ‘wanting’ for the reward is greater (e.g. food deprivation, drug
withdrawal) compared to states of low incentive salience (116).
1.5.2

Reward-Associated Brain Regions
The complexity and interactive nature of reward processing is reflected by the

numerous brain regions that mediate these behavioral characteristics. As mentioned in the
preceding paragraphs, the ventral tegmental area, nucleus accumbens, and ventral
pallidum are critical for ‘liking’ and/or ‘wanting’ in reward processing. However, many
additional brain regions further contribute to the perception or experience of reward. The
following paragraphs are meant to discuss the mesolimbic dopamine system and specific
brain regions identified as a priori regions of interest for the studies described in this
dissertation document and their roles in reward processing. Therefore, the regions
discussed below should not be interpreted as a comprehensive review of rewardassociated brain regions.
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Although debate continues on the specific role of mesolimbic dopamine in reward
processing, there is general consensus that this system is, in some way, critical for
mediating motivation to obtain rewards. Mesolimbic dopamine originates in the ventral
tegmental area and projects primarily to the nucleus accumbens within the ventral
striatum. However, dopaminergic neurons from the ventral tegmental area also project to
the amygdala, lateral hypothalamus, bed nucleus of stria terminalis, and lateral septal area
(117). Afferent projections to the ventral striatum include the aforementioned
dopaminergic projection from the ventral tegmental area, but also include projections
from the ventromedial prefrontal cortex, orbitofrontal cortex, anterior cingulate cortex,
insula, amygdala, hippocampus, and the midline nuclei of the thalamus (118). The
importance of the nucleus accumbens in reward processing was highlighted by Di Chiara
and Imperato (119) when they demonstrated that administration of drugs commonly
abused by humans (opiates, ethanol, nicotine, amphetamine, and cocaine) resulted in
substantially increased synaptic dopamine concentrations in the nucleus accumbens of
free-living rats. PET imaging studies in humans have since demonstrated that dopamine
concentrations in the nucleus accumbens increase both when drugs of abuse are
administered and when current drug users are presented with relevant drug-related cues
(120). Similar to drugs, the receipt of natural rewards such as novel and palatable foods
causes dopamine release in the nucleus accumbens of rodents (121). Data from human
neuroimaging studies reinforce the animal models and demonstrate that the ingestion of
palatable food as well as the anticipation of receiving palatable foods increases ventral
striatal activity (111, 122, 123).
Traditionally, neuroscience has segregated brain dopamine function into two
discreet systems; the aforementioned mesolimbic (or more expanded mesocorticolimbic
system) and its role in reward and motivation and the nigrostriatal system, which
originates in the substantia nigra, projects primarily to the dorsal striatum, and is most
commonly associated with motor control and the etiology of Parkinson’s disease (100).
This tendency to functionally separate the mesolimbic and nigrostriatal dopamine
systems persists even though anterograde and retrograde tracing studies have
demonstrated overlapping projection fields and anatomical origins of both dopamine
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“systems” (100). Further evidence for the role of nigrostriatal dopamine and the dorsal
striatum (caudate and putamen) in reward comes from electric brain stimulation studies,
which identified reward sites within both the substantia nigra and ventral tegmental area
(100). The dorsal striatum and its interactions with prefrontal brain regions may be
especially important for mediating the formation of habits, which may drive compulsive
reward seeking behavior (124, 125). Lesions to the dorsolateral striatum decreased lever
pressing by rats following devaluation of the predicted sucrose reward compared to sham
operated or rats with lesions to the dorsomedial striatum, which provides evidence of the
dorsal striatum’s role in habit formation (125). Data from human neuroimaging studies
further supports the role of the dorsal striatum in reward processing. Presentation of a
video depicting cocaine use elicited dopamine release in the caudate and putamen in a
group of active cocaine addicts, and dopamine release in these structures was correlated
with craving ratings (104). Similar responses were observed following the consumption a
“favorite meal.” Increased dopamine release was observed in the dorsal putamen and
dorsal caudate that was correlated with perceived pleasantness of the meal (126).
The orbitofrontal cortex may be particularly important for modulating motivated
behavior to obtain rewards. The orbitofrontal cortex receives sensory input including
gustatory, visual, olfactory, auditory, and somatosensory information that allows the
individual to form reward value predictions. The orbitofrontal cortex also receives major
projections from the amygdala, anterior cingulate cortex, and hippocampus, which
suggests that reward-related emotions and memories also be relayed to the orbitofrontal
cortex for refining predictions of reward value (127). A major role of the orbitofrontal
therefore appears to be integrating reward-related cues and making informed predictions
about the outcomes of behavioral decisions. Further evidence of this role in reward
processing is supported by observations that damage to the orbitofrontal cortex impairs
the ability of monkeys to learn and respond normally to cues that predict forthcoming
rewards (128). Orbitofrontal cortex responses to food-related cues have previously been
shown to be decreased when non-human primates (129) and humans (130) are sated
compared to when they are hungry. Importantly, the decrease in reward value is more
pronounced for the food(s) that were eaten to satiety compared to other, more acutely
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novel, foods, which suggests that the orbitofrontal cortex may be especially important for
the experience of sensory-specific satiety (130, 131).
The amygdala is an almond-shaped component of the brain’s limbic system with
functions related to emotion, reward, motivation, learning, memory, and attention.
Historically, the amygdala was thought to contribute primarily to negative affect and
encoding fear and encouraging avoidance behavior, but more recent data supports a
major role of the amygdala in positive affect as well (132). The amygdala interacts with
the orbitofrontal cortex and sensory-related brain regions to further adjust motivation to
pursue a reward by weighing possible negative and positive outcomes (118, 132). The
basolateral amygdala also promotes reward-seeking behavior through a direct interaction
with the nucleus accumbens. Evidence from a disconnection experiment in rats
demonstrated important features of the nature of the interaction between the amygdala
and nucleus accumbens. The results of this experiment revealed that reward-related cues
elicited responses in the amygdala that preceded responses in the nucleus accumbens and
amygdalar input is required for the nucleus accumbens to respond to the cue and initiate a
behavioral response (133).
The insula is characterized by numerous and varied connections throughout the
brain that contribute to its role in interoception, which refers to the mapping of bodily
states that are important for maintaining homeostasis (134). The insula has been
subdivided into a posterior, granular region and an anterior, agranular region, which have
functions related to somatosensory, vestibular, and motor integration and emotion and
motivation, respectively (135). To support these functions in motivated behavior, the
anterior insula has reciprocal connections to the anterior cingulate cortex, ventromedial
prefrontal cortex, amygdala, and ventral striatum. The anterior insula receives strong
dopaminergic innervation, contains a high concentration of endogenous opioids, and has
a high density of dopamine and µ-opioid receptors that likely contribute to its role in
reward processing (135). In addition to interpreting current bodily states, the insula is
involved in the recall of previous bodily states induced by particular behaviors and in
comparing bodily states resulting from contrasting behaviors that guide decision making.
Collectively these functions related to interoception all contribute to the insula’s role in
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motivated behavior and addiction (136). As regards food intake, the insula may signal
conscious pleasure while ingesting palatable foods, recall that state of conscious pleasure
when exposed to cues related to palatable foods, and weigh the potential bodily states
resulting from choosing whether or not to consume the palatable foods. The insula has
been proposed to have a particularly important role in relapse of drug use/abuse because
of this ability to recall and compare the bodily states resulting from drug use or to an
alternative goal (e.g. keeping a job, jail) (136). It is therefore possible that the insula may
also have a similar role in the decision to adhere to the dietary and/or physical activity
recommendations of a weight loss intervention.
Collectively, these brain regions and others work interactively to encode reward
value – including food reward – and influence motivated behavior to obtain rewards
(137). Evidence from human functional neuroimaging studies have demonstrated that
reward-related brain regions are responsive visual (111, 138) and olfactory (139, 140)
food stimuli, the receipt of palatable foods (122), and also to manipulations of
hunger/satiety (141, 142). Further, obese individuals demonstrate differential rewardrelated responses to food cues (137, 138) and alterations in resting-state activity in
networks associated with reward and ingestive behavior (143-146).
1.5.3

Human Studies: Responses to Visual and Olfactory Food Cues
The use of functional magnetic resonance imaging (fMRI) to investigate neural

reward responses to food stimuli has increased dramatically in recent years, especially
since 2009 (138). The most commonly employed fMRI paradigm utilizes a block design
to present images of foods (typically high-calorie or energy dense foods) and neutral,
nonfood images such as landscapes or tools. Meta-analytical findings from these studies
demonstrate that visual food stimuli elicit greater neural responses compared to nonfood
stimuli in many reward-related brain regions including the insula, amygdala, orbitofrontal
cortex, and striatum that are also responsive to smoking-related cues in current smokers
(111). Cross-sectional comparisons have also consistently demonstrated that visual food
stimuli elicit greater neural reward responses in obese compared to normal weight
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individuals (137, 138), which would be interpreted as representing increased reward
value of food cues and motivation to obtain food in obese individuals.
Longitudinal studies suggest that disrupted neural food cue processing may
precede and predict future changes in body weight. For example, lateral orbitofrontal
cortex responses to visual cues predicted future increases in BMI over a 1y follow-up
period in a group of 39 adolescent girls (Figure 1.6) (147). In another study of first-year
undergraduate female students, nucleus accumbens responses to visual food cues were
predictive of weight gain over 6 mo of follow-up (148). Further, neural reward responses
to visual food cues may predict the degree of success in a weight loss intervention. For
example, those who were least successful at losing weight in a 12 wk weight loss
intervention had greater pre-intervention responses to visual food cues in the nucleus
accumbens, anterior cingulate cortex, and insula. After 9mo of follow-up, greater postintervention responses in the insula, ventral tegmental area, putamen, and fusiform gyrus
were predictive of less successful weight loss maintenance (149).

Figure 1.6. Activation in the orbitofrontal cortex (OFC) in response to orientation to
appetizing food cues was related to future increases in BMI (147)
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While visual food stimuli is currently the most commonly used method for
investigating neural reward influences on ingestive behavior, similar results have been
observed with an olfactory food cue paradigm. In 5 normal-weight and 5 obese
individuals, appealing food odors compared to nonfood odors elicited responses in the
insula, operculum, anterior and posterior cingulate, and ventral striatum. Differences in
brain responsivity to the olfactory cues were also observed between lean and obese
individuals. Greater responses in the hippocampus/parahippocampal gyrus were observed
in obese individuals while lean individuals demonstrated greater responses in the
posterior insula (139). A subsequent study by the same research group found that food
odors produced greater responses than nonfood odors in many reward-related brain
regions including the medial prefrontal cortex, left lateral orbitofrontal cortex, and
inferior insula (150). However, a more recent comparison of normal-weight and obese
women found that both food and nonfood odors elicited robust responses in the ventral
frontal cortex. Among normal-weight individuals, food odors caused greater responses in
the ventromedial prefrontal cortex than nonfood odors after a 24 hr fast. On the other
hand, no a priori regions of interest (ventromedial prefrontal cortex and lateral
orbitofrontal cortex) displayed a differential response to food vs. nonfood odorants in
obese subjects. Perhaps most interestingly, the consumption of a satiating lunch led to
differences in peak responses in the left orbitofrontal cortex and right ventromedial
prefrontal cortex of normal weight subjects. However, this observed effect was largely
driven by meal-induced changes in the response to nonfood, rather than food, odors.
These results suggest that hunger may cause a relative devaluation of nonfood cues rather
enhancing the reward value of food-relevant stimuli (140).
1.5.4

Human Studies: Consummatory Responses to Palatable Food
Measuring neural consummatory responses to palatable food is another common

paradigm for the assessment of neural reward influences on obesity risk. In this paradigm,
a small amount of a palatable liquid or semi-liquid substance (e.g. sweetened liquid,
chocolate milkshake) or a tasteless solution (e.g. artificial saliva) is injected into the
subject’s mouth. Similar to visual food stimuli paradigm, the primary contrast of interest
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is the comparison response elicited by receipt of the food vs. nonfood stimuli. Results
from human neuroimaging studies demonstrate that the receipt of palatable food
compared to tasteless solution results in greater responses in brain regions relevant to
reward and/or gustatory function such as the lateral orbitofrontal cortex, frontal
operculum, insula, and striatum (122, 137). Limited data also indicate that fat and sugar
may differentially modulate responses to palatable food intake. A high-sugar milkshake
elicited greater responses compared to a high-fat milkshake in the insula, operculum, and
thalamus. Conversely, the high-fat milkshake resulted in greater responses in the caudate,
postcentral gyrus hippocampus, and inferior frontal gyrus. These results imply that sugar
may be particularly effective at stimulating brain regions associated with gustation while
the fat may be more effective in stimulating oral somatosensory regions (151).
Evidence from these studies also suggests reward processing alterations are
present in obesity and disruptions in reward processing may precede weight gain and the
development of obesity (122, 137). Cross-sectional data indicate that obese relative to
lean adolescents display greater consummatory responses to palatable food in regions
encoding gustation such as the insula and operculum, but relatively lower responses in
the dorsal striatum (152, 153). Interestingly, observed negative correlations between
dorsal striatal responses and BMI are accentuated in individuals with at least one copy of
the A1 allele at the TaqIA polymorphism of the dopamine D2 receptor gene, which is
associated with decreased dopamine signaling (152). The presence of the A1 allele also
moderated the relationship between dorsal striatal responses and weight gain over a 1yr
follow-up period. An inverse relationship between caudate and putamen activation and
weight change was observed in adolescents with the A1 allele, but was positively related
to weight gain in those without the A1 allele (152). These results indicate that individuals
with at least one copy of the A1 allele are more likely to display hyporeactivity to
palatable food consumption and that the degree of hyporesponsiveness may be predictive
of future weight gain in these individuals. On the other hand, greater striatal responses to
palatable food intake are predictive of weight gain in individuals lacking the A1 allele.
Collectively, these data support potentially distinct pathways in which reward processing
may contribute to weight gain and obesity risk.
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1.5.5

Human Studies: Resting-State Functional Connectivity
Whereas the previous two fMRI paradigms assess the level of responsivity to

sensory stimuli, resting-state functional connectivity analyses seek to identify
synchronous fluctuations of activity in 2 or more brain regions while the subject lays in a
supine position with his/her eyes closed (154). With this paradigm, neural networks
reflecting intrinsic processing have been identified. The default mode network (DMN) is
commonly studied by resting-state fMRI because, unlike other brain networks, activity in
this network increases during periods of internal focus and reflection (154, 155). The
brain regions comprising the DMN have been identified through numerous experimental
approaches including blocked task-induced deactivation, event-related task-induced
deactivation, and hippocampal functional connectivity. Convergence analyses among
these approaches identified the medial prefrontal cortex, posterior cingulate cortex, and
the inferior parietal lobule as key components of the DMN (155). Alterations in DMN
function have are relevant to some mental disorders such as autism, schizophrenia, and
Alzheimer’s disease (155), and others have subsequently demonstrated that obesity is
associated with altered activity within the DMN (144). Specifically, obese relative to lean
individuals demonstrated reduced functional connectivity bilaterally in the
precuneus/posterior cingulate cortex but reduced functional connectivity in the right
anterior cingulate cortex (144). These observed alterations of DMN activity in obesity
may suggest either enhanced or diminished internal focus on bodily states, such as hunger
satiety.
Other brain networks and regions related to reward processing have also been
investigated using resting-state fMRI in relation to obesity. Obesity was associated with
increased putamen functional connectivity within the salience network (143). After an
overnight fast, another research group noted differential functional connectivity between
the amygdala and insula of normal weight and obese individuals. Positive connectivity
between the amygdala and insula was observed in obese subjects, but the connectivity
was negative in normal weight subjects (145). Greater functional connectivity between
the left nucleus accumbens and anterior cingulate cortex and ventromedial prefrontal
cortex were also observed in obese relative to lean women (156). Collectively, results
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from these studies suggest potential enhancement of resting-state reward-related brain
activity that may prime the reward system to respond to food-relevant stimuli in the
environment and drive consumption.
1.6

Interactions between Homeostatic and Nonhomeostatic Systems

While it is common to dichotomize the regulation of ingestive behavior into 2
distinct systems, it is clear that interactions between the homeostatic and nonhomeostatic
systems are present (Figure 1.7) (157). For example, resting-state functional connectivity
between the hypothalamus (a region most typically associated with homeostatic
regulation of ingestive behavior) and bilateral caudate, putamen, and insula (rewardrelated regions) has been observed. Interestingly, it was further noted that the
connectivity between the hypothalamus and these reward-related regions was positive in
obese subjects, but negative in normal weight subjects (145). Other studies have
demonstrated that the administration of “appetite-related” hormones can modulate neural
reward responses to visual food stimuli. For example, in genetically leptin-deficient
adults, leptin replacement reduced neural responses to visual food stimuli in the ventral
striatum (158), insula, and parietal and temporal cortices and increased responses in the
prefrontal cortex (159). Leptin receptors have also been observed in the ventral tegmental
area and supports a direct role of leptin on the modulation of mesolimbic dopamine
signaling (160).
As previously described, ghrelin receptors are abundant within the arcuate
nucleus of the hypothalamus, which supports its role in the homeostatic regulation of
energy balance. However, ghrelin has also been suggested to be a potent modulator of
reward-driven behavior for both natural and drug rewards (161, 162). Like leptin, ghrelin
receptors have been identified on over half of dopaminergic neurons within the ventral
tegmental area and supports of role of ghrelin in modulating mesolimbic dopamine
signaling (161). These potential modulatory effects are further supported by results from
human neuroimaging studies. Intravenous ghrelin administration increased neural
responses to visual food stimuli in the amygdala, orbitofrontal cortex, anterior insula, and
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striatum (163). Considering the apparent overlap between neural homeostatic and
nonhomeostatic systems will be critically important as researchers begin to investigate
potential interventions to modulate neural influences on ingestive behavior.

Figure 1.7. Schematic flow diagram showing the relationship between the classical
homeostatic regulator (dark gray boxes) and neural systems involved in reward, cognitive,
and executive functions (light gray boxes) (157)

1.7

Influence of Dietary Protein on Body Weight, Ingestive Behavior, and Appetite
Increasing dietary protein consumption may represent one such intervention with

potential effects on both the homeostatic and non-homeostatic systems for influencing
ingestive behavior and, ultimately, body weight. Several systematic reviews/metaanalyses have been conducted regarding the effect of higher protein intakes in
randomized controlled trials on body weight/composition and indicators of metabolic
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health (48, 49, 164, 165). The results from these reviews present somewhat conflicting
findings that may be a consequence of differences in study inclusion criteria. The review
by Santesso et al (164) included studies of at least 4 weeks in duration, allowed inclusion
of studies with subjects with hyperlipidemia, hypertension, or metabolic syndrome, and
also allowed inclusion of studies with a concurrent exercise program so long as the cointervention was equally prescribed to both high and low protein groups. However,
studies that increased protein intakes through the use of meal replacements or
supplements were excluded. Using these criteria, Santesso et al reported moderate
beneficial effects of higher protein diets for weight loss, BMI, waist circumference,
systolic and diastolic blood pressure, and fasting high-density lipoprotein cholesterol
(HDL-C), insulin, and triglycerides. Although the effects on HDL-C and insulin were
abolished and the effect on triglycerides was attenuated when studies with a high risk for
bias were excluded. Conversely, higher and lower protein diets did not differentially
affect total cholesterol, low-density lipoprotein cholesterol (LDL-C), C-reactive protein,
glycated hemoglobin, fasting glucose, and markers of bone and kidney health (164). In a
separate meta-analysis, Wycherley et al (48) used similar inclusion criteria but excluded
studies with a concurrent exercise intervention. In this analysis, high protein diets
resulted in greater deceases in body mass, fat mass, and triglycerides and attenuated
reductions in fat-free mass and resting energy expenditure compared to low or standard
protein diets. However, no impact on other indicators of metabolic health (glucose, blood
pressure, total cholesterol, LDL-C, HDL-C) were observed (48). Finally, Schwingshackl
and Hoffman (49) included only studies with a minimum of 1 year follow-up and
concluded that higher protein diets did not result in long-term favorable outcomes related
to body weight/composition or metabolic health indicators compared to lower protein
diets. However, another meta-analysis of studies ≥ 12 months by Clifton, Condo, and
Keogh (165) concluded that low carbohydrate/high protein diets resulted in modestly
greater total and fat mass loss (~0.4 kg for each) and reduced triglycerides compared to
normal protein diets, but did not influence lean mass, total cholesterol, LDL-C, HDL-C,
or blood pressure. Results from these meta-analyses collectively indicate that higher
protein diets may have beneficial effects on body weight/composition and metabolic
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health, but that these effects may be more pronounced within the context of exercise
training and may be attenuated in the long-term.
Increased dietary protein intakes have been proposed to influence body weight
and composition outcomes by enhanced satiety, postprandial and resting energy
expenditure (166, 167), and/or muscle protein anabolism (168). The remainder of this
section will focus specifically on the role of dietary protein intake on satiety and energy
balance. In a majority of studies assessing macronutrient effects on postprandial satiety,
consumption of dietary protein causes greater increases in postprandial satiety compared
to carbohydrates and fats (166, 167). However, whether these observed increases in
postprandial satiety translate to reductions in subsequent meal energy intake is less clear.
One 2004 review (166) concluded that approximately half of reviewed trials
demonstrated decreased subsequent meal energy intake after higher protein meals, but a
more recent review found that only 18% of studies with high protein meals reported this
effect (167). The apparent effects of protein intake on appetite ratings are supported by its
effect on many of the aforementioned gut-derived peptides that influence ingestive
behavior. Ghrelin, which is thought to promote food intake through both homeostatic and
reward-driven mechanisms, is suppressed more strongly by protein ingestion compared to
fats and carbohydrates (167, 169). Putative satiety signals such as GLP-1 and PYY may
also be increased to a greater extent following protein consumption compared to other
macronutrients (167, 170). However, others have concluded that carbohydrates may be
the most potent and consistent stimulator of these gut-derived peptides (171).
Finally, limited data from habitually ‘breakfast-skipping’ adolescent girls
suggests that higher protein breakfasts may decrease pre-lunch neural responses to visual
food stimuli in reward-related brain regions including the insula and pre-frontal cortex
compared to a normal protein breakfast (172). Consumption of a higher protein breakfast
may also reduce neural responses to visual food stimuli later in the day as evidenced by
decreased pre-dinner hippocampal and parahippocampal responses following
consumption of a high protein vs. normal protein breakfast (173). Collectively, extant
data support a causal role of higher dietary protein intakes in increasing satiety, but less
support exists for a role in modifying actual ingestive behavior (e.g. subsequent meal
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energy intake). Further, many studies demonstrating beneficial effects of increased
protein consumption on ingestive behavior have utilized amounts of protein that may not
be feasible to maintain (e.g. ≥40% of energy from protein) (166). Additional research
with more modest increases in dietary protein intakes should therefore be conducted to
assess whether these potentially more feasible increases in protein may have beneficial
effects on ingestive behavior outcomes.
1.8

Influence of Dietary Fiber on Body Weight, Ingestive Behavior, and Appetite
Increasing dietary fiber consumption has similarly been touted as a potential

strategy for influencing energy balance and body weight. Data from long-term
prospective cohort studies demonstrate a strong inverse relationship with weight gain
(174, 175). In particular, data from the Nurses’ Health Study, which included 74,091
middle-aged women, demonstrated that women who increased their fiber take the most
over 12 y gained 1.52 kg less than those with the smallest increase in fiber intake.
Women in the highest quintile of fiber intakes also had approximately half the risk of
major weight gain (defined as ≥ 25 kg) than women in the lowest fiber intake quintile
(175). Results from the European Prospective Investigation into Cancer and Nutrition
(EPIC) study indicate that across the 6 study centers each 10 g/d increase in total fiber
intake was associated with modest weight loss (-39 g/y) over an average of 6.5 y of
follow-up. The specific effect of cereal fibers appeared to be somewhat more robust in
preventing weight gain, but the results are still modest. Each 10 g/d increase in cereal
fiber intake was associated with a weight change of -77 g/y (174). A systematic review of
randomized controlled trials found that 59% (39 of 66) of fiber vs. control comparisons
demonstrated a reduction in body weight for the fiber group (176). Similar to the
prospective studies, the effects of fiber on body weight are relatively modest with an
average loss of 1.3% of baseline body weight (-0.72 kg) over an average trial length of 11
wk. The physicochemical properties of the fibers investigated were also shown to have a
significant modulatory effect on changes in body weight. For example, less viscous, less
soluble, and less fermentable fibers were all found to be more effective at decreasing
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body weight compared to more viscous, soluble, and fermentable fibers, respectively
(176).
Enhancement of postprandial satiety is an often reported potential mechanism to
explain the apparent beneficial relationship between fiber intake and body weight.
However, data from randomized controlled trials on the effects of increased fiber intake
on satiety and ingestive behavior are mixed (176, 177) and may depend on the
physicochemical properties of fiber being tested (176). Further, differences in
experimental design and length of the study/trial can produce contradictory results.
Irrespective of fiber type, 43% (25 of 58) fiber vs. control comparisons demonstrated at
least a 10% reduction in appetite for the fiber group in preload study designs.
Interestingly, a greater proportion of studies (54%, 14 of 26 comparisons) demonstrated a
reduction in energy intake after the higher fiber preload (176). Contrary to the results for
body weight, more viscous and more soluble fibers were more effective at reducing
appetite and acute energy intake in a preload design compared to less viscous and less
soluble fibers. The fermentability of fibers did not appear to influence appetite, but more
fermentable fibers were more likely to reduce acute energy intake compared to less
fermentable fibers (176).
Data from longer-term intervention trials (average duration of ~8 wk) further
complicates the interpretation of fiber-induced alterations in ingestive behavior. With all
fiber types combined, total energy intake was reduced in the fiber group compared to the
control group in 24 of 38 (63%) fiber vs. control comparisons. Again, the
physicochemical properties of the fiber influenced the observed results. For these longerterm interventions, the effects of viscosity, solubility, and fermentability contradicted the
results from preload study designs, but matched those from the studies evaluating body
weight changes (decreased energy intake with less viscous, less soluble, and less
fermentable fibers) (176).
A more recent systematic review of the acute effects of fiber on satiety and food
energy intake did little to bring clarity to this complex issue. In this review, ~40% of
higher fiber groups in preload studies demonstrated increased satiety compared to the
control groups (177), which is relatively consistent with the previous systematic review
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(43% decreased appetite (176)). However, higher fiber was shown to decrease acute
energy intake in less than 20% of reviewed preload studies (177) compared to 54% in the
previous systematic review (176). As regards the impact of viscosity, solubility, and
fermentability, the more recent systematic review concluded that fiber-induced increases
in satiety and reductions in energy intake could not be generalized broadly by these
physicochemical properties. Rather, the effects of individual fiber types must be
considered. For example, β-glucan, fenugreek, guar gum, pectin, and psyllium fibers are
all classified as both soluble and viscous, but among these fibers only β-glucan was found
to consistently increase satiety and decrease energy intake (177). Therefore, when
interpreting results from “high fiber” interventions it is important for investigators to
consider the specific fiber(s) that were manipulated and its physicochemical properties,
and extrapolating results from preload study designs to longer-term changes in energy
intake and body weight may not be appropriate.
1.9

Influence of Exercise on Body Weight, Ingestive Behavior, and Appetite

Increasing physical activity – most often as aerobic exercise – is broadly
recommended as a component of comprehensive strategies to prevent weight gain, induce
weight loss, and promote weight loss maintenance (54, 178, 179). However, there
remains a considerable amount of debate amongst both the scientific and lay communities
regarding the role of aerobic exercise for weight loss and its influence on appetite and
energy balance (180, 181). Early observations in the classic study by Mayer, Roy, and
Mitra (182) demonstrated that 1) those who held a sedentary jobs had higher body
weights than those with occupations requiring more physical work and 2) the relationship
between daily energy intake and physical work followed a U-shaped curve (Figure 1.8).
These results are supported by data from epidemiological studies showing an inverse
relationship between physical activity and body weight/adiposity (183). Further, data
from the National Weight Control Registry, a descriptive study of individuals who have
lost at least 13.6 kg and maintained the weight loss for at least 1 y, indicate that these
individuals are highly active. Walking was the most common form of aerobic exercise
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utilized by these individuals and they reported expending 11,830 kJ/wk (2837 kcal/wk)
through physical activity, which is equivalent to walking approximately 45 km/wk (28
miles/wk). However, only approximately 1% of registry participants lost weight through
exercise or physical activity alone. The vast majority (89%) of participants lost weight by
restricting energy intake and increasing energy intake through exercise while 10%
reported losing weight through dietary restriction alone (184).

Figure 1.8. Caloric intake as a function of physical activity (182)
Results from meta-analyses of randomized controlled trials are reflective of
reported weight loss behaviors in the National Weight Control Registry. Collectively,
they support a relatively modest effects of exercise-only interventions for weight loss,
greater weight loss with diet-only compared to exercise-only interventions, and even
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greater weight loss with interventions that combine diet and exercise (55, 56, 185, 186).
Results from 2 meta-analysis found that exercise-only interventions caused
approximately 2 kg of weight loss in trials lasting up to 12 mo (55, 186). Diet-only
interventions produced, on average, 3.6 kg of additional weight loss compared to
exercise-only interventions (186). Interventions that combine both exercise and dietary
restriction have been clearly and consistently shown to produce more favorable weight
loss outcomes compared to diet-only (1.72 kg greater weight loss) and the results are
even stronger for exercise-only (6.29 kg greater weight loss) interventions (56).
A common explanation for the relatively limited utility of exercise-only weight
loss interventions is that exercise may cause compensatory overeating. However, results
from these trials are mixed and factors such as exercise intensity have been shown to
have a significant modulatory effect on weight loss and compensation. For example, a
large (n = 411) supervised 6 mo exercise training program in previously sedentary
postmenopausal women found that actual weight loss closely matched predicted weight
loss in women randomized to expend either 4 or 8 kcal·kg-1·wk-1 but actual weight loss
was only approximately half of predicted weight loss in women assigned to the 12
kcal·kg-1·wk-1 group (187). This study and others (188) have also described a substantial
degree of variability in responses to supervised exercise training interventions (Figure
1.9). The results and variability in responses to the exercise interventions observed in
these trials underscore the limitation of relying solely on mean responses to make
conclusions about the efficacy or effectiveness of an intervention. In both studies,
predicted and actual weight loss were closely matched (except for the highest intensity
exercise group in (187)), but reliance on the mean responses alone obscured a large
degree of inter-subject variability (187, 188).
Numerous trials have sought to investigate the effects of a single bout of aerobic
exercise on appetite sensations and/or subsequent energy intake (189-195). Results from
individual trials have demonstrated increased, no change, and decreased subsequent
energy intake (191). However, a 2013 meta-analysis concluded that compared to rest an
acute bout of exercise caused only a trivial increase in energy intake (207 kj or 50 kcal) at
the test meal, which resulted in a relatively large increase in relative energy expenditure
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(2017 kg or 482 kcal) (191). Similar to the effects of exercise on weight loss, a
substantial degree of inter-subject variability in acute appetite and ingestive behavior
responses to exercise have been observed. In a group of overweight and obese women,
mean energy intake did not differ on exercise vs. rest testing days, but differences in
energy intake between to the testing days ranged from -234 to 279 kcal (under- to overcompensation relative to the energy expenditure from exercise) (190). Meta-analytical
findings also found that the fitness level of the participants studied was a significant
modulator of exercise-induced effects on energy intake. Acute exercise suppressed
energy intake in participants with low or moderate fitness levels, but the opposite effect
was observed for highly fit/physically active participants (191).

Figure 1.9. Distribution of weight loss for each study group (187)
Alterations in circulating concentrations of appetite-related hormones have also
been observed following acute exercise that would be expected to influence neural
homeostatic and reward-driven regulation of food intake (196, 197). In general, acute
exercise tends to decrease acylated ghrelin and increase PYY and GLP-1 concentrations

43
(196), which would collectively be expected to suppress energy intake though both the
homeostatic nonhomeostatic systems. Although the meta-analysis above did not
demonstrate an absolute decrease in energy intake following exercise, this profile of
circulating hormones may be partially responsible for lack of large exercise-induced
increases in energy intake/compensation that result in a relative increase in energy
expenditure relative to intake.
Considering the large body of literature evaluating the effects of acute and chronic
exercise on body weight and ingestive behavior, it is not surprising that a number of
investigators have assessed exercise-induced modulation of neural processes relating to
these outcomes (197-200). The effects of acute aerobic and chronic exercise on neural
responses to visual food stimuli were assessed in 12 overweight/obese adults on 3 testing
days; prior to initiating a 6 mo supervised exercise training program and on 2 days after
training both with and without an acute exercise bout. Compared to responses at baseline,
insular responses were reduced after exercise training and these responses were positively
correlated with changes in in body and fat mass. Interestingly, insular responses to visual
food stimuli after an acute bout of exercise were intermediate to, but not statistically
different from, responses at baseline and after exercise training (Figure 1.10) (198).
These results suggest that acute exercise may increase orexigenic drive in
overweight/obese adults, while exercise training may suppress responsivity to food cues.
However, these results contrast with those in a study of healthy, habitually active
adults. In these subjects, responses in the insula, putamen, and rolandic operculum were
reduced after acute exercise vs. rest and support decreased orexigenic drive post-exercise
(199). In a study of 15 lean, healthy men, responses to high-calorie foods were increased
in the dorsolateral prefrontal cortex but decreased in the orbitofrontal cortex and
hippocampus after exercise compared to rest (197). Similar to observed differences in
subsequent energy intake, the data collectively suggest that body weight status and/or
fitness level may be significant modulators of the effects of acute exercise on neural
responses to visual food stimuli. Collectively, results across multiple study designs and
populations indicate that aerobic exercise is likely a significant factor in the regulation of
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body weight and ingestive behavior, but that exercise-induced effects on these outcomes
demonstrate considerable inter-subject variability.

Figure 1.10. Reduced responses to visual food cues following “chronic exercise” were
observed in the bilateral parietal cortices, left insula, and visual cortex. Inset: insula
responses in the “chronic + acute exercise” were intermediate between “baseline” and
“chronic exercise” conditions (198)

1.10 Conclusions
Obesity is a major public health concern and is causally related to the
development of today’s most deadly chronic diseases including cardiovascular diseases,
type-2 diabetes mellitus, and certain cancers. While American’s collectively spend
billions of dollars annually on weight loss products and services, long-term successful
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weight loss with behavioral interventions is generally poor and bariatric surgery currently
represents the most viable long-term strategy for substantial weight loss maintenance.
Neural processes within both homeostatic and reward-related brain regions likely drive
biological responses that contribute to weight regain after behavioral weight loss
interventions. Increasing dietary protein and fiber and aerobic exercise are commonly
utilized behavioral strategies to promote weight loss that may influence homeostatic and
reward-related neural processes. However, only limited data are currently available to
support the impact of these strategies in the modulation of the neural processing as it
relates to ingestive behavior, and no data currently exists on whether combinations of
protein, fiber, and/or exercise have additive, synergistic, or interactive effects.
Furthermore, a rapidly increasing number of published reports utilizing the visual
food stimuli paradigm are appearing in the literature despite a lack of data establishing
the reliability of this fMRI-based method for investigating these neural influences on
ingestive behavior. The reliability of a measurement has important implications for the
design and interpretation of trial results. In particular, statistical power, necessary sample
sizes, and observable correlations among study outcomes are all highly dependent upon
the reliabilities of utilized methods.
1.11 Purpose of Research
Therefore, the purpose of the research presented in this document was first to
assess the test-rest reliability and postprandial time course of fasting-state neural
responses to visual food stimuli in overweight and obese adults (Study 1). The purpose of
the subsequent randomized crossover studies was investigate the independent and
combined effects of increased dietary protein and fiber (Study 2) and dietary protein and
acute aerobic exercise (Study 3) on neural responses to visual food stimuli and perceived
appetite in overweight or obese adults.
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Study Importance
•

The brain’s reward system influences ingestive behavior and subsequently,
obesity risk.

•

Visual food cues produce robust responses in reward-associated brain regions that
are greater in obese compared to normal weight individuals.

•

Neural responses to visual food stimuli measured by functional magnetic
resonance imaging show considerable within-subject variability in overweight and
obese individuals that needs to be considered when designing future studies.
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2.1

Abstract

Objective: The brain’s reward system influences ingestive behavior and subsequently,
obesity risk. Functional magnetic resonance imaging (fMRI) is a common method for
investigating brain reward function. We sought to assess the test-retest reliability and
postprandial time course of neural responses to visual food cues using fMRI.
Methods: Fasting-state fMRI and appetite assessments were completed by 29 overweight
or obese women (n=17) and men (n=12) on 2 days for test-retest reliability analyses
determined by intraclass correlation coefficients. A subset of 3 women and 4 men
completed postprandial fMRI and appetite assessments 0, 90, 180, and 270 min after
consuming a 300 kcal meal to document the postprandial time course of responses.
Results: The left orbitofrontal cortex response demonstrated fair test-retest reliability,
and the reliabilities of responses in the other a priori brain regions of interest were poor
or completely unreliable. With the exception of the right orbitofrontal cortex response
just after consuming the meal (0 min), postprandial neural responses to visual food
stimuli were not different from fasting-state responses.
Conclusion: Our results demonstrate that fMRI-measured responses to visual food cues
show considerable within-subject variability and are largely unaffected by the
consumption of a meal in overweight and obese adults.
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2.2

Introduction

The brain’s reward system is an important modulator of ingestive behavior that
subsequently influences obesity risk (1). Functional magnetic resonance imaging (fMRI)
is commonly used to compare brain reward responses elicited by images of palatable
and/or energy dense foods compared to nonfood images such as landscapes, animals,
and/or household items (2-4). Meta-analytical findings from these studies demonstrate
that images of food elicit robust responses in reward-associated brain regions – such as
the insula, amygdala, orbitofrontal cortex, and striatum – (2) that are greater in obese
relative to normal weight individuals (3, 4).
These data have prompted investigators to consider potential interventions
designed to modulate brain reward responses to food cues and, subsequently, ingestive
behavior and obesity risk. For example, intervention studies have investigated potential
modulation of food cue-induced responses by aerobic exercise (5-7), dietary protein (8, 9),
as well as administration of exogenous “appetite-related” hormones (10-12). However,
data regarding the test-retest reliability and the postprandial time course of brain reward
responses to visual food cues are lacking. These data are critical for the proper
implementation and interpretation of intervention studies. The test-retest reliability of a
measurement has implications relating to sample size determination and the maximum
observable correlations among outcomes (13), and the timing of postprandial fMRI
scanning would be better informed by empirical data assessing chronological changes in
neural responses after meal consumption.
Therefore, the primary aims of this study were to assess the test-retest reliability
and the postprandial time course of the response to visual food cues in the insula,
amygdala, orbitofrontal cortex, and dorsal striatum (caudate and putamen) in overweight
and obese adults. We hypothesized that 1) fasting brain responses in these rewardassociated brain regions would demonstrate good or excellent test-retest reliability, 2)
responses to visual food cues would be attenuated immediately following the
consumption of a meal, and 3) responses to visual food cues would progressively return
to fasting values by 4.5 hours after meal consumption. The influences of time of day
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(morning vs. evening) and sex on fasting and postprandial neural responses and appetite
ratings were considered as secondary outcomes.
2.3
2.3.1

Methods

Subjects
Thirty-five individuals (20 female, 15 male) were recruited from the greater

Lafayette, IN, community to participate in a fMRI research study at Purdue University
(Figure 2.1). Thirty individuals (17 female, 13 male) completed all study procedures, but
data from 1 male subject were excluded due to excessive head movement (> 2.5 mm)
during fMRI scanning. The final sample included 29 individuals (17 female, 12 male)
(Figure 1). Fasting fMRI and appetite data were obtained from 22 individuals (13 female,
9 male) on 2 days during their participation in one of two ongoing randomized crossover
studies. Fasting and postprandial fMRI and appetite data were obtained on 2 days from an
additional 7 individuals (4 female, 3 male) who were not participating in one of the
aforementioned studies. Inclusion criteria for this study were: male or female; age 18 –
45 y; overweight or obese BMI (25.0-40.0 kg/m2); weight stable (± 3 kg for previous 6
mo); no tobacco use; no diabetes; not pregnant or lactating; not claustrophobic; no
implanted pacemakers/automated defibrillators or ferromagnetic metal. All subjects
provided written informed consent and received a monetary stipend. The consent form
and all study procedures and documents were approved for use by the Purdue University
Biomedical Institutional Review Board.
2.3.2

Experimental Design
Sixteen subjects completed 2 testing days in the morning (a.m.) beginning

between 0700 and 0900 after an overnight fast. Twelve subjects completed 2 testing days
in the evening (p.m.), which began at 1700, 5 hours after consuming a provided lunch (30%
of estimated daily energy requirement (14)). For descriptive purposes, assessments
completed before meal consumption on a.m. and p.m. testing days are referred to as
“fasting-state.” One subject completed one a.m. and one p.m. testing day. Therefore, 28
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of 29 subjects completed both testing days at the same time of day. All testing days were
separated by at least 3 days (mean: 18 days, range: 3 – 35 days) during which time the
subjects consumed self-chosen food and beverages ad libitum.
Upon arrival at the Purdue University MRI Facility, all subjects completed a
fasting-state appetite assessment and fMRI scanning session. The subset of 7 subjects
who completed postprandial assessments then consumed a 300 kcal meal with a
macronutrient distribution of 52% carbohydrate, 17% protein, and 31% fat. Appetite
assessments and fMRI scanning sessions were then completed at the following
postprandial time points: 0 min (as soon as possible after meal completion), 90 min, 180
min, and 270 min. Five of these 7 subjects completed p.m. testing days twice, 1 subject
completed a.m. testing days twice, and 1 subject completed one a.m. and one p.m. testing
day (same subject as mentioned above).
2.3.3

Body Mass Index
Body mass was measured using a digital platform scale (Ohaus, ES200L, Toledo,

OH, USA) and height was measured using a wall-mounted stadiometer (Holtain Ltd.,
Crymych, Wales, UK). Body mass index (kg/m2) was calculated using these
measurements.
2.3.4

Appetite Assessments
Subjects rated their hunger, desire to eat, and fullness on continuous visual analog

scales (VAS) (15) using Adaptive Visual Analog Scales software (16).
2.3.5

fMRI Data Acquisition
Functional imaging was performed using a 3.0 Tesla magnetic resonance scanner

(General Electric, Signa HDx, Milwaukee, WI, USA) while subjects were lying quietly in
a supine position and presented with visual stimuli using NordicNeuroLab’s
VisualSystem (Bergen, Norway). Visual stimuli consisted of images of food of high
hedonic value and neutral nonfood-related objects, which were previously validated (17)
and utilized in previously published reports (18-23). Head movement was limited by
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placing foam pads behind the subjects’ necks and between the 16-channel head coil
(Nova Medical, Inc., Model NMSC-025A, Wilmington, MA) and all sides of the subjects’
heads. A localizer scan was prescribed and centered at the subjects’ brow line. The type,
number and placement of foam pads, the location of subjects inside of the fMRI scanner,
and the location of localizer prescription were noted on the first testing day and replicated
to the greatest extent possible on the second testing day and for postprandial fMRI
sessions.
Three functional runs were performed during each fMRI session. Each run
consisted of 3 blocks of visual food stimuli and 3 blocks of visual nonfood stimuli
presented in a pseudorandomized order using PsychoPy, Version 1.76.00 (24). Each
block of visual stimuli lasted 30 seconds and included 10 images presented for 2.5
seconds each with a 0.5 second fade between each image. Blocks of a low-level baseline
stimulus (fixation cross) lasting 16 seconds each were presented before the first visual
stimuli block, in between blocks of visual stimuli, and after the final visual stimuli block.
Functional images were acquired with an echo-planar gradient-echo T2* blood
oxygenation level dependent (BOLD) contrast sequence, with TR = 2000 ms, TE = 30 ms,
642 matrix, 20 cm2 field of view, 40 slices to cover the whole brain, 3.1 mm think, and no
gap between slices. A high resolution, T1-weighted anatomical scan was completed after
functional imaging for coregistration with functional images.
2.3.6

fMRI Data Processing and Analysis
fMRI data preprocessing and first-level fMRI data analyses (food vs nonfood

BOLD contrasts) were completed using AFNI (http://afni.nimh.nih.gov) (25). The first
five volumes of each functional run (presented during the fixation cross block) were
excluded to eliminate any T1 relaxation effects that may have been present due the
relatively short TR of 2000 ms. Functional runs were then slice-time corrected, motion
corrected to the first non-excluded image of the first functional run, smoothed using a 4.0
mm Gaussian blur, and the signal was normalized. Motion and slice-time corrected
functional runs were then aligned with the high resolution anatomical scan.
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Censor files were created to identify volumes within each functional run with
excessive head motion (>2.5 mm). Those volumes that were censored were excluded and
the six (roll, pitch, yaw, left-right, superior-inferior, anterior-posterior) motion time-series
were included as covariates in the first-level, food vs. nonfood contrast regression model.
The resulting food vs. nonfood contrast was expressed as a β coefficient for each fMRI
session.
We first examined a priori regions of interest (bilateral insula, amygdala,
orbitofrontal cortex, caudate, and putamen) to search for local maxima from the food vs.
nonfood BOLD contrast during the fasting fMRI session on the first testing day.
Spherical regions of interest with a 3mm radii centered at the local maxima were then
created to form each functional region of interest. Functional regions of interest obtained
from the fasting fMRI scan on the first testing day were used again on the second testing
day and for all postprandial fMRI scans.
2.3.7

Statistical Analysis
Mean β coefficients (average of all voxels in each region of interest) representing

the first-level, food vs. nonfood BOLD contrast from the fasting fMRI scan on the first
testing day were analyzed using single-sample Student’s t-tests (SAS, Version 9.3, PROC
TTEST) to determine if the contrast was significantly different from zero. Additional
Student’s t-tests were performed on the subset of 7 subjects who completed the
postprandial assessments for postprandial time course analyses. A Bonferroni correction
was applied to correct for multiple comparisons among 10 a priori brain regions of
interest (α = 0.05 / 10 = 0.005). Only regions of interest demonstrating a significant food
vs. nonfood BOLD contrast in the fasting state on Day 1 were considered for further
analyses.
Repeated measures ANOVA (SAS, Version 9.3, PROC MIXED) was used to
assess the effects of testing day (Day 1 vs. Day 2), time of day (a.m. vs. p.m.), and sex on
fasting brain reward responses (food vs. nonfood contrast) and appetite (hunger, desire to
eat, and fullness) ratings. Test-retest reliabilities of fasting brain reward responses and
appetite ratings were determined by 2-way, mixed effects model intraclass correlation

68
coefficients [ICC(3,1)] (27) and Lin’s correspondence correlation coefficients (CCC) (28)
using IBM SPSS Statistics, Version 22. ICC(3,1) and CCC were interpreted as: < 0.40:
poor reliability, 0.40 – 0.59: fair reliability, 0.60 – 0.74: good reliability, ≥ 0.75: excellent
reliability (29). Negative ICC(3,1)s and CCCs were interpreted as being equivalent to
zero and to represent complete unreliability (30).
For the subset of subjects that completed postprandial assessments, doubly
repeated measures ANOVA (SAS, Version 9.3, PROC MIXED) was used to assess the
effect of time relative to meal completion (fasting-state vs. 0 min vs. 90 min vs. 180 min
vs. 270 min) on brain reward responses and appetite ratings. Testing day and time of scan
were included as repeated factors in the ANOVA model. A Dunnett-Hsu adjustment for
multiple comparisons was used to compare the 4 postprandial time points to the fastingstate time point. Correlations among brain reward responses, body mass index, and
appetite ratings were assessed using Pearson’s correlation coefficients (SAS, Version 9.3,
PROC CORR). Data are presented as mean ± SEM and significance was set at α = 0.05
unless otherwise noted.
2.4
2.4.1

Results

Subject Characteristics
On average, subjects were 27 years old and had a body mass index near the cutoff

for obesity (Table 2.1). Compared to the 22 subjects that completed fasting fMRI and
appetite assessments, the 7 subjects who completed fasting and postprandial assessments
had a lower body mass index but did not differ by body mass or age (Table 1).
2.4.2

Fasting fMRI Responses
Visual food stimuli presented in the fasting-state elicited greater responses

compared to neutral nonfood stimuli (P < 0.005) in all 10 a priori regions of interest: left
and right insula, amygdala, orbitofrontal cortex, caudate, and putamen (Table 2.2, Figure
2.2). According to the ANOVA model, fasting-state responses to visual food stimuli were
greater on Day 1 compared to Day 2 in the left insula and right amygdala (Table 2.3),
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and no responses were greater on Day 2 vs. Day 1. Differences in Day 1 vs. Day 2
responses in the left insula were confirmed by a voxel-wise subtraction analysis, but
differences right amygdala responses were not further substantiated by this secondary
analysis (Figure 2.3). Fasting-state responses were not different on Days 1 and 2 in the
other 8 regions of interest (Table 3). Although the left insula and right amygdala
responses were attenuated on Day 2, the food vs. nonfood contrasts remained significant
(left insula β: 9.22 x 10-4 ± 1.46 x 10-4, P < 0.0001; right amygdala β: 5.88 x 10-4 ± 1.77 x
10-4, P = 0.0025). There was a trend for a greater response in the right amygdala of
females compared to males (P = 0.06). Similarly, there was a trend for greater responses
in a.m. compared to p.m. sessions in the right insula, left amygdala, and left and right
putamen (P ≤ 0.10).
The left orbitofrontal response to visual food stimuli demonstrated fair test-retest
reliability. Reliabilities of responses in the other regions of interest were poor or
completely unreliable (Table 2.4).
2.4.3

Fasting Appetite Ratings
Fasting appetite ratings were not different on Day 1 vs. Day 2, respectively

(hunger: 50 ± 4 vs. 49 ± 4 mm; desire to eat: 51 ± 4 vs. 53 ± 4 mm; fullness: 26 ± 4 vs. 29
± 4 mm) and were not influenced by time of day (a.m. vs. p.m. sessions). Men reported
greater fasting hunger (P = 0.02) and desire to eat (P = 0.03) than women. Fullness
ratings were not influenced by sex.
Fasting hunger (ICC(3,1) = 0.571, CCC = 0.563) and desire to eat (ICC(3,1) =
0.485, CCC = 0.475) demonstrated fair reliability and fullness ratings had good reliability
(ICC(3,1) = 0.636, CCC = 0.627).
2.4.4

Correlations
No significant linear correlations among fasting appetite ratings and fasting brain

responses were observed. Fasting brain responses were not linearly correlated with body
mass index (data not shown).
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2.4.5

fMRI Postprandial Time Course
In the 7 subjects who completed postprandial assessments, a significant food vs.

nonfood contrast (P < 0.005) was observed in the left and right insula and left and right
orbitofrontal cortex. Only these 4 brain regions were considered for postprandial
assessments.
The food vs. nonfood contrast was significant (P < 0.005) in the left and right
insula and left and right orbitofrontal cortex at all postprandial time points with the lone
exception being the right orbitofrontal cortex response at 0 min (β: 8.34 x 10-4 ± 3.90 x
10-4, P = 0.03). Time did not influence the neural responses to visual food stimuli
according to the doubly repeated measures ANOVA in any of the brain regions (left
insula: P = 0.82; right insula: P = 0.92; left orbitofrontal cortex: P = 0.80; right
orbitofrontal cortex: P = 0.73).
2.4.6

Appetite Postprandial Time Course
Hunger and desire to eat were suppressed and fullness increased immediately

after meal consumption (Figure 2.4). Hunger and fullness ratings remained suppressed
and increased, respectively, for 90 minutes, but were not significantly different from
fasting-state after 180 and 270 minutes. Desire to eat ratings at 90, 180, and 270 minutes
after meal consumption were not significantly different than fasting-state.
2.5

Discussion

The primary aim of this study was to assess the test-retest reliability of fastingstate neural responses to visual food stimuli in select reward-associated brain regions.
Contrary to our hypothesis, no regions demonstrated good or excellent reliability. The left
orbitofrontal cortex response had fair reliability, but reliabilities for the other 9 a priori
regions of interest were poor or completely unreliable. Conversely, appetite ratings
demonstrated fair (hunger, desire to eat) to good (fullness) test-retest reliability.
While we are unaware of extant data regarding the test-retest reliability of neural
reward responses to visual food stimuli, a number of studies have assessed the reliability
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of reward responses using alternative fMRI study designs (30-32). In a group of alcoholdependent individuals, reliabilities for responses to visual alcohol cues were poor to fair
in the left ventral and dorsal striatum, but excellent in the right ventral and dorsal striatum
(31). Reported ICCs for anticipatory reward responses were poor to fair in two eventrelated study designs utilizing monetary reward paradigms (30, 32). Furthermore, a
review of fMRI reliability studies investigating a range of study designs, outcomes, and
brain regions found that the mean ICC across fMRI studies is 0.50 and overall have a fair
reliability rating (33). This suggests that the relatively poor reliability observed in the
current study is not isolated to this single study or even to reward responses, but is rather
more broadly characteristic of fMRI research.
On the other hand, the current study and previous studies (30-32) have reported
that mean or group-level reward responses are relatively consistent. This general lack of
good to excellent test-retest reliability ratings but good group-level consistency in fMRImeasured reward responses has important implications for the design and interpretation
of fMRI-based intervention studies. Consistent group-level results suggest that parallel
group design studies – without repeated fMRI scanning of subjects – are appropriate for
fMRI-based studies of reward processing. Longer-term interventions that induce a
physiological adaptation (e.g. weight loss, exercise training) may also cause group shifts
in reward responses from pre- to post-intervention testing that could be detected by fMRI.
Crossover intervention studies may be appropriate given that certain criteria are
considered. For example, it is critical that investigators include chronological testing
order as a factor in their statistical models and utilize standard randomization procedures
to ensure that potential intervention effects cannot be explained by day-to-day withinsubject variability in responses.
The test-retest reliability of a measurement also influences the maximum
observable correlations (ρo) among study outcomes. The ρo between two variables a and b
is theoretically limited by their reliabilities (Ra and Rb) such that the ρo is equal to the
product of the true correlation (ρt) and the square root of the product of Ra and Rb.
ρo = ρt√RaRb

(13)
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Using this equation, the likelihood of observing significant correlations with
measurements demonstrating poor reliability or complete unreliability is severely
compromised. Until the reliability of fMRI measurements can be improved, there is
limited translational potential for developing inexpensive, effective tools that correlate
well with fMRI-measured reward responses at the individual clinical patient level.
The second aim of this study was to assess the influence of meal consumption on
the neural responses to visual food stimuli. These data are important for the timing of
postprandial fMRI assessments for acute meal interventions that mirror the preload study
design commonly utilized in appetite and ingestive behavior research (34). Contrary to
our hypothesis, postprandial neural responses to visual food stimuli remained largely
unchanged in the postprandial state despite alterations in appetite ratings up to 90 minutes
after meal consumption.
These results are, however, consistent with previous research demonstrating
persistent neural responses to visual food stimuli (4, 35, 36) and enhanced attentional bias
to food images (37) in overweight and obese relative to lean adults in the postprandial
state. Collectively, these data further support the theory of disordered reward processing
in obesity (3, 4) and suggest that the reward value of food may be relatively unaffected
by meal consumption in overweight and obese adults. Future research should focus on
determining the most appropriate study design (e.g. crossover vs. parallel, block vs.
event-related), timing of postprandial scanning, and meal size to support or refute this
conclusion.
A primary strength of this study is the large sample size (n = 29) relative to
previously published fMRI test-retest reliability assessments, which commonly have
sample sizes of < 15 subjects (33). The study was conducted in overweight and obese
individuals, and this is an appropriate group for nutrition-based interventions. Finally,
factors likely to influence fMRI signal detection and reliability were controlled by strictly
adhering to experimental procedures and utilizing appropriate statistical controls.
The use of ICC for test-retest reliability assessments has some limitations, notably
that a wider range of measurements/responses may result in a higher ICC and that nonnormally distributed data may influence the resulting rating (38). The CCC index,
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however, produces robust results with non-normal distributions (28). Similar ICC and
CCC ratings observed in the current study lend greater confidence to the results. While
the overall sample size was large, a relatively small number of subjects (n = 7) completed
the postprandial appetite and fMRI assessments. The size of the served meal was also
small. However, this 300-kcal meal is consistent with the average size of breakfast in this
age group (39). Further, appetite ratings were significantly influenced by this meal based
on data from this number of subjects.
In conclusion, fMRI-measured neural responses to visual food cues in this group
of overweight and obese adults demonstrated considerable within-subject variability, but
relatively consistent mean or group-level results on 2 days with similar experimental
conditions. These findings have important implications relating to experimental design,
sample size determination, and observable correlations among study outcomes. Further,
neural responses to visual food cues were largely unaffected by the consumption of a
meal, which may limit the utility of preload-type study designs for the study of neural
reward influences on ingestive behavior.
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Table 2.1. Subject characteristics1
Parameter
Male/Female
Age (y)
Body Mass (kg)
Body Mass Index (kg/m2)
1
Values are mean ± SEM.

All Subjects
(n = 29)
12/17
27 ± 1
86.1 ± 2.3
29.4 ± 0.7

Fasting Only
(n = 22)
9/13
27 ± 1
87.8 ± 2.3
30.0 ± 0.8

Postprandial Time
Course2 (n = 7)
3/4
25 ± 1
80.8 ± 2.4
27.5 ± 0.3*

2

All subjects completed fasting fMRI and appetite assessments. Twenty-two subjects
completed only fasting assessments (Fasting Only) while 7 subjects completed fasting
and postprandial assessments (Postprandial Time Course).
* Indicates Postprandial Time Course subjects different from Fasting Only subjects (P <
0.05). Unpaired Student’s t-test (PROC TTEST, SAS, Version 9.3) indicated that body
mass index was lower in Postprandial Time Course subjects relative to Fasting Only
subjects.
Abbreviations: fMRI, functional magnetic resonance imaging
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Table 2.2. Responses to visual food vs. nonfood stimuli in the fasting-state on Day 1
MNI coordinates1
T value2
P value3
x
y
z
Insula (L)
-38
-7
6
11.25
< 0.0001
Insula (R)
39
-4
4
6.47
< 0.0001
Amygdala (L)
-23
0
-17
4.93
< 0.0001
Amygdala (R)
24
0
-18
5.56
< 0.0001
OFC (L)
-25
35
-18
6.29
< 0.0001
OFC (R)
23
33
-20
4.88
< 0.0001
Caudate (L)
-13
15
4
3.60
0.0012
Caudate (R)
14
14
6
3.87
0.0006
Putamen (L)
-22
8
2
3.08
0.0047
Putamen (R)
27
5
0
4.23
0.0002
1
Stereotactic coordinates in MNI space for local maxima for the food vs. nonfood
contrast within each a priori brain region of interest.
Brain Region

2

T values reported for results of single sample t-tests for comparison of mean β
coefficient of all voxels in each region for food vs. nonfood contrast to zero.
3

Uncorrected P values.

Single sample Student’s t-tests (PROC TTEST, SAS, Version 9.3) indicated that visual
food stimuli elicited greater brain responses compared to nonfood stimuli in all 10 a
priori regions of interest (P < 0.005). A Bonferroni correction was applied for
determination of statistical significance (α = 0.05 / 10 ROI = 0.005).
Abbreviations: MNI, Montreal Neurological Institute; OFC, orbitofrontal cortex; L, left;
R, right.

76
Table 2.3. Comparison of fasting-state neural responses to visual food stimuli on Day 1
and Day 21
Brain Region
Day 1 Response (β)
Day 2 Response (β)
P value2
-3
-4
-4
-4
Insula (L)
1.22 x 10 ± 1.08 x 10
9.22 x 10 ± 1.46 x 10
0.049*
Insula (R)
9.58 x 10-4 ± 1.48 x 10-4
9.06 x 10-4 ± 1.12 x 10-4
0.81
-3
-4
-3
-4
Amygdala (L)
1.36 x 10 ± 2.75 x 10
1.16 x 10 ± 2.48 x 10
0.56
Amygdala (R)
1.26 x 10-3 ± 2.23 x 10-4
5.88 x 10-4 ± 1.77 x 10-4
0.015*
OFC (L)
1.75 x 10-3 ± 2.78 x 10-4
1.54 x 10-3 ± 2.31 x 10-4
0.36
-3
-4
-3
-4
OFC (R)
1.35 x 10 ± 2.77 x 10
1.29 x 10 ± 1.72 x 10
0.79
Caudate (L)
5.35 x 10-4 ± 1.49 x 10-4
4.20 x 10-4 ± 1.17 x 10-4
0.58
-4
-4
-4
-4
Caudate (R)
5.64 x 10 ± 1.46 x 10
4.03 x 10 ± 1.39 x 10
0.48
Putamen (L)
3.66 x 10-4 ± 1.19 x 10-4
3.51 x 10-4 ± 9.58 x 10-5
0.97
-4
-4
-4
-4
Putamen (R)
5.69 x 10 ± 1.34 x 10
4.65 x 10 ± 1.32 x 10
0.67
1
Values are reported as mean β coefficient of all voxels in each region for food vs
nonfood contrast. Variability is reported as ± SEM.
2

P values for comparison of Day 1 and Day 2 responses.

* Indicates greater responses to visual food stimuli on Day 1 compared Day 2. Repeated
measures ANOVA (PROC MIXED, SAS, Version 9.3) indicate that visual food stimuli
elicited greater responses in the left insula and right amygdala on Day 1 compared to Day
2.
Abbreviations: OFC, orbitofrontal cortex; L, left; R, right.
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Table 2.4. Reliabilities of fasting state responses to visual food cues
Brain Region
ICC(3,1)
CCC
Rating1
Insula (L)
0.363
0.355
Poor
Insula (R)
0.255
0.248
Poor
Amygdala (L)
0.377
0.368
Poor
Amygdala (R)
0.149
0.145
Poor
OFC (L)
0.575
0.566
Fair
OFC (R)
0.306
0.298
Poor
Caudate (L)
-0.250
-0.240
Unreliable
Caudate (R)
-0.170
-0.163
Unreliable
Putamen (L)
0.102
0.099
Poor
Putamen (R)
-0.375
-0.357
Unreliable
1
Reliability ratings determined from ICC(3,1) and CCC analyses were interpreted as: <
0.40: poor reliability, 0.40 – 0.59: fair reliability, 0.60 – 0.74: good reliability, ≥ 0.75:
excellent reliability. Negative ICCs were interpreted as being equivalent to zero and to
represent complete unreliability.
ICC(3,1) and CCC were calculated using IBM SPSS Statistics, Version 22. Fasting state
responses to visual food cues were mostly poor or completely unreliable, with only the
left orbitofrontal cortex response demonstrating fair reliability.
Abbreviations: ICC(3,1), 2-way mixed models type intra-class correlation coefficient;
CCC, Lin’s concordance correlation coefficient; OFC, orbitofrontal cortex; L, left; R,
right.
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Figure 2.1. Study recruitment flow diagram

79

Figure 2.2. Fasting-state neural responses to visual food stimuli on Day 1. Greater
responses to visual food stimuli vs. nonfood stimuli (PROC TTEST, SAS, Version 9.3; P
< 0.005) were observed in all 10 a priori regions of interest. Black circles represent
functional regions of interest with 3mm radii within a priori brain regions of interest with
known reward functions. Images are in the axial plane and left side of the figure
corresponds to the right side of the body and vice versa. Display threshold: p < 0.001
(uncorrected), minimum cluster size of 250 voxels.
Abbreviations: OFC, orbitofrontal cortex
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Figure 2.3. Voxel-wise subtraction of Day 1 vs. Day 2 fasting-state neural responses.
Greater responses to visual food stimuli in the left insula were observed on Day 1 vs. Day
2. Day 1 > Day 2 right amygdala responses indicated by the ANOVA model (PROC
MIXED, SAS, Version 9.3) were not confirmed by the voxel-wise subtraction analysis.
Images are in the axial plane and left side of the figure corresponds to the right side of the
body and vice versa. Display threshold: p < 0.05 (uncorrected), minimum cluster size of
250 voxels.

81

Figure 2.4. Postprandial appetite ratings. Values are presented as mean change from
fasting-state rating ± SEM. Doubly repeated measures ANOVA (PROC MIXED, SAS,
Version 9.3) was used to compare postprandial appetite ratings (0, 90, 180, and 270
minutes) to fasting-state (-45 minutes) ratings. Relative to fasting-state ratings, hunger
was decreased and fullness increased 0 and 90 minutes after meal consumption (P < 0.05,
Dunnett-Hsu adjusted), but hunger and fullness ratings 180 and 270 minutes after the
meal were not different from fasting-state. Desire to eat was decreased at 0 min compared
to fasting-state (P < 0.05, Dunnett-Hsu adjusted), but not at the later postprandial time
points.
∆, change from fasting-state rating.
* indicates postprandial hunger rating different from fasting-state (P < 0.05, Dunnett-Hsu
adjusted).
† indicates postprandial desire to eat rating different from fasting-state (P < 0.05,
Dunnett-Hsu adjusted).
‡ indicates postprandial fullness rating different from fasting-state (P < 0.05, DunnettHsu adjusted).
Abbreviations: VAS, visual analog scales for appetite
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3.1

Abstract

Increasing either protein or fiber at mealtimes has relatively modest effects on
satiety and ingestive behavior. Whether increasing protein and fiber in the same meal has
additive or interactive effects on these outcomes is not known. Five female and 10 male
overweight (BMI: 27.1 ± 0.2 kg/m2) young adults (26 ± 1 y) were provided with all
breakfast meals of varying protein and fiber amounts (normal protein /normal fiber,
normal protein/high fiber, high protein/normal fiber, high protein/high fiber) during 4, 2week interventions. At the end of each intervention, fasting and postprandial appetite
ratings and neural responses to visual food stimuli were collected. Ad libitum energy
intake at lunch was also measured. Increasing fiber consumption at breakfast did not
affect ingestive behavior outcomes. Higher protein breakfasts decreased desire to eat 60
minutes after breakfast but not at later postprandial time points. Energy intake at lunch
was not influenced by higher protein consumption. Right insula responses to visual food
stimuli were decreased after consuming normal protein, but not high protein, breakfasts.
In conclusion, these data do not support increasing dietary protein and fiber at breakfast
as effective strategies for modulating ingestive behavior in overweight adults.
Keywords: fMRI; food reward; overweight; appetite regulation; dietary protein; dietary
fiber
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3.2

Introduction

Obesity continues to be a major public health concern in the United States with
nearly 70% of adults being overweight or obese (BMI ≥ 25.0 kg/m2) according to the
National Health and Nutrition Examination Survey (NHANES) 2011-2012 [1].
Aggregated data from the NHANES 2007-2012 revealed that, for the first time, the total
number of people with obesity (BMI ≥ 30 kg/m2) outnumbers those with an overweight
BMI (25.0 - 29.9 kg/m2) [2]. Results from the NHANES II (1976-1980) and the
NHANES III (1988-1994) suggest that BMI increased across the entire population, but
those at the higher end of the BMI distribution were at greater risk for weight gain [3].
Several prospective studies have also shown that those with an overweight BMI are at
risk of continued weight gain and progression to obesity [4-6]. Therefore, lifestyle
interventions designed to prevent further weight gain in overweight individuals could
have a significant public health impact by preventing obesity-related chronic morbidities
[7] and mortality [8].
Increasing the amount of dietary protein at breakfast is one such potential
intervention. Higher protein diets are associated with modestly decreased adiposity [9],
and meta-analytical results from randomized clinical trials demonstrate greater weight
loss with high protein vs. standard protein diets [10]. The observed effects of higher
protein diets on body weight and/or adiposity are likely partially explained by enhanced
postprandial satiety, decreases in subsequent energy intake, and increased postprandial
thermogenesis [11]. Increasing dietary protein specifically at breakfast rather than other
mealtimes may be desirable because protein consumption is lower at breakfast compared
to lunch and dinner, [12] and increases in dietary protein at breakfast have been
previously shown to have greater effects on satiety compared to other mealtimes [13].
Limited data also suggest that higher protein breakfasts may decrease pre-lunch neural
responses to visual food stimuli in reward-related brain regions including the insula and
pre-frontal cortex [14]. Consumption of a higher protein breakfast may also confer
reductions in neural responses to visual food stimuli throughout the day as evidenced by
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decreased pre-dinner hippocampal and parahippocampal responses following
consumption of a high vs. normal protein breakfast [15].
Increasing dietary fiber consumption is another potentially promising strategy to
prevent weight gain in overweight adults. Ninety-five percent of Americans are
consuming less than the Adequate Intake for fiber, and fiber was identified as a nutrient
of concern by the 2015 Dietary Guidelines Advisory Committee [16]. Increased fiber
consumption is associated with decreased body weight, which may be partially explained
by reductions in hunger and subsequent energy intake with higher fiber meals/diets [17].
However, the effects of fiber on subjective appetite, energy intake, and body weight are
likely influenced significantly by the physiochemical properties of the fiber being studied
[17], and at least one systematic review found that the majority of studies did not support
a beneficial impact of fiber on appetite or energy intake, regardless of fiber-type [18].
Considering the relatively modest individual effects of dietary protein and fiber
on body weight and ingestive behavior, interventions to increase both protein and fiber
may be more effective for modifying appetite and ingestive behavior than either approach
alone. However, the interactive and/or additive effects of dietary protein and fiber are
understudied. Therefore, the purpose of randomized, double-blind, crossover study was to
evaluate the individual and combined effects of higher protein and fiber at breakfast on
subjective appetite, neural responses to visual food stimuli, ad libitum energy intake at
lunch in overweight adults. We hypothesized that increasing either dietary protein or
fiber at breakfast would increase postprandial fullness and decrease postprandial hunger,
desire to eat, energy intake at lunch, and neural responses to visual foods stimuli, and that
a high protein and high fiber breakfast would have an additive effect on these outcomes.
3.3
3.3.1

Experimental Section

Subjects
Eighteen (6 female and 12 male) subjects were recruited from the greater

Lafayette, IN community to participate in a research study at Purdue University (Figure
3.1). Thirteen (4 female and 9 male) subjects completed all study procedures. One male
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subject completed all appetite and ad libitum energy intake assessments, but did not
complete fMRI scans due to non-ferromagnetic metal-containing dental work that
interfered with the magnetic resonance signal. One female subject withdrew from the
study after completing 3 of 4 testing days due to time conflicts with the study, and data
from this subject were included in statistical analyses. One male subject withdrew from
the study after completing 1 testing day, and 3 subjects (1 female and 2 male) withdrew
prior to completing any testing days. Data from these 4 subjects were not included in any
statistical analyses. Schedule conflicts were reported as the primary reason for study
withdrawal for 3 of these 4 subjects and the remaining female subject was withdrawn
from the study due to an inability to fully comply with study procedures.

Figure 3.1. Study recruitment flow diagram.
Inclusion criteria for this study were: male or female; age 21 – 45 years;
overweight BMI (25.0 – 29.9 kg/m2); regularly eating breakfast (≥ 5 days/week); weight
stable (± 3 kg for previous 6 mo); not participating in organized sports or regular exercise
(≥ 2 days/week); no tobacco use; no diabetes; not pregnant or lactating for 6 months; not
claustrophobic; no implanted pacemakers/automated defibrillators or ferromagnetic
metal. All subjects provided written informed consent and received a monetary stipend.
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The consent form and all study procedures and documents were approved for use by the
Purdue University Biomedical Institutional Review Board. This trial was registered on
ClinicalTrials.gov (NCT02169245).
3.3.2

Experimental Design
On 4 testing days after an overnight fast, subjects consumed one of the following

breakfasts in random order: normal protein/normal fiber (NPNF), normal protein/high
fiber (NPNF), high protein/normal fiber (HPNF), and high protein/high fiber (HPHF).
Subjects and investigators were blinded to the protein and fiber content of the breakfasts
until after statistical analyses were completed. Fasting-state subjective appetite
assessments (hunger, desire to eat, and fullness) and functional magnetic resonance
imaging (fMRI) were completed upon subject arrival at the Purdue University MRI
Facility at 0700, 0800, or 0900 (-45 minutes). Additional appetite assessments were
completed immediately before (-15 minutes) and after breakfast (0 minutes), 60, 120,
180, and 240 minutes after breakfast (also served as pre-lunch assessment), and
immediately after consuming an ad libitum lunch. A postprandial fMRI scan was
completed immediately after subjects completed the appetite assessment at the 180
minute postprandial time point. Lunch was served immediately after subjects completed
the 240 minute appetite assessment and ad libitum energy intake at lunch was measured.
Subjects were served an approximately 1000 kcal serving of pasta with marinara sauce in
a room with limited distractions (no investigators, TV, radio, phone, etc.) and instructed
to eat until they were comfortably full.
All testing days were separated by ≥ 26 days (mean: 30 days, range: 26 – 49 days)
and subjects were provided with all breakfast meals for 2 weeks prior to each testing days
(breakfast intervention period). The protein and fiber contents of the provided breakfasts
matched that of the breakfast served on each testing day. Subjects were not given
additional instructions or dietary advice and were allowed to choose and consume selfselected foods and beverages at other eating occasions during each breakfast intervention
period. A minimum 2-week washout period was completed after each testing day during
which time subject consumed self-selected foods and beverages ad libitum.
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3.3.3

Breakfast Characteristics
All breakfast meals were 400 kcal and provided 50g of available carbohydrates.

Normal and high protein breakfasts provided 12.5g and 25g of protein, respectively. The
difference in protein content between the normal and high protein breakfasts was derived
from whole eggs and/or egg white powder. Normal and high fiber breakfasts provided 2
and 8g of dietary fiber, respectively. The additional fiber in the high fiber breakfasts was
achieved by the discrete addition of powdered psyllium husk to the meals. Four breakfast
meal types (egg and potato casserole, quiche, breakfast sandwich, and breakfast burrito)
were provided within each 2-week breakfast intervention period. The breakfast burrito
was consumed for all testing days. The meals were designed by the research dietitian to
be indistinguishable in appearance and flavor between breakfast intervention periods.
3.3.4

Body Composition
Baseline body mass and % body fat were measured using the BOD POD Gold

Standard Body Composition Tracking System (COSMED USA, Inc., Concord, CA).
Height was measured using a wall-mounted stadiometer (Holtain Ltd., Crymych, Wales,
UK). Body mass index (kg/m2) was calculated at the beginning of the study using weight
and height measurements.
3.3.5

Fasting-state Serum Glucose and Lipid Profile
Baseline fasting-state blood samples were collected from an antecubital vein into

3.5mL serum-separator tubes, allowed to sit at room temperature for 30 minutes, and
centrifuged for 15 minutes at 4400 rpm and 4ºC to obtain serum. Serum samples were
sent to a professional laboratory (Mid America Clinical Laboratories, Lafayette, IN) for
analysis.
3.3.6

Appetite Assessments
Subjects rated their hunger, desire to eat, and fullness on continuous visual analog

scales (VAS) [19] using Adaptive Visual Analog Scales software [20].
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3.3.7

fMRI Data Acquisition
Functional imaging was performed using a 3.0 Tesla magnetic resonance scanner

(General Electric, Signa HDx, Milwaukee, WI, USA) while subjects were lying quietly in
a supine position and presented with visual stimuli using NordicNeuroLab’s
VisualSystem (Bergen, Norway). Visual stimuli consisted of images of food of high
hedonic value and neutral nonfood-related objects, which were previously validated [21]
and utilized in previously published reports [22-27]. Head movement was limited by
placing foam pads behind the subjects’ necks and between the 16-channel head coil
(Nova Medical, Inc., Model NMSC-025A, Wilmington, MA) and all sides of the subjects’
heads. A localizer scan was prescribed and centered at the subjects’ brow line. The type,
number and placement of foam pads, the location of subjects inside of the fMRI scanner,
and the location of localizer prescription were noted during the first fMRI scanning
session and replicated to the greatest extent possible for subsequent scanning sessions.
Three functional runs were performed during each fMRI session. Each run
consisted of 3 blocks of visual food stimuli and 3 blocks of visual nonfood stimuli
presented in a pseudorandomized order using PsychoPy, Version 1.76.00 [28]. Each
block of visual stimuli lasted 30 seconds and included 10 images presented for 2.5
seconds each with a 0.5 second fade between each image. Blocks of a low-level baseline
stimulus (fixation cross) lasting 16 seconds each were presented before the first visual
stimuli block, in between blocks of visual stimuli, and after the final visual stimuli block.
Functional images were acquired with an echo-planar gradient-echo T2* blood
oxygenation level dependent (BOLD) contrast sequence, with TR = 2000 ms, TE = 30 ms,
642 matrix, 20 cm2 field of view, 40 slices to cover the whole brain, 3.1 mm think, and no
gap between slices. A high resolution, T1-weighted anatomical scan was completed after
functional imaging for coregistration with functional images.
3.3.8

fMRI Data Processing and Analysis
fMRI data preprocessing and first-level fMRI data analyses (food vs nonfood

BOLD contrasts) were completed using AFNI (http://afni.nimh.nih.gov) [29]. The first
five volumes of each functional run (presented during the fixation cross block) were
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excluded to eliminate any T1 relaxation effects that may have been present due the
relatively short TR of 2000 ms. Functional runs were then slice-time corrected, motion
corrected to the first non-excluded image of the first functional run, smoothed using a 4.0
mm Gaussian blur, and the signal was normalized. Motion and slice-time corrected
functional runs were then aligned with the high resolution anatomical scan.
Censor files were created to identify volumes within each functional run with
excessive head motion (>2.5 mm). Those volumes that were censored were excluded and
the six (roll, pitch, yaw, left-right, superior-inferior, anterior-posterior) motion time-series
were included as covariates in the first-level, food vs. nonfood contrast regression model.
The resulting food vs. nonfood contrast was expressed as a β coefficient for each fMRI
session.
We first examined a priori regions of interest (bilateral insula, amygdala,
orbitofrontal cortex, caudate, and putamen) to search for local maxima from the food vs.
nonfood BOLD contrast during the fasting fMRI session on the first testing day.
Spherical regions of interest with a 3mm radii centered at the local maxima were then
created to form each functional region of interest. Functional regions of interest obtained
from the fasting-state fMRI scan on the first testing day were used for all subsequent
fMRI scans.
3.3.9

Statistical Analyses
Mean β coefficients (average of all voxels in each region of interest) representing

the first-level, food vs. nonfood BOLD contrast from the fasting fMRI scan on the first
testing day were analyzed using single-sample Student’s t-tests (SAS, Version 9.3, PROC
TTEST) to determine if the contrast was significantly different from zero. A Bonferroni
correction was applied to correct for multiple comparisons among 10 a priori brain
regions of interest (α = 0.05 / 10 = 0.005). Only regions of interest demonstrating a
significant food vs. nonfood BOLD contrast in the fasting state on the first testing day
were considered for further analyses.
Repeated measures ANOVA was used to assess the effects of chronological
testing order (Day 1 vs. Day 2 vs. Day 3 vs. Day 4), the protein and fiber content of the
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breakfast meals, and interactions on fasting-state (-45min) hunger, desire to eat, fullness,
and neural responses to visual food stimuli, ad libitum energy intake at lunch, and total
area under the curve (AUC) for postprandial hunger, desire to eat, and fullness. AUCs for
appetite assessments were calculated using the trapezoidal rule. Doubly repeated
measures ANOVA (SAS, Version 9.3, PROC MIXED) was used to assess the effects of
chronological testing order (Day 1 vs. Day 2 vs. Day 3 vs. Day 4), time (fasting-state vs.
postprandial), the protein and fiber content of the breakfast meals, and interactions on
neural responses to visual food stimuli. Doubly repeated measures ANOVA (SAS,
Version 9.3, PROC MIXED) was also used to assess the effects of chronological testing
order (Day 1 vs. Day 2 vs. Day 3 vs. Day 4), time (pre-meal/-15min vs. 0min vs. 60min
vs. 120min vs. 180min vs. 240min), protein and fiber content of the breakfast meals, and
interactions on hunger, desire to eat, and fullness ratings. A Tukey-Kramer adjustment
for multiple comparisons was used as needed for post-hoc analyses. Linear correlations
among appetite ratings, ad libitum energy intake, and neural responses to visual food
stimuli were assessed using Pearson’s correlation coefficients (SAS, Version 9.3, PROC
CORR). Data are presented as mean ± SEM and significance was set at α = 0.05 unless
otherwise noted.
3.4
3.4.1

Results

Subject Characteristics

Table 3.1. Baseline subject characteristics mean and standard error (SEM) (n = 15).
Parameter
Age (y)
Body Mass (kg)
BMI (kg/m2)
% Body Fat
Glucose (mg/dL)
Total Cholesterol (mg/dL)
LDL-Cholesterol (mg/dL)
HDL-Cholesterol (mg/dL)
Triglycerides (mg/dL)

Mean ± SEM
26 ± 1
82.3 ± 2.7
27.1 ± 0.2
26.3 ± 2.4
94 ± 2
164 ± 7
97 ± 7
48 ± 3
98 ± 10
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On average, subjects were 26 ± 1 years and overweight (BMI: 27.1 ± 0.2 kg/m2,
26.3 ± 2.4% body fat). Indicators of baseline metabolic health (fasting glucose and lipid
profile) were within the normal reference ranges (Table 3.1).
3.4.2

Appetite Ratings and Ad Libitum Energy Intake at Lunch
Fasting-state (-45min) hunger, desire to eat, and fullness ratings were not different

on the 4 testing days (chronological testing order) and were not influenced by protein or
fiber intake during the preceding 2-week breakfast intervention period.
Compared to pre-meal (-15min) ratings, hunger and desire to eat were decreased
and fullness increased for 180 minutes following breakfast consumption (main effect of
time), but appetite ratings 240 minutes after breakfast consumption were not different
from fasting-state ratings (Figures 3.2, 3.3, 3.4). The doubly repeated measures ANOVA
model indicated a significant time x protein interaction for desire to eat (P = 0.022) and
post-hoc analyses indicated that desire to eat was lower 60 minutes after consuming a
high (23 ± 3 mm) vs. normal protein (31 ± 4 mm) breakfast (Tukey-adjusted P = 0.036).
Additionally, time x chronological testing order interactions were indicated for hunger (P
= 0.046) and desire to eat (P = 0.036). Post-hoc analyses indicated that pre-meal (-15min)
hunger and desire to eat were decreased on the 4th testing day relative to testing days 1
through 3, but postprandial appetite assessments (0min – 240min) were not influenced by
chronological testing order.
AUCs for hunger, desire to eat, and fullness were not influenced by the amount of
protein or fiber at breakfast (Figures 2, 3, 4). Ad libitum energy intake at lunch was also
not influenced by the protein and fiber content of the breakfasts (Table 3.2), and postlunch hunger, desire to eat, and fullness ratings were not different on any testing days nor
were they influenced by the breakfast intervention.
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Figure 3.2. Postprandial time course (left) and area under the curve (AUC) (right) for
hunger on the 4 testing days. Postprandial time points with different letters are
statistically different (main effect of time, Tukey-adjusted P < 0.05).

Figure 3.3. Postprandial time course (left) and AUC (right) for desire to eat on the 4
testing days. Postprandial time points with different letters are statistically different (main
effect of time, Tukey-adjusted P < 0.05).
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Figure 3.4. Postprandial time course (left) and AUC (right) for fullness on the 4 testing
days. Postprandial time points with different letters are statistically different (main effect
of time, Tukey-adjusted P < 0.05).
Table 3.2. Ad Libitum Energy Intake at Lunch1
Breakfast Type
Normal Protein + Normal Fiber
Normal Protein + High Fiber
High Protein + Normal Fiber
High Protein + High Fiber
1
All values are mean ± SEM.
3.4.3

Energy Intake (kcal)
553 ± 46
548 ± 60
539 ± 57
520 ± 64

Neural Responses to Visual Food Stimuli
Greater fasting-state responses to food vs. nonfood visual stimuli on the 1st testing

day were observed in the left and right insula, left and right amygdala, and left
orbitofrontal cortex (Table 3.3, Figure 3.5), but not the left and right caudate, left and
right putamen, or right orbitofrontal cortex. Fasting-state neural responses to visual food
stimuli in these 5 a priori brain regions were not influenced by chronological testing
order. A significant protein x fiber interaction (P = 0.029) was observed for the fastingstate left insula response. Post-hoc analyses indicated that the left insula response to
visual food stimuli was decreased after the HPHF 2-week breakfast intervention period (β
coefficient = 7.61 x 10-4 ± 2.35 x 10-4) compared to the HPNF intervention (β coefficient
= 1.34 x 10-3 ± 2.13 x 10-4). The fasting-state left insula response after the HPHF
intervention was numerically lower than those responses measured after the NPNF (β
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coefficient = 9.48 x 10-4 ± 2.64 x 10-4) and NPHF (β coefficient = 1.06 x 10-3 ± 1.43 x 104

) interventions, but these differences were not statistically confirmed.

Table 3.3. Responses to visual food vs. nonfood stimuli in the fasting-state on Day 1
MNI coordinates1
T value2
P value3
X
y
Z
Insula (L)
-38
-7
7
6.22
< 0.0001
Insula (R)
40
-5
4
5.94
< 0.0001
Amygdala (L) -23
0
-17
4.46
0.0006
Amygdala (R) 22
0
-20
4.20
0.0010
OFC (L)
-26
33
-18
4.12
0.0012
1
Stereotactic coordinates in MNI space for local maxima for the food vs. nonfood
contrast within each brain region of interest.
Brain Region

2

T values reported represent the results of single sample t-tests for comparison of mean
β coefficient of all voxels in each region for food vs. nonfood contrast to zero.

3

Uncorrected P values.

Abbreviations: MNI, Montreal Neurological Institute; OFC, orbitofrontal cortex; L, left;
R, right.
A time x protein interaction was observed for the right insula response to visual
food stimuli (P = 0.030) and post-hoc analyses indicated that postprandial responses were
decreased relative to fasting-state responses after consuming the normal protein (fastingstate β coefficient = 1.13 x 10-3 ± 1.53 x 10-4; postprandial β coefficient = 5.19 x 10-4 ±
1.51 x 10-4; Tukey-adjusted P = 0.017), but not high protein breakfasts (fasting-state β
coefficient = 9.58 x 10-4 ± 1.73 x 10-4; postprandial β coefficient = 8.99 x 10-4 ± 1.52 x
10-4; Tukey-adjusted P = 0.99). However, postprandial neural responses were not
statistically different following the normal protein and high protein breakfasts (Tukeyadjusted P = 0.13). Postprandial neural responses to visual food stimuli also tended to be
lower than fasting-state responses in the left amygdala (P = 0.065) and right amygdala (P
= 0.051).
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Figure 3.5. Fasting-state neural responses to visual food stimuli on Day 1. Greater
responses to visual food stimuli vs. nonfood stimuli (PROC TTEST, SAS, Version 9.3; P
< 0.005) were observed in the bilateral insula and amygdala and left orbitofrontal cortex.
Black circles represent functional regions of interest with 3mm radii within a priori brain
regions of interest with known reward functions. Images are in the axial plane and left
side of the figure corresponds to the right side of the body and vice versa. Display
threshold: p < 0.001 (uncorrected), minimum cluster size of 250 voxels.
Abbreviations: OFC, orbitofrontal cortex
3.4.4

Correlations
Ad libitum energy intake at lunch was not linearly correlated with postprandial

neural responses to visual food stimuli in any a priori brain regions of interest. The left
orbitofrontal cortex response was positively, linearly correlated with hunger and desire to
eat but was not linearly related to fullness. The left amygdala response was positively,
linearly correlated with desire to eat, but not with hunger or fullness. Lastly, the right
amygdala response was negatively, linearly correlated with fullness, but not linearly
correlated with hunger or desire to eat. Left and right insula responses were not linearly
correlated with any measure of subjective appetite (Table 3.4).
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Table 3.4. Correlations among postprandial neural responses and appetite and ad libitum
energy intake at lunch1
Brain Region
Energy Intake
Hunger
Desire to Eat
Fullness
Insula (L)
-0.18 (0.26)
0.084 (0.40)
0.075 (0.46)
-0.012 (0.91)
Insula (R)
-0.18 (0.24)
0.061 (0.55)
0.068 (0.50)
-0.030 (0.77)
Amygdala (L)
-0.093 (0.55)
0.15 (0.13)
0.23 (0.018)*
-0.16 (0.10)
Amygdala (R)
0.11 (0.49)
0.089 (0.38)
0.089 (0.38)
-0.21 (0.033)*
OFC (L)
0.047 (0.76)
0.29 (0.0029)*
0.34 (0.0005)*
-0.028 (0.78)
1
Values are reported as Pearson’s correlations coefficient and P values are in
parentheses.
* Significant linear correlation (α = 0.05)
Abbreviations: OFC, orbitofrontal cortex; L, left; R, right.
3.5

Discussion

The primary aim of this study was to assess whether altering the amount of
protein and/or fiber consumed at breakfast would influence ingestive behavior as
measured via subjective appetite ratings, neural responses to visual food stimuli, and ad
libitum energy intake at lunch. Contrary to our hypotheses, the discreet manipulation of
protein and fiber at breakfast had only limited and inconsistent effects on these outcomes.
Limited evidence for a greater suppression of motivation to obtain food following a
higher protein and higher protein and fiber breakfast is suggested by the observations that
1) 60min postprandial desire to eat was decreased to a greater extent following higher
protein compared to normal protein breakfasts and 2) fasting-state neural responses to
visual food stimuli in the left insula were numerically lowest after consuming the HPHF
breakfasts for 2 weeks. However, these data are contradicted by the observation that right
insula responses to visual food stimuli were decreased relative to fasting-state after
consuming normal protein, but not high protein, breakfasts.
The utilization of fMRI and visual food stimuli to investigate neural reward
influences on ingestive behavior has increased substantially in recent years, especially
since 2009 [30]. The selection of a priori reward-related brain regions of interest for the
current study was informed by meta-analytical findings of activation to food vs. nonfood
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visual stimuli in the insula, striatum, amygdala, and orbitofrontal cortex of normal weight
adults [31]. Further, overweight/obese individuals have been consistently shown to
demonstrate greater responses to visual food stimuli in the same brain regions compared
to normal weight individuals [30,32]. In the current study and using a block design,
visual food stimuli presented in the fasting state on the first testing day elicited greater
responses compared to nonfood stimuli in 5 of 10 a priori regions of interest (left and
right insula, left and right amygdala, and left orbitofrontal cortex).
Collectively, these brain regions work interactively to encode reward value and
influence motivated behavior [32]. More specifically, the insula interprets current,
previous, and predicted bodily states through interoception that guide behavioral decision
making. The insula is also characterized by a high density of dopamine and µ-opioid
receptors that contribute to its role in reward processing [33,34]. The amygdala has long
been associated with encoding fear and encouraging avoidance behavior. However, the
amygdala is now known to be heavily involved in positive affect as well and interacts
with the orbitofrontal cortex and sensory regions to adjust motivational state [35,36]. The
orbitofrontal cortex receives inputs from numerous brain regions including the anterior
cingulate cortex, amygdala, and hippocampus, which support its role in integrating
reward-related cues and making informed outcome predictions [37,38]. While the insula
was not associated with subjective measures of appetite in the current study, observed
linear correlations between the left amygdala and desire to eat, right amygdala and
fullness, and left orbitofrontal cortex and hunger/desire to eat support their roles in
encoding the reward value of visual food cues.
Previous research has demonstrated that neural responses to visual food cues are
attenuated following meal consumption in normal weight adults. However, neural
responses in the insula, amygdala, orbitofrontal cortex, and other reward-related brain
regions have been reported to be relatively unaffected by meal consumption in obese
adults [30]. Our results in overweight young adults are probably most comparable to
those of Leidy et al [14], which reported meal-induced reductions in responses to visual
food stimuli in the hippocampus, amygdala, cingulate, and parahippocampus 3hr after
eating compared to breakfast skipping. Furthermore, a high protein breakfast reduced
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insular and middle prefrontal cortex responses compared to a normal protein breakfast
[14]. The results of current study contrast with these findings. As regards a general effect
of meal consumption on neural responses, only non-significant trends for reduced 3hr
postprandial responses were observed in the left and right amygdala while left insula and
left orbitofrontal responses were unaffected by the consumption of breakfast. Contrary to
our hypotheses and to previous research [14], the consumption of normal protein
breakfasts reduced right insula responses compared to fasting-state responses but high
protein breakfasts did influence postprandial responses.
While the current and Leidy et al [14] studies both included individuals in the
overweight category and completed postprandial fMRI scanning 3hr after consuming
breakfast, a number differences in study designs exist that may have contributed to the
conflicting findings. Subjects in current study included both males and females aged, on
average, 26 years while Leidy et al recruited only females with an average age of 15
years [14]. Indeed, previous research has demonstrated that visual food stimuli caused
greater dorsolateral prefrontal cortex responses in women compared to men [25]. Another
fundamental difference between study subjects between the two studies is that Leidy et al
sought to study individuals who regularly skip breakfast (~5 times/week) [14], while the
current study used regular breakfast consumption (defined as ≥ 5 times/week) as an
inclusion criteria for study participation. Other notable differences between the two
studies include the energy content of the meals (400 vs. 490 kcals), protein amounts (NP:
12.5g vs. 18g; HP: 25g vs. 50g), lack of “breakfast skipping” condition in the current
study, and employment of a double-blind design with respect to protein (and fiber)
amounts in the current study [14]. Given the complexity of energy balance regulation
[39] and paucity of extant data on the influence of meal composition on postprandial
neural reward processing, further research is necessary to bring clarity to the role of
dietary protein and other nutrients in the modulation of reward-driven eating behaviors.
The amount of protein in the breakfast meals did not have a substantial influence
on subjective appetitive sensations or ad libitum energy intake at lunch served 4hr after
breakfast completion. Compared to normal protein breakfasts, higher protein breakfasts
decreased desire to eat at the 60min postprandial time point, but desire to eat was not
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different at 180min (time of postprandial scanning) or 240min (pre-lunch rating). Further,
postprandial AUCs for hunger, desire to eat, and fullness were also unaffected by the
protein and fiber content of the breakfasts. The effects of higher protein consumption on
postprandial appetite sensations are mixed, but in general, higher protein meals do appear
to have a modest beneficial effect on satiety [11,40]. However, it is important to note that
the majority of studies demonstrating increased satiety/fullness and/or decreased hunger
and desire to eat have utilized protein amounts that were greater than the current study. A
2004 review by Halton and Hu [11] noted that a majority of high protein meals
demonstrating a significant satiety effect were at least 40% protein as a percentage of
total energy compared to 25% in the current study. Although not rigorously tested, a
protein quantity threshold of 30g has been proposed to be necessary to elicit a satiety
effect [40]. If this is the case, the 25g high protein meal served in the current study may
not have been sufficient to substantially alter postprandial appetite sensations. However,
25g of protein represents a nearly doubling of protein intake at breakfast for adults as
reported in the NHANES 2011-2012 [12]. Considering the well-documented lack of
long-term adherence to dietary interventions [40], a more dramatic increase in dietary
protein is unlikely to maintained in a free-living condition.
Similar to protein, the addition of ~6 g of fiber at breakfast did not influence
subjective appetite sensations or ad libitum energy intake at lunch. Higher fiber intake
has been consistently associated with lower body weight and prevention of weight gain in
epidemiologic studies [17]. Despite a widespread belief that fiber enhances satiety,
empirical data supporting this claim are inconsistent and mixed [17,18]. One systematic
review concluded that the majority of studies evaluating the effects of higher fiber
diets/meals on appetite sensations and ingestive behavior did not support a beneficial role
of fiber, regardless of fiber type [18]. A previous systematic review, on the other hand,
concluded that more viscous fibers were more effective than less viscous fibers at
reducing appetite and energy intake [17]. The additional 6g of fiber in the high fiber
breakfast meals in the current study was derived from psyllium husk powder, which is
classified as a viscous fiber [17]. It is possible that difference in fiber between the normal
and high fiber breakfasts (2 g vs. 8 g) may not have been sufficient to elicit differential

105
appetite and ingestive behavior responses. However, data regarding the effect of fiber
dose on perceived satiety and ad libitum energy intake are unclear. For example, fiber
doses ranging from 5.0 – 7.4 g and 10.0 – 14.9 g appear to be most effective for
increasing satiety but doses of ≥ 30 g may be necessary to affect energy intake [18].
Similar to protein amounts, 8 g of fiber at breakfast represents more than a doubling of
“typical” fiber intakes amongst American adults [12] and larger increases in fiber intake
may be difficult to maintain long-term.
Strengths of the current study include the use of double-blind study design that
would be expected to limit potential biases of both the subjects and investigators, which
is especially important for a study with subjective variables such as appetite ratings.
Physiologically relevant a priori brain regions of interest with a history of responsiveness
to visual food stimuli paradigms were chosen for the current study. The addition of
objectively measured ad libitum energy intake at lunch represents another strength of the
current study that is commonly lacking from other fMRI studies. Limitations of the
current study include a relatively small sample size comprised of a homogenous study
population (young adults, overweight BMI). Therefore, caution is warranted when
interpreting and generalizing the results of this study to wider populations.
3.6

Conclusions

In conclusion, discreetly and modestly increasing protein and/or fiber amounts at
breakfast may not be effective strategies for modulating ingestive behavior in overweight
young adults. More profound alterations to protein and fiber intakes may be necessary to
achieve changes in ingestive behavior, but the practicality of adopting and sustaining
such large changes in eating behavior must be considered.
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4.1

Abstract

Background: Alterations in neural reward processing have been observed in obesity, and
the protein content of a meal and aerobic exercise have previously been shown to
modulate responses to visual food stimuli in reward-related brain regions.
Objective: The purpose of this randomized crossover pilot study was to utilize functional
magnetic resonance imaging (fMRI) to assess the acute effects of aerobic exercise and
dietary protein at dinner on neural responses to visual food stimuli and resting-state brain
activity in obese women.
Methods: Eight obese women (age: 29 ± 3 years, BMI: 35.0 ± 1.1 kg/m2) completed 4
testing days in random order: normal protein with rest, normal protein with exercise, high
protein with rest, and high protein with exercise. fMRI scans were completed 5 hours
after lunch and over a 4-hour period following the consumption of a normal or high
protein dinner. Subjects either rested or completed 30 minutes of aerobic exercise
immediately prior to dinner. A priori brain regions/networks of interest included bilateral
insula, amygdala, orbitofrontal cortex, caudate, and putamen and the default mode
network.
Results: Visual food stimuli presented before dinner elicited significant responses in the
bilateral insula, amygdala, and orbitofrontal cortex, but not the caudate or putamen.
Neural responses to visual foods stimuli and resting-state brain activity in the default
mode network were not affected by meal consumption or aerobic exercise.
Conclusion: The lack of meal-induced changes in neural responses to visual food stimuli
and resting-state brain activity provides further evidence of disruptions in reward
processing in obesity that may adversely affect ingestive behavior.
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4.2

Introduction

The influence of the brain’s reward system on ingestive behavior and obesity risk
has gained considerable interest in recent years [1]. Evidence from functional magnetic
resonance imaging (fMRI) studies suggest that obesity is associated with disordered
reward processing through multiple experimental paradigms including responses to visual
[2, 3] and olfactory [4, 5] food stimuli, consummatory responses to palatable foods [6],
and resting-state activity [7-10] in reward-associated brain regions and networks.
Consequently, researchers have begun to investigate potential interventions designed to
modulate reward processing and subsequently ingestive behavior [11-15].
Altering dietary protein at mealtimes is a promising option for such interventions
because increased dietary protein results in greater perceived satiety when substituted for
carbohydrates and/or fats [16, 17]. Protein intake also affects circulating concentrations
of hormones such as insulin, ghrelin, cholecystokinin, peptide YY, and glucagon-like
peptide 1that influence ingestive behavior through both homeostatic [18] and rewardassociated pathways [19-23]. In overweight breakfast-skipping adolescent girls,
consumption of a high protein breakfast led to greater reductions in pre-lunch neural
responses to visual food stimuli in the insula and middle prefrontal cortex [11] and in predinner responses in the hippocampus and parahippocampus [12] compared to
consumption of a normal protein breakfast.
Acute aerobic exercise is also a significant modulator of appetite and ingestive
behavior [24] and impacts circulating concentrations of hormones such as ghrelin,
peptide YY, and glucagon-like peptide 1 [25]. Acute aerobic exercise stimulates the
release of brain-derived neurotrophic factor, endocannabinoids [26], and endorphins [27],
which could have direct effects on reward processing. When fMRI scanning is performed
as soon as possible after an acute exercise bout, neural responses to images of highcalorie foods were reduced in normal weight individuals [13, 14], but not in
overweight/obese individuals [15]. To our knowledge, the effects of aerobic exercise on
neural responses to visual food stimuli at later postprandial time points are not known nor
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have potential interactive/additive effects with dietary protein been previously
investigated.
Therefore, the purpose of this randomized crossover pilot study was to utilize
fMRI to assess the acute effects of aerobic exercise and dietary protein at dinner on
neural responses to visual food stimuli and resting-state activity in obese women. We
hypothesized that 1) the consumption of dinner (regardless of the amount of protein in the
meal) would suppress postprandial neural responses to visual food in reward-associated
brain regions (bilateral insula, amygdala, orbitofrontal cortex, caudate, and putamen [28])
and decrease resting-state activity in the default mode network (DMN); 2) consumption
of a high protein dinner would further suppress these neural responses compared to a
normal protein dinner; and 3) acute exercise would result in greater neural responses to
visual food stimuli and resting-state DMN activity compared to rest only when performed
prior to the completion of a normal protein dinner.
4.3
4.3.1

Methods

Subjects
Nine women were recruited from the greater Lafayette, IN community to

participate in a fMRI research study at Purdue University (Figure 4.1). Eight of the
women completed all study procedures. Inclusion criteria for this study were: female; age
18 – 45 y; obese BMI (30.0 – 40.0 kg/m2); weight stable (± 3 kg for previous 6 mo); not
participating in organized sports or regular exercise (≥ 2 d/wk); no tobacco use; no
diabetes; not pregnant or lactating for 6 months; not claustrophobic; no implanted
pacemakers/automated defibrillators or ferromagnetic metal. All subjects provided
written informed consent and received a monetary stipend. The consent form and all
study procedures and documents were approved for use by the Purdue University
Biomedical Institutional Review Board.
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4.3.2

Experimental Design
Subjects completed 5 testing days for this research study and all testing days were

separated by ≥ 7 days (mean: 10 days, range: 7 – 14 days). Aerobic fitness (maximal
oxygen consumption) was estimated using a YMCA submaximal protocol [29] on a cycle
ergometer (Monark, Ergomedic 828E, Vansbro, Sweden) on the first testing day. On the
remaining 4 testing days, subjects completed fMRI and appetite assessments under the
following experimental conditions in random order: normal protein with rest, normal
protein with exercise, high protein with rest, and high protein with exercise.
Breakfast, lunch, and all beverages were provided to subjects by a research
dietitian and dinner was served at the Purdue University MRI Facility on fMRI scanning
testing days. Breakfast and lunch were identical on all 4 testing days. Breakfast was
served at 0800 and was designed to provide 20% of the subjects’ estimated daily energy
requirements. Lunch was served at 1200 and provided 30% of subjects’ estimated daily
energy requirements. The macronutrient distributions of the breakfast and lunch meals
were 15% protein, 60% carbohydrate, and 25% fat.
Subjects arrived at the Purdue University MRI Facility at 1700 (5 hours after
consuming lunch) and completed appetite and fMRI assessments upon arrival. For
descriptive purposes, this time point will be referred to as “fasting-state.” Subjects
completed a second appetite assessment and then either rested for 30 minutes or
performed 30 minutes of aerobic exercise on a cycle ergometer (Monark, Ergomedic
828E, Vansbro, Sweden) at 60% of their estimated maximal oxygen consumption. Dinner
was served at ~1800 and was designed to provide 30% of the subjects’ estimated daily
energy requirements. The macronutrient distribution of the normal protein dinners were
15% protein, 60% carbohydrate, and 25% fat. The macronutrient distribution of the high
protein dinners were 30% protein, 45% carbohydrate, and 25% fat. Subjects and
investigators (except AJW) were blinded to the macronutrient contents of the dinner
meals. Subjects completed appetite assessments immediately prior to and after
consuming dinner. Additional appetite and fMRI assessments were completed 60, 150,
and 240 minutes after the completion of dinner.
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The breakfast, lunch, and dinner meals collectively provided 80% of the subjects’
estimated daily energy requirements, and subjects were unaware of this modest energy
restriction. Daily energy requirements were estimated using weight status-, age-, gender-,
and physical activity-dependent equations published by the Institute of Medicine [30]. All
diet-related activities and assessments were performed in conjunction with in conjunction
with the National Institutes of Health-supported Indiana Clinical Research Center
Bionutrition Facility at Purdue University.
4.3.3

Body Mass Index
Body mass was measured using a digital platform scale (Ohaus, ES200L, Toledo,

OH, USA) and height was measured using a wall-mounted stadiometer (Holtain Ltd.,
Crymych, Wales, UK). These measurements were used to calculate each subject’s body
mass index in kg/m2.
4.3.4

Appetite Assessments
Subjects rated their hunger, desire to eat, and fullness on continuous visual analog

scales (VAS) [31] using Adaptive Visual Analog Scales software [32].
4.3.5

Visual Food Stimuli fMRI Data Acquisition
Functional imaging was performed using a 3.0 Tesla magnetic resonance scanner

(General Electric, Signa HDx, Milwaukee, WI, USA) while subjects were lying quietly in
a supine position and presented with visual stimuli using NordicNeuroLab’s
VisualSystem (Bergen, Norway). Visual stimuli consisted of images of food of high
hedonic value and neutral nonfood-related objects, which were previously validated [33]
and utilized in previously published reports [34-39]. Head movement was limited by
placing foam pads behind the subjects’ necks and between the 16-channel head coil
(Nova Medical, Inc., Model NMSC-025A, Wilmington, MA) and all sides of the subjects’
heads. A localizer scan was prescribed and centered at the subjects’ brow line. The type,
number and placement of foam pads, the location of subjects inside of the fMRI scanner,
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and the location of localizer prescription were noted on the first testing day and replicated
to the greatest extent possible for all subsequent fMRI scanning sessions.
Three functional runs were performed during each fMRI session. Each run
consisted of 3 blocks of visual food stimuli and 3 blocks of visual nonfood stimuli
presented in a pseudorandomized order using PsychoPy, Version 1.76.00 [40]. Each
block of visual stimuli lasted 30 seconds and included 10 images presented for 2.5
seconds each with a 0.5 second fade between each image. Blocks of a low-level baseline
stimulus (fixation cross) lasting 16 seconds each were presented before the first visual
stimuli block, in between blocks of visual stimuli, and after the final visual stimuli block.
Functional images were acquired with an echo-planar gradient-echo T2* blood
oxygenation level dependent (BOLD) contrast sequence, with TR = 2000 ms, TE = 30 ms,
642 matrix, 20 cm2 field of view, 40 slices to cover the whole brain, 3.1 mm think, and no
gap between slices. A high resolution, T1-weighted anatomical scan was completed after
functional imaging for coregistration with functional images.
4.3.6

Visual Food Stimuli fMRI Data Processing and Analysis
fMRI data preprocessing and first-level fMRI data analyses (food vs nonfood

BOLD contrasts) were completed using AFNI (http://afni.nimh.nih.gov) [41]. The first
five volumes of each functional run (presented during the fixation cross block) were
excluded to eliminate any T1 relaxation effects that may have been present due the
relatively short TR of 2000 ms. Functional runs were then slice-time corrected, motion
corrected to the first non-excluded image of the first functional run, smoothed using a 4.0
mm Gaussian blur, and the signal was normalized. Motion and slice-time corrected
functional runs were then aligned with the high resolution anatomical scan.
Censor files were created to identify volumes within each functional run with
excessive head motion (>2.5 mm). Those volumes that were censored were excluded and
the six (roll, pitch, yaw, left-right, superior-inferior, anterior-posterior) motion time-series
were included as covariates in the first-level, food vs. nonfood contrast regression model.
The resulting food vs. nonfood contrast was expressed as a β coefficient for each fMRI
session.
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We first examined a priori regions of interest (bilateral brain regions with known
reward functions: insula, amygdala, orbitofrontal cortex [28], caudate, and putamen [42])
to search for local maxima from the food vs. nonfood BOLD contrast during the fasting
fMRI session on the first testing day. Spherical regions of interest with a 3mm radii
centered at the local maxima were then created to form each functional region of interest.
Regions of interest obtained from the fasting-state fMRI scan on the first testing day were
used again for all subsequent fMRI scanning sessions.
4.3.7

Resting-State fMRI Data Acquisition
Resting-state fMRI scans were completed during the fasting-state and 60 minute

postprandial scanning sessions. Therefore, equipment and methods for localization and
head/neck stability are the same as above. For resting-state scans, the screen on the
goggles was turned off and subjects were instructed to close their eyes and relax but to
remain awake. Resting-state functional images were acquired with an echo-planar
gradient-echo T2* blood oxygenation level dependent (BOLD) contrast sequence, with
TR = 1500 ms, TE = 21.4 ms, 64x64 matrix, 20 cm2 field of view, 38 slices to cover the
whole brain, 3.1 mm slice thickness, and no gap between slices.
4.3.8

Resting-State fMRI Data Processing and Analysis
Resting-state fMRI data preprocessing were completed using AFNI

(http://afni.nimh.nih.gov) [41] and Physiologic Estimation by Temporal ICA (PESTICA).
After removing the first 4 volumes, functional images were corrected for head motion
(AFNI) and cardiorespiratory noise (PESTICA). Additional preprocessing steps were
completed in AFNI and included identifying and censoring outlier volumes, despiking,
slice-time correction, anatomical-to-functional alignment, and segmentation, resampling,
blurring, and recombination of gray matter, white matter, and cerebrospinal fluid.
Functional images were then prepared for regression, which included censoring of outlier
volumes, motion regressors, and bandpass regressors.
Preprocessed functional images were then concatenated and input into FSL’s
MELODIC (Multivariate Exploratory Linear Optimized Decomposition into Independent

119
Components) program to create 20 independent components for fasting-state and 60 min
postprandial fMRI scans on each of the 4 testing days for each subject (8 total). These
components were then examined to identify the component that contains the default mode
network (DMN) for each of the 8 scanning sessions in each of the 8 subjects. These 64
components were then averaged together to create a DMN mask that was used to extract
data from the components within the mask. Only voxels with a z-score of 3 or higher
were included in the DMN mask. DMN activity was exported as a z-score for each
subject and scanning session. This z-score was treated as a continuous variable for
comparisons among time points and interventions.
4.3.9

Statistical Analysis
Mean β coefficients (average of all voxels in each region of interest) representing

the first-level, food vs. nonfood BOLD contrasts from the fasting-state and 3 postprandial
(60 min, 150 min, and 240 min) fMRI scans were analyzed using single-sample Student’s
t-tests (SAS, Version 9.3, PROC TTEST) to determine if the contrasts were significantly
different from zero. Only regions of interest demonstrating significant food vs. nonfood
BOLD contrasts at this time were considered for further analyses. A Bonferroni
correction was applied to correct for multiple comparisons among 10 a priori brain
regions of interest (α = 0.05 / 10 = 0.005).
Repeated measures ANOVA (SAS, Version 9.3, PROC MIXED) was used to
assess the effects of chronological testing order (Day 1 vs. Day 2 vs. Day 3 vs. Day 4) on
fasting-state appetite (hunger, desire to eat, fullness) ratings and neural responses to
visual food stimuli (mean β-coefficients for food vs. nonfood contrasts). Total area under
the curve (AUC) was calculated using the trapezoidal rule for postprandial appetite
ratings and neural responses to visual food stimuli. Repeated measures ANOVA (SAS,
Version 9.3, PROC MIXED) was used to assess the effects of chronological testing order,
protein (high vs. normal), exercise (rest vs. exercise), and interactions on AUCs for
postprandial appetite ratings and neural responses to visual foods stimuli.
Doubly repeated measures ANOVA (SAS, Version 9.3, PROC MIXED) was used
to assess the effects of chronological testing order, time (-45 min [pre-exercise/rest] vs. -
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15 min [post-exercise/rest, pre-dinner] vs. 0 min [immediately after dinner consumption]
vs. 60 min vs. 150 min vs. 240 min), protein, exercise, and interactions on appetite
ratings. The same doubly repeated measures ANOVA model was used to assess these
effects on neural responses to visual food stimuli (fasting-state vs. 60 min vs. 150 min vs.
240 min) and resting-state DMN activity (fasting-state vs. 60 min).
A Tukey-Kramer adjustment was utilized as needed for post-hoc analyses. Linear
correlations among brain reward responses and appetite ratings were assessed using
Pearson’s correlation coefficients (SAS, Version 9.3, PROC CORR). Data are presented
as mean ± SEM and significance was set at α = 0.05 unless otherwise noted.
4.4
4.4.1

Results

Subject Characteristics
On average, subjects were 29 ± 3 years and had a BMI of 35.0 ± 1.1 kg/m2.

4.4.2

Fasting-state Appetite and Neural Responses
Fasting-state ratings of hunger, desire to eat, and fullness were not different on

Days 1, 2, 3, and 4. Visual food stimuli presented at the fasting-state time point elicited
greater responses compared to nonfood stimuli (P < 0.005) in the left and right insula,
amygdala, and orbitofrontal cortex, but not the caudate or putamen (Figure 4.2, Table
4.1). Therefore, postprandial neural responses in the caudate and putamen were not
investigated. A trend for a main effect of chronological testing order on fasting-state
neural responses to visual food stimuli was found in the left insula (P = 0.05), left
amygdala (P = 0.06), and right orbitofrontal cortex (P = 0.08). Post-hoc analyses
indicated that responses on Day 1 tended to be greater than Day 3 in these regions, but
the differences were not statistically confirmed after adjusting for multiple comparisons
(Tukey-Kramer).
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4.4.3

Postprandial Appetite and Neural Responses
Postprandial hunger AUC was greater on exercise compared to rest days (Figure

4.3), but AUCs for postprandial desire to eat and fullness were not influenced by exercise
(Supplemental Figures 4.4 and 4.5). AUCs for postprandial appetite ratings were not
influenced by the amount of protein consumed at dinner. Postprandial AUCs for neural
responses to visual food stimuli in the left and right insula, amygdala, and orbitofrontal
cortex were not influenced by exercise or the amount of protein consumed at dinner
(Supplemental Figures 4.6, 4.7, 4.8, 4.9, 4.10, and 4.11). No significant linear
correlations among AUCs for appetite ratings and brain responses were observed (data
not shown).
The results of the doubly repeated measures ANOVA model indicated a main
effect of time on hunger, desire to eat, and fullness that was not further influenced by the
amount of protein at dinner or the acute bout of exercise/rest (Figure 3, Supplemental
Figures 1 and 2). Appetite ratings were not influenced acutely by the bout of exercise/rest
(-45min vs. -15min). Compared to pre-dinner (-15min), hunger and desire to eat ratings
were decreased and fullness ratings increased 0, 60, 150, and 240 minutes after
consuming dinner. No effect of chronological testing order was observed.
With data from all 4 testing days combined, food stimuli elicited greater
responses compared to nonfood stimuli the left and right insula, amygdala, and
orbitofrontal cortex at all postprandial time points with the exception of the right insula
response 60 minutes after dinner (Table 4.2). A significant time x protein interaction was
observed for the right amygdala response to visual food stimuli. Compared to the fastingstate response, the right amygdala response was suppressed 60 minutes after consuming a
normal protein dinner, but not high protein dinner (Supplemental Figure 4.9). This effect
was largely driven by a trend for a difference in fasting-state responses (normal protein β
coefficient: 1.48 x 10-3 ± 2.81 x 10-4; high protein β coefficient: 5.89 x 10-4 ± 2.27 x 10-4;
Tukey-Kramer adjusted P = 0.09). Right amygdala responses to visual food stimuli were
not different 60 minutes after consuming a normal (β coefficient: 5.41 x 10-4 ± 1.74 x 10-4)
vs. high protein dinner (β coefficient: 8.35 x 10-4 ± 3.15 x 10-4; Tukey-Kramer adjusted P
= 0.96). No additional effects of chronological testing order, time, protein, exercise, or
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interactions were observed for neural responses to visual food stimuli (Supplemental
Figures 4.6, 4.7, 4.8, 4.10, and 4.11). No significant linear correlations among appetite
ratings and brain responses were observed (data not shown).
4.4.4

Resting-State Brain Activity
Resting-state activity in the DMN was not different on the 4 testing days in the

fasting-state. DMN activity was not influenced by dinner consumption, aerobic exercise,
or the amount of protein consumed at dinner (Figure 4.12).
4.5

Discussion

The purpose of this randomized crossover pilot study was to investigate the acute
effects of aerobic exercise and the amount of dietary protein consumed at dinner on
neural responses to visual food stimuli and resting-state activity in the DMN of obese
women. Contrary to our hypotheses, postprandial neural responses to visual food stimuli
and resting-state DMN activity were largely unaffected by the consumption of dinner
regardless of the protein content of the meal or whether subjects completed a bout of
aerobic exercise or rested prior to eating. Our hypotheses regarding protein- and/or
exercise-induced modulation of postprandial neural responses to visual food stimuli and
resting-state DMN activity were predicated on the assumption of a main effect of time
after dinner consumption on these outcomes (as was observed for postprandial hunger,
desire to eat, and fullness ratings). The lack of an observed main effect of meal
consumption on these neural outcomes hindered our ability to determine modulatory
effects of protein and/or exercise in this group of obese women.
Attenuated neural responses to visual food stimuli following a meal have been
reported in normal weight adolescents [43] and adults [3] and also overweight adolescent
girls [11]. However, our results are consistent with previous research demonstrating that
obese adults have persistent responses to visual food stimuli in the postprandial state in
the insula, amygdala, orbitofrontal cortex, caudate, pre-frontal cortex, and anterior
cingulate [3] and in the insula and pre-frontal cortex of those identified as “obesity-prone”
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[38]. Our findings extend those of previous research by demonstrating a lack of mealinduced changes in neural responses to visual food stimuli in the insula, amygdala, and
orbitofrontal cortex in multiple fMRI scans over a 4-hour postprandial period.
Collectively, these data provide more evidence for disruptions in reward processing with
obesity and suggest that food may retain its reward value in the postprandial state in
obese relative to normal weight individuals.
Emerging data also suggest that resting-state functional connectivity in brain
networks associated with ingestive behavior may be differentially affected by food intake
in lean vs. obese individuals. Using a seed-based approach, Lips et al. [9] observed mealinduced alterations in resting-state functional connectivity between the hypothalamus,
bilateral insula, and dorsal striatum of lean individuals while the functional connectivity
of these regions was unaffected by meal consumption in obese individuals. Interestingly,
the post-meal pattern of connectivity among these regions in lean individuals resembled
that of the obese individuals in the fasted-state. These results may suggest an inability to
effectively evaluate hunger and satiety cues in obesity [9]. Our results further support a
lack of meal-induced changes resting-state brain activity in obesity that may influence
ingestive behavior.
While neural responses to visual food stimuli and resting-state activity were not
influenced by the consumption of dinner in this group of obese women, a strong main
effect of time after the meal was observed for hunger, desire to eat, and fullness ratings.
However, appetite ratings were not influenced by the amount of protein in the meal when
assessed as either time x diet interactions or using an AUC approach. A number of
possibilities exist that may have contributed to this lack of a protein effect. First, hunger
and desire to eat remained suppressed and fullness increased throughout the entire 4-hour
postprandial period. This may have resulted in floor and ceiling effects for hunger and
desire to eat and fullness, respectively, whereby further suppression/enhancement of
appetite sensations by the high protein dinner would be difficult to observe. Second, the
time of day has been previously shown to influence protein’s effects on appetite
sensations. A high protein breakfast increased fullness compared to a normal protein
breakfast, but there was no difference in postprandial fullness following the normal vs.
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high protein lunch or dinner [44]. Third, it has been suggested that 30 grams of protein is
necessary to elicit satiety responses [45], and increasing protein from 30 to 65 grams at
dinner may not lead to a further suppression of hunger (Supplemental Figure 4.13;
Paddon-Jones et al., unpublished observations). In the current study, the normal and high
protein dinners provided 30 ± 1 and 61 ± 2 grams of protein, respectively, and appetite
ratings did not differ following the two dinners, which supports these previous
observations. Lastly, the small number of subjects in this pilot study may not have
provided sufficient statistical power to observe differences in postprandial appetite
ratings.
However, postprandial hunger AUC was increased on exercise compared to rest
testing days, which supports the suitability of the current study to observe interventionlevel effects. Exercise has been previously shown to have variable effects on perceptions
of appetite and ingestive behavior [24]. The majority of acute studies demonstrate no
effect of exercise on perceptions of appetite or subsequent energy intake [46, 47],
although some studies have observed increased hunger after exercise [48, 49]. Most
studies of the effects of exercise on appetite and/or ingestive behavior have utilized a preload study design. In these cases, appetite ratings are collected for a specified amount of
time after completing the bout of exercise and ad libitum energy intake may or may not
be measured. We utilized a different approach in the current study, which may partially
explain differences in our results compared to the majority of previous studies.
In the current study, subjects consumed fixed-energy dinners immediately after
the exercise/rest bouts and additional appetite ratings were collected in the postprandial
period. This study design allows for the assessment of the satiety value of a meal. King et
al [50] found that the satiety value of a fixed breakfast was increased after 12 weeks of
supervised exercise training. However, data on the acute effects of exercise compared to
rest on the satiety value of a fixed meal in sedentary adults are poorly understood.
Previous research has found that acute exercise increased satiety responses to a 75 g
glucose drink in type-2 diabetic adults [51], but in a group of normal weight,
recreationally active men aerobic exercise completed 120 minutes prior to eating
decreased the satiety value of the meal [52]. The observed increase in postprandial
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hunger AUC on exercise days in the current study suggests that acute aerobic exercise
may decrease the satiety value of a fixed-energy dinner in sedentary obese women, which
may influence ingestive behavior later in the evening. Larger studies incorporating an ad
libitum energy intake component should be conducted to further elucidate the effects of
acute and chronic exercise on meal-induced satiety in obesity.
Strengths of the current study include the use of double-blind conditions with
respect to the protein content of the dinner meals and also the strict control of energy
intake on testing days. The decision to study only obese women may represent both a
strength and a limitation. The use of a homogenous group of subjects may decrease the
variability in study outcomes, which would increase the statistical power of this pilot
study. On the other hand, our results have generally poor generalizability and are
applicable to only young to middle-aged obese women. The primary limitation of the
current study is the small sample size, which may not have provided sufficient statistical
power, especially for the doubly repeated measures ANOVA utilized for some outcomes.
In conclusion, visual food stimuli elicited significant responses in reward-related
brain regions of obese women that persisted after the consumption of a normal or high
protein dinner and were not influenced by an acute bout of aerobic exercise. These results
provide more evidence of disrupted reward processing in obesity that may adversely
affect ingestive behavior.
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Table 4.1. Responses to visual food vs. nonfood stimuli in the fasting-state
MNI coordinates1
T value2
P value3
x
y
z
Insula (L)
-36
-7
8
5.72
< 0.0001
Insula (R)
38
-1
6
3.84
0.0006
Amygdala (L)
-24
0
-17
3.91
0.0005
Amygdala (R)
25
1
-16
5.17
< 0.0001
OFC (L)
-23
37
-19
6.06
< 0.0001
OFC (R)
24
31
-20
4.75
< 0.0001
1
Stereotactic coordinates in MNI space for local maxima for the food vs. nonfood
contrast within each a priori brain region of interest.
Brain Region

2

T values reported for mean β coefficient of all voxels in each region for food vs nonfood
contrast.
3

Uncorrected P values.

Single sample t-tests (PROC TTEST, SAS, Version 9.3) indicated that visual food stimuli
elicited greater brain responses compared to nonfood stimuli in the bilateral insula,
amygdala, and orbitofrontal cortex (P < 0.005). A Bonferroni correction was applied for
determination of statistical significance (α = 0.05 / 10 a priori ROI = 0.005).
Abbreviations: MNI, Montreal Neurological Institute; L, left; R, right; OFC, orbitofrontal
cortex.

240 min
7.03 x 10-4 ± 9.45 x 10-5 *
4.19 x 10-4 ± 9.85 x 10-5 *
1.07 x 10-3 ± 2.00 x 10-4 *
7.63 x 10-4 ± 1.78 x 10-4 *
1.15 x 10-3 ± 2.15 x 10-4 *
6.21 x 10-4 ± 1.82 x 10-4 *

Abbreviations: min, minutes; L, left; R, right; OFC, orbitofrontal cortex.

Single sample t-tests (PROC TTEST, SAS, Version 9.3) indicated that visual food stimuli elicited greater
postprandial neural responses compared to nonfood stimuli in the bilateral insula, amygdala, and
orbitofrontal cortex with the lone exception of the right insula response 60 minutes after dinner. A
Bonferroni correction was applied for determination of statistical significance (α = 0.05 / 10 a priori ROI
= 0.005).

* Food > Non-food, P < 0.005.

Brain Region

Postprandial Time Point1
60 min
150 min
Insula (L)
8.64 x 10-4 ± 1.36 x 10-4 * 7.77 x 10-4 ± 1.29 x 10-4 *
Insula (R)
3.30 x 10-4 ± 1.49 x 10-4
5.22 x 10-4 ± 1.27 x 10-4 *
Amygdala (L) 7.90 x 10-4 ± 2.03 x 10-4 * 7.61 x 10-4 ± 1.74 x 10-4 *
Amygdala (R) 6.93 x 10-4 ± 1.80 x 10-4 * 8.88 x 10-4 ± 1.58 x 10-4 *
OFC (L)
1.43 x 10-3 ± 2.25 x 10-4 * 1.55 x 10-3 ± 2.66 x 10-4 *
OFC (R)
6.87 x 10-4 ± 1.92 x 10-4 * 8.46 x 10-4 ± 1.91 x 10-4 *
1
Values reported as mean β coefficient ± SEM.

Table 4.2. Postprandial neural responses to visual food stimuli
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Figure 4.1. Study recruitment flow diagram.
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Figure 4.2. Fasting-state neural responses to visual food stimuli. Greater responses to
visual food compared to non-food stimuli were observed in the bilateral insula, amygdala,
and orbitofrontal cortex. A Bonferroni correction was utilized to correct for 10 a priori
brain regions of interest. Responses were considered significant when P < 0.005. A
threshold was applied to display only regions with a significant food vs. non-food
contrast.
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Figure 4.3. Time course of hunger ratings and postprandial hunger AUC. Hunger was
suppressed following the consumption dinner and remained decreased relative to predinner ratings throughout the 4-hour postprandial period. Hunger AUC was increased on
exercise compared to rest testing days, but the amount of protein consumed at dinner did
not influence postprandial hunger AUC.
Time points with different letters are significantly different (main effect of time).
* Exercise > rest, P < 0.05.
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Figure 4.4. Time course of desire to eat ratings and postprandial desire to eat AUC.
Desire to eat was suppressed following the consumption dinner and remained decreased
relative to pre-dinner ratings throughout the 4-hour postprandial period.
Time points with different letters are significantly different (main effect of time).
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Figure 4.5. Time course of fullness ratings and postprandial fullness AUC. Fullness was
increased following the consumption dinner and remained increased relative to pre-dinner
ratings throughout the 4-hour postprandial period.
Time points with different letters are significantly different (main effect of time).
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Figure 4.6. Left insula responses to visual food stimuli and postprandial left insula
responses AUC. Left insula responses to visual food stimuli were not influenced
generally by meal consumption nor were they influenced by the exercise or the amount of
protein in the dinner meal.
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Figure 4.7. Right insula responses to visual food stimuli and postprandial right insula
responses AUC. Right insula responses to visual food stimuli were not influenced
generally by meal consumption nor were they influenced by the exercise or the amount of
protein in the dinner meal.
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Figure 4.8. Left amygdala responses to visual food stimuli and postprandial left
amygdala responses AUC. Left amygdala responses to visual food stimuli were not
influenced generally by meal consumption nor were they influenced by the exercise or
the amount of protein in the dinner meal.
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Figure 4.9. Right amygdala responses to visual food stimuli and postprandial right
amygdala responses AUC. Postprandial right amygdala AUC was not influenced by the
amount of protein consumed at dinner or exercise. A significant time x protein
interactions was observed such that right amygdala responses were decreased at the 60
min postprandial time point relative to fasting-state after consumption of normal protein
dinners. However, post-hoc analyses indicated no differences in 60 min postprandial right
amygdala responses between normal and higher protein dinners.
* Fasting-state > 60 min
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Figure 4.10. Left orbitofrontal cortex responses to visual food stimuli and postprandial
left orbitofrontal cortex responses AUC. Left orbitofrontal cortex responses to visual food
stimuli were not influenced generally by meal consumption nor were they influenced by
the exercise or the amount of protein.
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Figure 4.11. Right orbitofrontal cortex responses to visual food stimuli and postprandial
right orbitofrontal cortex responses AUC. Right orbitofrontal cortex responses to visual
food stimuli were not influenced generally by meal consumption nor were they
influenced by the exercise or the amount of protein.
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Figure 4.12. Combined visual representation of resting-state default mode network.
Default mode network activity was not influenced by dinner consumption or acute
aerobic exercise.

140

Figure 4.13. Effects of dietary protein on hunger ratings after breakfast and dinner.
Compared to 10 g of protein, consumption of 30 g of protein at breakfast decreased
hunger ratings. However, consumption of 65 g of protein at dinner did not result in a
greater suppression of hunger compared to the consumption of 30 g of protein.
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS

5.1

Research Conclusions

As detailed in Chapter 2, the reliability of a research technique can have profound
implications on experimental design and the interpretation of data from studies which
utilized that particular technique. In our test-retest reliability study, neural responses to
visual food stimuli demonstrated a somewhat paradoxical discrepancy between mean or
group-level and within-subject reliability. At the group level, the visual food stimuli
paradigm clearly activated reward-related brain regions of interest on both testing days.
However, the test-retest reliability (a marker of within-subject variability) of neural
responses to visual food stimuli was generally quite poor. These observations lend to the
conclusion that the use of repeated fMRI scans on the same subject in a study requires
special attention to certain experimental design characteristics. In particular, investigators
must utilize robust randomization procedures and include period or chronological testing
order in all statistical models to ensure that differences in neural responses cannot be
explained simply by day-to-day variability in responses. Also, the ability to statistically
observe correlations among study outcomes is severely compromised when the
techniques used to measure these outcomes are characterized by poor reliability. In the
case of the fMRI studies included in this document, it is difficult to interpret the potential
implications of a response in a brain region if that response cannot be consistently
correlated with or predictive of another measure of motivation or ingestive behavior (e.g.
desire to eat, energy intake).
A second common finding in the studies presented herein was a general lack of
meal-induced changes in neural responses to visual food stimuli. These observations are
consistent with previously published of other published research in overweight and obese
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individuals, which also consistently demonstrate persistent responses to food-relevant
stimuli in reward-related brain regions in the postprandial state. On the other hand,
published research in normal weight individuals demonstrate reduced responsivity to
food cues, and theoretically a devaluation of food reward, after a meal. Collectively, the
results of the studies herein further support the theory of disrupted neural reward
processing in response to food-relevant stimuli in overweight and obese individuals.
Studies 2 and 3 sought to investigate potential modulatory effects of dietary
protein and fiber (Study 2) and dietary protein and aerobic exercise (Study 3) on
postprandial neural responses to visual food stimuli and other “traditional” measures of
ingestive behavior. The lack of a general meal-induced suppression of neural responses
may have hindered the ability of the current studies to demonstrate further modulation by
protein, fiber, and/or exercise. On the other hand, it could be argued that a theoretically
more satiating meal (e.g. high protein) would be more likely to suppress neural reward
responses. Regardless of the reason, no consistent effects of our interventions on neural
responses to visual foods stimuli were observed. Further, only limited intervention effects
on appetite ratings were observed (transient decrease in desire to eat with high protein,
increased hunger AUC on exercise days), which supports the lack of effect on neural
responses. Importantly, a strong main effect of time on appetite ratings (decreased hunger
and desire to eat and increased fullness) was observed following the meal in all three
studies, and these changes relative to fasting-state were present at the time of postprandial
scanning. Therefore, if neural responses to visual food stimuli were highly dependent
upon perceived sensations of appetite, it would be expected that alterations in the
responses would have been observed as well.
As regards dietary protein specifically, two aspects of our study designs may have
contributed to the lack of observed effects of higher protein intake on appetite ratings.
First, subjects in Studies 2 and 3 were blinded to the protein content of the meals. In
Study 2, subjects were aware of the protein component of the intervention but both
investigators and subjects were blinded to the intervention order. In Study 3, subjects
were not informed that meals varied by protein content among the interventions and
investigators were blinded to the protein content of the meals until after statistical
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analyses. Dietary protein is widely recognized as a “satiating” macronutrient and it is
therefore possible that blinding subjects (and investigators) to the protein content of
meals may have abolished any potential cognitive effects and personal biases of protein
on appetite ratings.
Second, the higher protein meals provided 25 g and ~60 g of protein in Study 2
and Study 3, respectively. Though empirical data supporting the hypothesis are limited, it
has been proposed that 30 g of protein may be necessary to elicit beneficial changes in
appetite and ingestive behavior and that increasing protein intake beyond 30 g may not
result in further changes in these outcomes. Therefore, it is possible that the protein
amount served in Study 2 may not have met this purported threshold. Although, it seems
unlikely that an additional 5 g of protein would substantially alter observed appetite
ratings in Study 2. The amount of protein served to subjects in Study 3 clearly met the
potential 30 g threshold, but the normal protein dinner also provided ~30 g of protein. If
the protein threshold/ceiling effects are true, it may be possible that further suppression of
hunger or enhancement of satiety with 60 g of protein was unlikely to be observed. This
theory is supported by the observation that hunger and desire to eat ratings remained
suppressed and fullness increased throughout the entire 4 hr postprandial period.
In conclusion, the results of Study 1 suggest that future investigators and readers
need to consider potential issues regarding the reliability of fMRI-based studies of
ingestive behavior. In my reading of this literature, I have not found this issue to have
been raised by any authors despite its potential to profoundly influence observed study
results. The observation of persistent neural responses to visual food stimuli yet
significantly altered appetite ratings in the postprandial state across all three studies
supports a disruption of reward processing in overweight and obesity and suggests a
potential disconnect between reported appetite sensations and neural reward responses.
5.2

Future Directions

As is often the case, the findings from these three research projects – in particular
Study 1 – have raised more questions than answers. An attempt to replicate our
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observation of generally poor test-retest reliability of neural responses to visual food
stimuli should be a priority. If our results are confirmed, future research should focus on
potential strategies to improve the reliability of the measurement of these responses.
Sources of unreliability in our study design could have resulted from some intrinsic
limitations of either the fMRI technology, in particular the BOLD signal, or the visual
stimulus presentation. Alternatively, the subjects represent a potential major source of
variability that likely affects the reliability assessments. In all likelihood, a combination
of intrinsic limitations of the study and unaccounted within-in subject variability
contribute to the observed poor reliability in Study 1.
As was mentioned in the Discussion of Study 1, a review of fMRI-based studies
across multiple experimental designs concluded that the test-retest reliability of these
studies was generally only fair (ICC = 0.50). This suggests that fMRI studies utilizing a
BOLD signal approach are limited in their ability to produce highly reliable results. The
potential to develop new fMRI-based imaging techniques that are not dependent on the
blood oxygenation contrast therefore represents one avenue for improving the reliability
of fMRI-based results. In our reliability study, subjects were exposed to the same 180
food and nonfood images (90 of each) in a block design. We observed significant mean
activation on both testing days in our a priori brain regions of interest, but we did
observe that the results were statistically reduced on Day 2 in the left insula and right
amygdala. This suggests that some habituation to the stimuli may be occurring, and
future research should determine whether presentation of novel stimuli improves both
group- and individual-level reliability. The nature of the stimuli could also affect the
response. For example, we used images of food but visual food stimuli could also include
videos that may produce different results. We also used a block design, which is very
common in this particular field of study. Additional research testing the reliability of
other study designs (e.g. event-related) also should be encouraged.
The subjects also represent an obvious potential source of error that could
contribute to the poor reliability assessments observed in Study 1. Several potential
aspects exist that could be modified in future studies to determine whether these changes
influence reliability. Possibly the most obvious modification would be to impose stricter
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dietary controls on the subjects prior to fMRI scanning. In Study 1, we simply asked
subjects to arrive after an overnight fast for morning sessions and after a 5 hr fast since
lunch for afternoon sessions. Providing the subjects with all meals and beverages for at
least 24 hrs would probably be a reasonable approach to help ensure that subjects are
arriving in similar metabolic states on each testing day. However, we felt as though our
methods were representative of many previously published fMRI-based studies on
ingestive behavior and therefore provided information regarding the reliability of the
method as it is commonly employed. Also, female subjects were scanned in Study 1
without regard to the phase of their menstrual cycle, which also may influence appetite
and ingestive behavior and neural reward responses to food stimuli. Given the welldocumented differences in reward processing between normal weight and
overweight/obese individuals, the reliability assessments in Study 1 should not
necessarily be extrapolated to normal weight populations, or any population other than
overweight and obese adults.
Future research on the reliability of neural responses to visual food stimuli should
be prioritized prior to the implementation of future intervention studies and should be
assessed in additional populations (e.g. normal weight, children, and older adults). If
future research confirms the relatively poor reliability as was observed in Study 1, a
major focus of fMRI-based research should be to explore options for improving its
reliability. Even if the reliability of the measurement cannot be improved, knowing its
reliability would be valuable for the design of future intervention trials. This information
would at least allow investigators to decide whether to use parallel or crossover study
designs, perform statistical power calculations, and develop the appropriate statistical
models for future randomized controlled trials. Until the reliability of neural responses to
visual stimuli is improved, or at least better documented, there appears to be little utility
in performing additional pre-load studies with repeated fMRI scans on subjects.
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Appendix A

Study 1 Consent Forms

RESEARCH PARTICIPANT SCREENING CONSENT FORM
Reproducibility and time course
For IRB Office Use Only
evaluation of the neural response
to visual food stimuli
Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science

Purpose of Research
The purpose of this research is to evaluate changes in brain activity in response to
viewing pictures of food on different days and at different times after eating a meal.
Specific Procedures
You understand that the information you will provide during screening may also be used
for the study. You have been asked to fill out a Medical History Questionnaire. You will
then come to the Department of Nutrition Science at Purdue University to complete the
screening procedures described below and to have all of your questions about the study
answered.
Medical History Questionnaire and MRI Screening Form
To the best of your knowledge, you have provided a complete history of all your medical
disorders during the screening process. To the best of your knowledge, you are free from
disease that might make participation in this study unsafe. You will let Professor
Campbell know all of the medications, drugs, and/or supplements that you currently take.
It is expected that you will not take any new medications, drugs, or supplements during
this study. It is expected that you will not change the dose of the medications that you
are currently taking during the study. You will contact Professor Campbell to inform him
of any change to your medications (change in dosage, beginning a new medication, or
stopping a medication) either before the medication change or as soon as possible
immediately afterward. You have also completed an MRI screening form to ensure that
you are safe to utilize the MRI device.
Fasting-state Blood Sample: Just prior to taking the blood sample, you will have a
finger stick blood test to measure your fasting blood glucose level. You will have a blood
sample taken from a vein in your arm by a trained clinical research technician. This
blood sample will be taken in the early morning before you have had anything to eat
(after fasting overnight for 10 hours). The sample will be used to measure various
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indicators of overall health. The amount of blood taken will be approximately 3
teaspoons (15ml).
Body Weight and Body Height: Your weight will be measured using a platform scale
and your height will be measured using a wall-mounted ruler. Your Body Mass Index
will be calculated using these two measurements.
Duration of Participation
You will complete one day of screening procedures that last a total of 1 hour.
Benefits to the Individual
While you are not guaranteed any benefit from participating in this part of the study, you
may benefit from the information given to you concerning your general overall health
status from your blood sample.
Risks to the Individual
The potential risks you may encounter include pain and the development of a small bruise
and/or infection at the puncture site on the arm where blood is drawn or at the site of the
finger stick. There is also a very slight risk of forming a blood clot in the vein that is
punctured. You may also feel lightheaded and there is a slight risk of fainting. There are
no known risks when completing questionnaires or having your body weight and body
height measured.
There is always a slight risk of unauthorized access to your personal information.
However, there are safeguards in place to minimize this risk.
Compensation
You will not be paid for completing this screening process.
Injury or Illness
You understand that Purdue University will not provide medical treatment or financial
compensation if you are injured or become ill as a result of participating in this research
project. This does not waive any of your legal rights nor release any claim you might
have based on negligence.
Confidentiality
The project's research records may be reviewed by the Purdue University Institutional
Review Board, the Office for Human Research Protections, and by departments at Purdue
University responsible for regulatory and research oversight. All personal information
you provide will be kept confidential, and will only be viewed by Dr. Campbell, his
research staff, and selected members of his department’s information technology
resources staff. There is a risk of breach of subject confidentiality, but safeguards are in
place to minimize this risk.
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Voluntary Nature of Participation
You do not have to participate in this study. If you agree to participate, you can
withdraw your participation at any time without penalty.
Human Subject Statement:
If you have any questions about this research project, you can contact Professor Wayne
W. Campbell at (765)494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone
number for the Board is (765) 494-5942. The email address is irb@purdue.edu.
Documentation of Informed Consent
You have had the opportunity to read this consent form and have had the research study
explained. You have had the opportunity to ask questions about the research project and
your questions have been answered. You are prepared to participate in the research
project described above. You will receive a copy of this consent form after you sign it.
_____________________________
Participant’s Signature

___________________
Date

______________________________
Researcher’s Signature

___________________
Date

Please check only one of the two boxes below
You agree to allow the use of your data and/or specimens collected during this
research project to be used for future research that is unrelated to this study.
______________________________
Participant’s Signature

__________________
Date

You request your data and/or specimens collected during this research project NOT
to be used for any future research that is unrelated to this study.
___________________________
Participant’s Signature

__________________
Date
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RESEARCH PARTICIPANT STUDY CONSENT FORM
Reproducibility and time course evaluation of
For IRB Office Use Only
the neural response to visual food stimuli
Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science

Purpose of Research
The purpose of this research is to evaluate changes in brain activity in response to
viewing pictures of food on different days and at different times after eating a meal.
Medical History Questionnaire and MRI Screening Form
To the best of your knowledge, you have provided a complete history of all your medical
disorders during the screening process. To the best of your knowledge, you are free from
disease that might make participation in this study unsafe. You will let Professor
Campbell know all of the medications, drugs, and/or supplements that you currently take.
It is expected that you will not take any new medications, drugs, or supplements during
this study. It is expected that you will not change the dose of the medications that you
are currently taking during the study. You will contact Professor Campbell to inform him
of any change to your medications (change in dosage, beginning a new medication, or
stopping a medication) either before the medication change or as soon as possible
immediately afterward. You have also completed an MRI screening form to ensure that
you are safe to utilize the fMRI device.
Specific Procedures
Upon meeting the study screening criteria, you will read this Participant Study Consent
Form and give written consent for the following procedures and measurements.
Study Overview: You will be asked to come to the Purdue MRI Facility on 3 occasions
for a “Brain Scanning Session.” On each of these days, your brain activity in response to
viewing pictures of food will measured using functional magnetic resonance imaging,
which is also called fMRI. An overview of the “Brain Scanning Session” is shown in
Figure 1.
Brain Scanning: You will come to the Purdue MRI facility at InnerVision West for 3
“Brain Scanning Sessions” during the study. One session will be in the morning after at
least a 10-hour overnight fast, one will be in the afternoon approximately 5 hours after
eating lunch, and the last one will be a repeat of either of the morning or afternoon
scanning session. You will be provided with and asked to eat a meal prior to each “Brain
Scanning Session.” For morning sessions, this meal should be eaten at dinnertime the
evening prior to the scanning session. For afternoon sessions, this meal should be eaten at
lunchtime the day of the scanning session. Five brain scans will be completed on each
day (15 total brain scans), and each brain scan will take approximately 30 minutes. You
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will complete the first brain scan after you complete an assessment of your appetite
(hunger, fullness, and desire to eat). After the first brain scan, you will be provided with a
meal and asked to eat the entire meal within 15 minutes. You will complete additional
brain scans immediately after and 1.5, 3, and 4.5 hours after finishing the meal.
Prior to entering the room in which the MRI machine is located, metallic or magnetic
objects will be removed from your possession and stored safely. During the brain scans,
you will lie on your back with your head and shoulders inside of the brain scanner and
focus on pictures of food, non-food objects, and blurred images. These images will be
viewed through a pair of goggles.
Appetite Assessment: You will be asked to rate your hunger, fullness, and desire to eat
before and after each brain scan.

Figure 1. Brain Scanning Session
30 min.

Pre-Meal
Brain Scan

30 min.

Eat

Post-Meal
Brain Scan

30 min.

Brain Scan
1.5 Hours After Meal

30 min.

Brain Scan
3 Hours After Meal

30 min.

Brain Scan
4.5 Hours After Meal

Appetite Questionnaire (Hunger, Fullness, Desire to Eat)
Brain Scan using fMRI

Duration of Participation
You understand that the study will take 2 weeks to complete. Each of the “Brain
Scanning Sessions” will last approximately 6 hours. You will be expected to remain at
the Purdue MRI facility for the entire 6-hour period on these three days.
Benefits to the Individual
No benefit is guaranteed for your participation.
Risks to the Individual
You understand that the following risks exist:
Magnetic Resonance Imaging
A. You might experience a sense of uneasiness or anxiety from being in a confined
place when inside the fMRI scanner. If this were to occur, you could easily
verbalize these feelings to the technician who will immediately halt the procedure.
You might also experience slight discomfort in your lower back and legs from
lying on your back during the fMRI scan.
B. High magnetic field: Due to the strong magnetic fields that are present in the
magnetic resonance imager, loose magnetic objects (pocket knives, key chains,
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necklaces, earrings, loose change, etc.) can fly into the magnet with great force if
brought into the environment of the fMRI scanner.
C. Radio-wave effects: If metal wires or electrodes (such as ECG leads) are attached
to a person being imaged, the radio-wave energy radiated by the imaging coils of
the fMRI scanner may induce sufficient electrical currents in the wires to cause
burns where the electrodes or wires contact the skin. We know of no risks or
adverse effects to the body or brain from the radio frequency transmissions used
in this study.
D. Hearing: The fMRI scanner produces high levels of noise during operation and
may cause discomfort in some subjects. Earplugs will be provided during each
scan.
E. Burning: There is also the risk of a burn to subjects wearing medication patches
(e.g. nicotine patch, birth control or hormone replacement therapy patch, etc.)
while undergoing the procedure.
F. There are no known risks associated with completing appetite questionnaires.
G. This is a risk of breach of confidentially that is associated with all research,
however safeguards are in place to minimize this risk as outlined in the
confidentially section.
Compensation
You will be paid $150 for completing all three “Brain Scanning Sessions.”
Injury or Illness
You understand that Purdue University will not provide medical treatment or financial
compensation if you are injured or become ill as a result of participating in this research
project. This does not waive any of your legal rights nor release any claim you might
have based on negligence.
Confidentiality
The project's research records may be reviewed by the Purdue University Institutional
Review Board, the Office for Human Research Protections, and by departments at Purdue
University responsible for regulatory and research oversight. All personal information
you provide will be kept confidential, and will only be viewed by Dr. Campbell, his
research staff, and selected members of his department’s information technology
resources staff. Your name and social security number will also be given to the business
office for payment purposes. There is a risk of breach of subject confidentiality, but
safeguards are in place to minimize this risk.
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Voluntary Nature of Participation
You do not have to participate in this study. If you agree to participate, you can
withdraw your participation at any time without penalty.
Human Subject Statement:
If you have any questions about this research project, you can contact Professor Wayne
W. Campbell at (765)494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone
number for the Board is (765) 494-5942. The email address is irb@purdue.edu.
Documentation of Informed Consent
You have had the opportunity to read this consent form and have had the research study
explained. You have had the opportunity to ask questions about the research project and
your questions have been answered. You are prepared to participate in the research
project described above. You will receive a copy of this consent form after you sign it.
_____________________________
Participant’s Signature

___________________
Date

______________________________
Researcher’s Signature

___________________
Date

Please check only one of the two boxes below
You agree to allow the use of your data and/or specimens collected during this
research project to be used for future research that is unrelated to this study.
______________________________
Participant’s Signature

__________________
Date

You request your data and/or specimens collected during this research project to
NOT be used for any future research that is unrelated to this study.
___________________________
Participant’s Signature

__________________
Date
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Appendix B

Study 2 Consent Forms

RESEARCH PARTICIPANT SCREENING
CONSENT FORM
Effects of Protein and Fiber at Breakfast on Brain
Activity, Appetite, and Health

For IRB Office Use Only

Principal Investigator:
Megan A. McCrory, PhD. Purdue University,
Department of Nutrition Science
Co-Investigators:
Kimberly Buhman, PhD. Purdue University, Department of Nutrition Science
Wayne Campbell, PhD. Purdue University, Department of Nutrition Science
David Kareken, PhD. Indiana University School of Medicine, Department of Neurology
Thomas Talavage, PhD. Purdue University, Department of Electrical and Computer
Engineering
Purpose of Research
You are being invited to participate, as a volunteer, in a research study at Purdue
University. In order to determine your eligibility to participate in that study, you must go
through a medical screening process. If you are found eligible, you will be asked to sign a
separate consent form for the study. The medical screening exam will take place at the
Purdue University campus in West Lafayette, IN.
Specific Procedures
Medical History Questionnaire
You have provided (to the best of your knowledge) a complete history of all your medical
disorders during the screening process. To the best of your knowledge, you are free from
disease that might make participation in this study unsafe. You will let Professor
McCrory know all of the medications, drugs, and/or supplements that you currently take.
It is expected that you will not take any new medications, drugs, or supplements during
this study. It is expected that you will not change the dose of medications that you keep
taking during the study. If you find that you must change the dose of your medications,
you will contact Professor McCrory before the medication change or as soon as possible
immediately afterward. You understand that you may skip any question that makes you
feel uncomfortable. You also understand that by not answering these questions, it may
make you ineligible to participate in this research study.

157
Body Height and Weight
Your height and weight measurements will be made to determine whether you meet the
Body Mass Index (BMI) eligibility criteria for this study.
Fasting Blood Draw
Just prior to taking the blood sample, you will have a finger stick blood test to measure
your fasting blood sugar level. A trained phlebotomist (person who draws blood) will
then draw 15ml (~1 Tablespoon) of blood from your vein for various routine blood
measurements (e.g. Kidney, liver, and thyroid function, blood cholesterol, glucose, and
insulin) to determine your overall health. If you qualify for the study, we will use your
blood sample as part of the measurements in the main study, and samples of your blood
may be stored at Purdue University for up to 10 years after the study is completed, for the
purpose of possibly measuring additional hormones related to hunger, appetite, and
metabolism, and additional parameters related to chronic disease risk. Your samples will
be identified with non-personal identifiers such as a code. If you do not qualify for the
study, samples of your blood will be destroyed. Your samples will be destroyed
according to standard methods, which involve sealing them in a safety container,
sterilizing the container and contents, and disposing of it in the trash.
Duration of Participation
The screening visit should take approximately 1 hour.
Risks
The total amount of your blood drawn during the medical screening exam will not exceed
15 ml (~1 Tablespoon). You may experience some momentary discomfort during the
finger stick and blood draw. You may suffer small bruises as a result of the finger stick
and blood draw and there is a slight risk of infection and scarring.
You may feel hungry due to being required to fast overnight (not eat for 10 h before
arriving at the Purdue laboratory for testing the next morning).
There is a risk of breach of confidentiality. The investigators will ensure to the best of
their ability that all information will be maintained in secure research files accessible
only to those involved in conducting the research study, as outlined in the confidentiality
section.
Benefits
There are no direct benefits to you for participating in this screening process.
Compensation
You will not be compensated for participating in this screening process.
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Injury or Illness
Purdue University will not provide medical treatment or financial compensation if you
are injured or become ill as a result of participating in this research project. This does not
waive any of your legal rights nor release any claim you might have based on negligence.
Confidentiality
The project's research records may be reviewed by the American Egg Board (which is
sponsoring the study) and departments at Purdue University responsible for regulatory
and research oversight.
We intend to keep information obtained in medical screening exam confidential, except
as required by law, through the use of non-name identifiers on data. Data will be entered
into a computer database with a code that will be used solely for the purpose of this
database and that will replace your name and study number. Only study investigators will
have access to a separate file linking your name and study number. No addresses, phone
numbers, names, or social security numbers will be entered into this database. Your date
of birth and visit date to Purdue University will be included in the database and could
possibly be linked to you. However, the code used will limit the possibility of linking the
information to your identity. Your blood sample and hardcopies of your data will be
labeled with your screening number and not your name or other personal identifiers, and
will be kept in file cabinets for up to 10 years after the study is completed under lock and
key accessible only to study investigators. The urine specimen you provided for
screening measurements will be destroyed just after the measurements are made.
Voluntary Nature of Participation
You do not have to participate in this research project. If you agree to participate, you can
request that a procedure be terminated or withdraw your participation at any time without
penalty. Also, the Investigator or the Institution may decide, at any time and for any
reason, that your participation in the screening process will be terminated.
Contact Information:
If you have any questions about this research project, you can contact Megan A. McCrory,
PhD, 765-494-2631. If you have concerns about the treatment of research participants,
you can contact the Committee on the use of Human Research Subjects at Purdue
University, Ernest C. Young Hall,10th Floor, Room 1032, 155 S. Grant Street, West
Lafayette, IN 47907-2114. The phone number for the Board’s secretary is (765) 4945942. The email address is irb@purdue.edu.
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Please CHECK the following if applicable:
I consent to allow the researchers to keep my name on file to be contacted for
future studies.
Documentation of Informed Consent
I have had the opportunity to read this consent form and have the research study
explained. I have had the opportunity to ask questions about the research project and my
questions have been answered. I am prepared to participate in the research project
described above. I will receive a copy of this consent form after I sign it.
__________________________________________
Participant’s Signature

_____________________
Date

__________________________________________
Participant’s Name
__________________________________________
Researcher’s Signature

_____________________
Date
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RESEARCH PARTICIPANT STUDY CONSENT FORM
Effects of protein and fiber at breakfast on brain
activity, appetite, and health

For IRB Office Use Only

Principal Investigator:
Megan A. McCrory, PhD. Purdue University,
Department of Nutrition Science
Co-Investigators:
Kimberly Buhman, PhD. Purdue University, Department of Nutrition Science
Wayne Campbell, PhD. Purdue University, Department of Nutrition Science
David Kareken, PhD. Indiana University School of Medicine, Department of Neurology
Thomas Talavage, PhD. Indiana University, Department of Electrical and Computer
Engineering
Purpose of Research
You are being invited to participate, as a volunteer, in a research study at Purdue
University. One purpose of this study is to find out if eating different amounts of protein
and fiber at breakfast affects the way your brain responds to looking at pictures of food
and other objects. Another purpose of this study is to see if different amounts of protein
and fiber at breakfast will change your blood sugar and cholesterol levels. Most
procedures will take place at the Purdue University Clinical Research Center or MRI
facility in West Lafayette, IN. A few procedures will take place while you are at home
(some questionnaires, telephone interviews, eating test foods at breakfast for 2 weeks,
wearing a continuous glucose monitor for 7 days). All of the study procedures are
described in detail later in this consent form.
Specific Procedures
Baseline testing will be completed during the first week of the study. You will be asked
to come to the Purdue University Clinical Research Center on 1 day to complete
questionnaires about your appetite, food intake, exercise, mood, and sleeping pattern.
Also during the baseline phase, you will be asked to recall all of the foods you ate during
the previous day on 3 separate days. A registered dietitian will help you remember what
you ate by talking with you either in-person or on the phone. It is expected that it will
take you approximately 4 hours to complete all the questionnaires and approximately 1
hour for each diet recall (3 hours total). After you complete baseline testing, you will
complete four 2-week phases where your breakfast will be given to you (Breakfast Given
Phase) separated by 2-weeks where you will eat your usual foods (Usual Diet Phase).
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Breakfast Given Phase:
During each of the four 2-week breakfast given phases, you will be given and asked to
eat specific breakfast meals every day. These breakfast meals will have different amounts
of protein and fiber, but you will not be told how much protein or fiber is in the meal. If
you normally do not consume many fruits, vegetables, beans or grains, you may find the
fiber content of the meals to be slightly higher than you are used to. You will be asked to
eat all of the foods we provide to you and to bring the empty containers (not washed) to
Purdue at the end of each week. During each breakfast given phase, you will complete
daily logs of your average daily appetite, mood, activity, and general health.
Usual Diet Phase:
You will eat your normal diet during the washout periods.
Both Phases:
While enrolled in this study, you should keep performing your usual daily routine and
physical activities/exercise, except for the morning of each testing day (described below).
On these days you should not exercise or drink alcohol or caffeinated beverages and you
should not exercise (normal walking is OK) the day prior to each test day. It is important
that you do not make changes to your usual eating and activity patterns throughout the
study period, except when you are asked to eat the breakfasts given to you. You should
drink plenty of unsweetened water while you are in the study, especially the day before
and the day of the test day. You agree that you are the only person who will consume any
of the meals provided to you while enrolled in this study. The food provided to you
during the study will be prepared in the professional kitchen at Purdue University. Food
handling and preparation techniques will be done according to safety procedures
established by the U.S. Food and Drug Administration.
Testing Days:
Before and after each 2-week dietary intervention, you will come into the Purdue Clinical
Research Center for the “Body size measurement Testing Day” (total of 8 days).
Measurements on these day include your height, weight, and body composition
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(including body fat and lean mass) as well as a blood draw. Each “Body Composition
Testing Day” will last approximately 1 hour.
Your daily blood sugar level will be measured using a continuous glucose monitoring
system on 7 days during each breakfast given phase. Also, you will be asked to recall all
of the foods you ate during the previous day on 3 separate days.
At the end of each breakfast given phase, you will come to the Purdue University MRI
Facility after a 10-hour overnight fast for the “Brain Scanning Day” (total of 4 days). On
these testing days, you will eat breakfast and lunch at the MRI facility, undergo two brain
scans (one before breakfast and one before lunch) using machine that measures the
activity in different parts of your brain, called functional magnetic resonance imaging
(fMRI), and answer questionnaires about hunger, appetite etc. A trained member of the
research team will obtain a blood sample from a vein in your arm before breakfast and 1,
2, 3, and 4 hours after you finish breakfast. The total amount of blood taken during each
“Brain scanning day” will be no more than 75 ml or about 5 tablespoons (total of 300 ml
or 20 tablespoons during the entire study). The “Brain Scanning Day” will last
approximately 6 hours.
Description of Procedures
Pregnancy test. If you are a woman, your urine will be tested to determine if you are
pregnant on the morning of each day a brain scan will be given, before any other
procedures are done. If you are pregnant, you will be withdrawn from the study and no
further testing will be performed. If you intend to become pregnant during the study, you
should not participate in the study. You must notify the investigator(s) immediately if you
learn you’ve become pregnant during the study.
Blood draws: Blood will be drawn from a vein on your arm or hand using an indwelling
catheter by a trained member of the research team at various times throughout the study.
The total amount of your blood drawn over the entire length of the study, not including
the medical screening exam, which you already completed, is estimated to be
approximately 345 ml or about 1.5 cups. This amount is less than what you would give if
you were to donate blood.
Brain scan (fMRI): This research requires the use of a magnetic resonance imaging
(MRI) machine to acquire images of the brain while you look at pictures of food and
other non-food objects through a special set of goggles. Prior to entering the room in
which the MRI machine is located, metallic or magnetic objects will be removed from
your possession and stored safely. It is necessary that you attempt to remain still during
the course of the imaging session. You may relax and converse with the experimenters or
other individuals present when data is not being acquired. The imaging session will begin
with acquisition of anatomical data to locate the brain structures that are of interest to the
experimenters. Next, “functional” imaging data will be obtained by acquiring images of
your brain while you look at the pictures. After the final functional imaging activity has
been completed, a second set of anatomical images may be obtained to permit assessment
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of the total motion of your head during the course of the imaging session. The total
amount of time spent in the MRI machine will be approximately 30 minutes for each
session. You will then be promptly removed from the MRI machine and provided as
much time as required to recover after the extended period of reclining in the imager.
After recovery, any belongings removed from your possession prior to entering the
imaging room will be returned. Should brain structure or behavior be observed during the
course of the imaging session that falls outside the normal experience of the investigators,
you will be removed from the imager and provided with documentation that may be of
future value, should you experience a serious head injury or a nervous system-related
illness (e.g., meningitis). However, the imaging procedures conducted during this session
are neither intended nor optimized for collection of diagnostic information.
Daily glucose monitoring: Starting at the end of the first week of each period of breakfast
given phase and for the next 7 days, you will wear a small pager-sized monitor which
measures your blood sugar continuously. This monitor has a small sensor (catheter). At
first the sensor contains a small needle which will be inserted underneath the skin in your
abdominal area by qualified personnel but after the insertion the needle will be removed
and the sensor secured. When you shower or bathe you will continue to wear the sensor
but you should remove the pager-sized monitor. You will be given instruction on how to
use this device on your own at home.
Blood glucose by finger stick: You will be trained to do finger stick blood sample at
home on your own. You will measure your blood sugar at home up to 4 times daily while
wearing the continuous glucose monitor using the finger stick method. You will be
shown how to enter your blood sugar values into the continuous glucose monitor
(described above). This will help ensure the continuous glucose monitor is measuring
your blood sugar accurately. You may have pain, light-headedness, infection, bleeding, or
bruising and there is a slight risk of infection and scarring at the site of the finger stick;
however, the staff will use proper technique while taking blood samples in order to
reduce unwanted effects and you will be trained to do so as well.
Questionnaires and interviews: You will be given questionnaires and be asked questions
about your dietary intake, hunger and other eating-related sensations, activity, health,
eating habits, symptoms of gastrointestinal discomfort and some psychological
parameters at home and on some test days. You may refuse to answer any question.
Body size and composition: Waist and hip circumference will be measured using a tape
measure. Your body weight and how much fat and lean tissue you have will be measured
using the BodPod method. For this test, you will either wear a lycra bathing suit or lycra
shorts (and lycra exercise top for women).
For the BodPod test, you will sit comfortably in a chamber with a big window for less
than 1 minute, repeated several times (usually 3-10 times). You will be breathing normal
room air and very small air pressure changes inside the chamber will be made, but they
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are so small (<1 cubic centimeter of water) that you may not be able to feel them. The
door will be opened between each measurement to allow fresh room air into the chamber.
After this, the amount of air in your lungs during normal breathing will be measured
while you are in the chamber. For this lung test, you will be breathing room air through a
snorkel device and then the airway will be closed for 2 seconds. While the airway is
closed, you will gently blow against the closure. The body composition measurement is
safe and will take about 15 minutes (including body and lung tests inside the chamber,
and time out of the chamber for instructions).
Duration of Participation
You will be asked to complete the entire study. It is expected that the study will
completed in 15-16 weeks if the 2 weeks of baseline measurements and the dietary
intervention periods are completed consecutively. If you choose to participate, your total
time devoted to this study is estimated to be approximately 76 hours, not including travel
time to and from the university.
Benefits to the Individual
You understand no benefit is guaranteed, there may be no benefit to you. You may
perceive a benefit from knowing your blood profile from your blood draw and your body
composition report.
Risks to the Individual
Provided Food: Although standard safety procedures will be followed to prevent foodbased illness from occurring as a result of consuming the study foods, there is a small risk
of this to you. You should inform the investigators of any changes in your health such as
nausea, vomiting, or diarrhea. Although we have screened individuals for known food
allergies and sensitivities, there is a small chance you may experience an allergic or
sensitive reaction to a food or ingredient in the study. In the case of an emergency, you
should contact your personal physician and also inform the investigators as soon as
possible.
If you normally consume a very low fiber diet, you could experience some abdominal
discomfort, including gas in your intestines, during and after digesting the meals
containing beans. Drinking plenty of unsweetened water while you are in the study,
especially the day before and the day of the test day will help to minimize any discomfort
you may experience.
Brain Scanning (fMRI): Due to the magnetic fields that are present in the MRI machine,
loose magnetic objects can fly into the magnet with great force if brought into the
environment of the MR imager. You will be asked to remove such objects from your
clothes and body to prevent such an occurrence.
There are some individuals who should not participate in an MR study. These include
persons with some types of metallic implants, such as aneurysm clips or some types of
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prostheses, or persons with electronic implants such as cardiac pacemakers. Surgical pins
and plates are not generally a risk to the individual, but the investigators should be
informed of the presence of such implants. Individuals who suffer from claustrophobia
should also not participate in an MR study due to the confining conditions of the MRI
machine.
The MR imager produces short duration, high level noise during operation that may cause
discomfort in some subjects. To minimize discomfort, you will be provided with
disposable earplugs.
The devices used in our research create rapidly-changing (radio frequency) magnetic
fields that are within the limits specified by the Food and Drug Administration (FDA).
We know of no risks or adverse effects to the body or brain from the radio frequency
energies used in this study. Some individuals undergoing the rapid imaging procedures
using in functional magnetic resonance imaging (fMRI) have experienced minor nerve
stimulation effects such as muscle twitches and tingling sensations. There are no known
risks associated with these effects.
If metal wires or electrodes (such as ECG leads) are attached to you during imaging, the
radio-wave energy radiated by the imaging coils of the MR imager may induce sufficient
electrical currents in the wires to cause burns where the electrodes or wires contact the
skin. The experimenters are aware of this risk and know proper usage techniques to
avoid this problem.
There is no evidence to suggest that MRI is harmful to pregnant persons or fetuses.
Nevertheless, women who are pregnant should not participate in this study.
Fasting: You may feel hungry or weak during the times you are required to fast overnight
(not eat for 10 hours before arriving at the Purdue laboratory for testing the next
morning).
Blood collection: You may develop a small bruise and/or infection at the puncture site on
the arm where the blood is drawn or at the site of the finger prick. You may also feel
lightheaded and there is a slight risk of fainting. The total amount of your blood drawn
over the entire length of the study, not including the medical screening exam, which you
already completed, is estimated to be approximately 345 ml or about 1.5 cups. This
amount is less than what you would give if you were to donate blood. While this amount
of blood drawn is extremely unlikely to present any hazard to your physical well-being,
you must agree not to donate blood for at least one month prior to, during, and for one
month after the study.
Daily glucose monitoring: You may have slight pain, infection, bruising and there is a
slight risk of infection and scarring at the site of the sensor placement; however, the
qualified personnel will use proper technique to reduce unwanted effects. Also, there is a
slight risk of infection for having the sensor in place for the 7days. You will be shown
how to maintain the sight at home and keep it clean in order to reduce this risk. If you do
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experience signs or symptoms of infection at home or have any general problem after the
sensor placement, please inform the research team right away.
BodPod: There is some risk that if you feel uncomfortable in an enclosed space, you may
feel uncomfortable in the BodPod. However, there is a very large window in the BodPod
and nearly all people we have tested who have a history of feeling uncomfortable in an
enclosed space do not feel that way in the BodPod. You will be given the chance to sit in
the BodPod with the door open prior to testing to see how you feel. You may refuse the
test if you feel uncomfortable.
Breach of confidentiality: There is a risk of breach of confidentiality. The investigators
will ensure to the best of their ability that all of your information will be maintained in
secure research files accessible only to those involved in conducting the research study,
as outlined in the confidentiality section below.
Compensation
You will be paid $450 if you complete the entire study. If you chose to withdraw before
completing the entire study, you will be partially compensated according to the duration
of your participation. The rate of compensation for partial completion of the study is $4
per day that you participated.
Injury or Illness
Purdue University will not provide medical treatment or financial compensation if you
are injured or become ill as a result of participating in this research project. This does not
waive any of your legal rights nor release any claim you might have based on negligence.
Confidentiality
The project's research records may be reviewed by the American Egg Board (which is
sponsoring the study) and departments at Purdue University responsible for regulatory
and research oversight.
Your name and social security number may be collected for the business office for
payment purposes.
We intend to keep information obtained in this study about you confidential, except as
required by law, through the use of non-name identifiers on blood samples and data. Data
will be entered into a computer database with a code that will be used solely for the
purpose of this database and that will replace your name and study number. Only study
investigators will have access to a separate file linking your name and study number. No
addresses, phone numbers, names, or social security numbers will be entered into this
database. Your date of birth and visit dates to Purdue University will be included in the
database and could possibly be linked to you. However, the code used will limit the
possibility of linking the information to your identity. Blood samples and hardcopies of
your data will be labeled with your study number and not your name or other personal
identifiers, and will be kept in file cabinets for up to 10 years after the study is completed
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under lock and key accessible only to study investigators. We may use the blood sample
and data you provide for this study for the purpose of possibly measuring additional
hormones related to hunger, appetite, and metabolism, and additional parameters related
to chronic disease risk..
We will be communicating with you by email, telephone, and/or postal mail. While we
are using secure software with internet security protections in place, complete
confidentiality cannot be guaranteed since no means of communication is completely
confidential.
Voluntary Nature of Participation
You do not have to participate in this research project. If you agree to participate you can
withdraw your participation at any time without penalty. If you withdraw from the study,
you will be paid up to the day you withdraw, and the amount will be proportional to the
time you spent in the study. If this happens you may be asked to complete a questionnaire
so that investigators can better understand why you chose not to continue to participate,
but you can refuse to fill it out. Also, the Investigator or the Institution may decide, at any
time and for any reason, that your participation in the study will be terminated. In this
event, you will be paid up to the day of the termination and the amount will be
proportional to the time you have spent in the study.
Contact Information:
If you have any questions about this research project, you can contact Megan A.
McCrory, PhD, 765-494-2631. If you have concerns about the treatment of research
participants, you can contact the Committee on the use of Human Research Subjects at
Purdue University, Ernest C. Young Hall,10th Floor, Room 1032, 155 S. Grant Street,
West Lafayette, IN 47907-2114. The phone number for the Board’s secretary is (765)
494-5942. The email address is irb@purdue.edu.
Please CHECK all of the following which are applicable:
I consent to allow the researchers to keep my name on file to be contacted for
future studies.
I consent to allow the researchers to use my blood samples in the future for
purposes other than this study.
I consent to allow the researchers to use my blood samples even if I discontinue
the study.

Documentation of Informed Consent
I have had the opportunity to read this consent form and have the research study
explained. I have had the opportunity to ask questions about the research project and my
questions have been answered. I am prepared to participate in the research project
described above. I will receive a copy of this consent form after I sign it.
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_________________________________
Participant’s Signature

_________________________
Date

________________________________
Participant’s Name
________________________________
Researcher’s Signature

___________________________
Date
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Appendix C

Study 3 Consent Forms

RESEARCH PARTICIPANT SCREENING CONSENT FORM
Effect of aerobic exercise on appetite and neural
For IRB Office Use Only
response to visual food stimuli
Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science

Purpose of Research
The purpose of this research is to evaluate whether exercise performed before dinner
affects brain activity in response to viewing pictures of food.
Specific Procedures
You understand that the information you will provide during screening may also be used
for the study. You have been asked to fill out a Medical History Questionnaire. You will
then come to the Department of Nutrition Science at Purdue University to complete the
screening procedures described below and to have all of your questions about the study
answered.
Medical History Questionnaire and MRI Screening Form: To the best of your
knowledge, you have provided a complete history of all your medical disorders during
the screening process. To the best of your knowledge, you are free from disease that
might make participation in this study unsafe. You will let Professor Campbell know all
of the medications, drugs, and/or supplements that you currently take. It is expected that
you will not take any new medications, drugs, or supplements during this study. It is
expected that you will not change the dose of the medications that you are currently
taking during the study. You will contact Professor Campbell to inform him of any
change to your medications (change in dosage, beginning a new medication, or stopping
a medication) either before the medication change or as soon as possible immediately
afterward. You have also completed an MRI screening form to ensure that you are
eligible to utilize the MRI device.
Pregnancy test: Your urine will be tested to determine if you are pregnant. Please note
all of the study procedures are safe for pregnant women, but pregnant women do not
qualify for the study due to changes in body function that may affect the results of the
study. If you are pregnant, you will be withdrawn from the study and no further testing
will be performed. If you intend to become pregnant during the study, you should not
participate in the study. You must notify the investigator(s) immediately if you learn you
have become pregnant during the study.
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Fasting-state Blood Sample: Just prior to taking the blood sample, you will have a
finger stick blood test to measure your fasting blood glucose level. You will have a blood
sample taken from a vein in your arm by a trained clinical research technician. This
blood sample will be taken in the early morning before you have had anything to eat
(after fasting overnight for 10 hours). The sample will be used to measure various
indicators of overall health. The amount of blood taken will be approximately 3
teaspoons (15ml).
Body Weight and Body Height: Your weight will be measured using a platform scale
and your height will be measured using a wall-mounted ruler. Your Body Mass Index
will be calculated using these two measurements.
Duration of Participation
You will complete one day of screening procedures that last a total of 1 hour.
Benefits to the Individual
While you are not guaranteed any benefit from participating in this part of the study, you
may benefit from the information given to you concerning your general overall health
status from your blood sample.
Risks to the Individual
The potential risks you may encounter include pain and the development of a small bruise
and/or infection at the puncture site on the arm where blood is drawn or at the site of the
finger stick. There is also a very slight risk of forming a blood clot in the vein that is
punctured. You may also feel lightheaded and there is a slight risk of fainting. There are
no known risks when completing questionnaires or having your body weight and body
height measured.
There is always a risk of unauthorized access to your personal information. However,
there are safeguards in place to minimize this risk.
Compensation
You will not be paid for completing this screening process.
Injury or Illness
You understand that Purdue University will not provide medical treatment or financial
compensation if you are injured or become ill as a result of participating in this research
project. This does not waive any of your legal rights nor release any claim you might
have based on negligence.
Confidentiality
The project's research records may be reviewed by the Purdue University Institutional
Review Board, Clinical and Translational Sciences Institute (CTSI) Purdue Project
Development Team, the Office for Human Research Protections, and by departments at
Purdue University responsible for regulatory and research oversight. All personal
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information you provide will be kept confidential, and will only be viewed by Dr.
Campbell, his research staff, and selected members of his department’s information
technology resources staff. There is a risk of breach of subject confidentiality, but
safeguards are in place to minimize this risk.
Voluntary Nature of Participation
You do not have to participate in this study. If you agree to participate, you can
withdraw your participation at any time without penalty.
Human Subject Statement:
If you have any questions about this research project, you can contact Professor Wayne
W. Campbell at (765)494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone
number for the Board is (765) 494-5942. The email address is irb@purdue.edu.
Documentation of Informed Consent
You have had the opportunity to read this consent form and have had the research study
explained. You have had the opportunity to ask questions about the research project and
your questions have been answered. You are prepared to participate in the research
project described above. You will receive a copy of this consent form after you sign it.
_____________________________
Participant’s Signature

___________________
Date

______________________________
Researcher’s Signature

___________________
Date

Please check only one of the two boxes below
You agree to allow the use of your data and/or specimens collected during this
research project to be used for future research that is unrelated to this study.
______________________________
Participant’s Signature

__________________
Date

You request your data and/or specimens collected during this research project
NOT to be used for any future research that is unrelated to this study.
___________________________
Participant’s Signature

__________________
Date
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RESEARCH PARTICIPANT STUDY CONSENT FORM
Effect of aerobic exercise on appetite and neural
For IRB Office Use Only
response to visual food stimuli
Wayne W. Campbell, Ph.D.
Purdue University
Department of Nutrition Science

Purpose of Research
The purpose of this research is to evaluate whether exercise performed before dinner
affects brain activity in response to viewing pictures of food.
Medical History Questionnaire and MRI Screening Form
To the best of your knowledge, you have provided a complete history of all your medical
disorders during the screening process. To the best of your knowledge, you are free from
disease that might make participation in this study unsafe. You will let Professor
Campbell know all of the medications, drugs, and/or supplements that you currently take.
It is expected that you will not take any new medications, drugs, or supplements during
this study. It is expected that you will not change the dose of the medications that you
are currently taking during the study. You will contact Professor Campbell to inform him
of any change to your medications (change in dosage, beginning a new medication, or
stopping a medication) either before the medication change or as soon as possible
immediately afterward. You have also completed an MRI screening form to ensure that
you are eligible to utilize the MRI device.
Specific Procedures
Upon meeting the study screening criteria, you will read this Participant Study Consent
Form and give written consent for the following procedures and measurements.
Study Overview: The entire study will take approximately 5 weeks (35 days) to
complete. There are 5 testing days during the study and each testing day will be separated
by at least 7 days. On the first testing day, you will have your fitness level tested by
pedaling on an exercise bike for approximately 6 minutes. On the remaining 4 testing
days, you will be provided with breakfast, lunch, and dinner meals to eat, asked to
complete assessments of your appetite (hunger, fullness, and desire to eat), and have your
brain activity measured using a method called functional magnetic resonance imaging or
fMRI. You will also complete 30 minutes of exercise (pedaling on an exercise bike) on
two of the testing days. You will be asked not drink alcohol or perform any vigorous
exercise for 2 days (48 hours) prior to each testing day.
Pregnancy test: Your urine will be tested to determine if you are pregnant. Please note
all of the study procedures are safe for pregnant women, but pregnant women do not
qualify for the study due to changes in body function that may affect the results of the
study. If you are pregnant, you will be withdrawn from the study and no further testing
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will be performed. If you intend to become pregnant during the study, you should not
participate in the study. You must notify the investigator(s) immediately if you learn you
have become pregnant during the study.
Provided Meals: A registered dietitian will prepare breakfast, lunch, and dinner for you
on the 4 testing days following the fitness test. All of your beverages for each of these
testing days will also be provided to you. You will eat the breakfast and lunch meals in
the metabolic research kitchen (Stone Hall, Room 231) and the dinner will be eaten at the
Purdue MRI Facility. You will be asked not to eat or drink anything other than the foods
and beverages provided to you on testing days. The size and calorie content of the meals
will be based on your age, weight, gender, and activity level. You will be asked to
completely finish all meals on the testing days.
Exercise: On the first day of the study, your fitness level will be measured by pedaling
on an exercise bike for approximately 6 minutes. Your heart rate will be measured during
this test to estimate you fitness level. On 2 of the remaining 4 testing days, you will pedal
on an exercise bike for 30 minutes before eating dinner. On the other 2 testing days, you
will sit quietly in the waiting room at the Purdue MRI Facility for 30 minutes before
eating dinner.
Brain Scanning: You will come to the Purdue MRI facility at InnerVision West at 5 pm
on 4 testing days so we can measure your brain activity while you are viewing pictures
through a pair of goggles. We will measure your brain activity 4 times during each
testing day (16 total brain scans for entire study). The first brain scan will completed at
approximately 5:00 pm before you eat dinner. The remaining 3 brain scans will be started
1 hour, 2.5 hours, and 4 hours after finishing dinner (see Figure 1 below).
Prior to entering the room in which the MRI machine is located, metallic or magnetic
objects will be removed from your possession and stored safely. During the brain scans,
you will lie on your back with your head and shoulders inside of the MRI machine and
focus on pictures of food and non-food objects (such as animals and tools) that you will
see through a pair of goggles.

Figure 1. Brain Scanning Session
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Appetite Assessment: You will be asked to rate your hunger, fullness, and desire to eat
at various times throughout the day on each testing day. These times include: every hour
between 8am and 5pm, before and after each meal, before and after 30 minutes of
exercise or resting, and before and after each brain scan.
Duration of Participation
You will be asked to complete the entire study, but you may withdraw from the study at
any time. You understand that the study will take at least 5 weeks (35 days) to complete.
Benefits to the Individual
No benefit is guaranteed for your participation.
Risks to the Individual
You understand that the following risks exist:
Magnetic Resonance Imaging (Brain Scans)
You might experience a sense of uneasiness or anxiety from being in a confined place
when inside the fMRI scanner. If this were to occur, you could easily verbalize these
feelings to the technician who will immediately halt the procedure. You might also
experience slight discomfort in your lower back and legs from lying on your back during
the fMRI scan.
High magnetic field: Due to the strong magnetic fields that are present in the magnetic
resonance imager, loose magnetic objects (pocket knives, key chains, necklaces, earrings,
loose change, etc.) can fly into the magnet with great force if brought into the
environment of the fMRI scanner.
Radio-wave effects: If metal wires or electrodes (such as ECG leads) are attached to a
person being imaged, the radio-wave energy radiated by the imaging coils of the fMRI
scanner may induce sufficient electrical currents in the wires to cause burns where the
electrodes or wires contact the skin. We know of no risks or adverse effects to the body
or brain from the radio frequency transmissions used in this study.
Hearing: The fMRI scanner produces high levels of noise during operation and may
cause discomfort in some people. Earplugs will be provided during each scan.
Burning: There is also the risk of a burn to subjects wearing medication patches (e.g.
nicotine patch, birth control or hormone replacement therapy patch, etc.) while
undergoing the procedure.
Exercise
There are some risks associated with the fitness testing and exercise. By following the
proper warm-up and cool-down procedures the risks are minimal, but may include

175
muscle tightness, soreness and fatigue, pulled muscles, and joint injuries. The
cardiovascular risks of performing these exercises and tests are very low but include heart
attack and cardiac arrest.
Confidentiality
This is a risk of breach of confidentially that is associated with all research, however
safeguards are in place to minimize this risk as outlined in the confidentially section.
Compensation
A payment of $50 will be provided for each time you complete the brain scanning testing
day. If you complete the entire 5-week study (fitness testing and 4 brain scanning testing
days), you will receive a payment of $200. No payment will be provided if you decided
to terminate your participation prior to the first brain activity scan.
Injury or Illness
You understand that Purdue University will not provide medical treatment or financial
compensation if you are injured or become ill as a result of participating in this research
project. This does not waive any of your legal rights nor release any claim you might
have based on negligence.
Confidentiality
The project's research records may be reviewed by the Purdue University Institutional
Review Board, Clinical and Translational Sciences Institute (CTSI) Purdue Project
Development Team, the Office for Human Research Protections, and by departments at
Purdue University responsible for regulatory and research oversight. All personal
information you provide will be kept confidential and will only be viewed by Dr.
Campbell, his research staff, and selected members of his department’s information
technology resources staff. Your name and social security number will also be given to
the business office for payment purposes. There is a risk of breach of subject
confidentiality, but safeguards are in place to minimize this risk.
Voluntary Nature of Participation
You do not have to participate in this study. If you agree to participate, you can
withdraw your participation at any time without penalty.
Human Subject Statement:
If you have any questions about this research project, you can contact Professor Wayne
W. Campbell at (765)494-8236. If you have concerns about the treatment of research
participants, you can contact the Institutional Review Board at Purdue University, Ernest
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone
number for the Board is (765) 494-5942. The email address is irb@purdue.edu.
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Documentation of Informed Consent
You have had the opportunity to read this consent form and have had the research study
explained. You have had the opportunity to ask questions about the research project and
your questions have been answered. You are prepared to participate in the research
project described above. You will receive a copy of this consent form after you sign it.
_____________________________
Participant’s Signature

___________________
Date

______________________________
Researcher’s Signature

___________________
Date

Please check only one of the two boxes below
You agree to allow the use of your data and/or specimens collected during this
research project to be used for future research that is unrelated to this study.
______________________________
Participant’s Signature

__________________
Date

You request your data and/or specimens collected during this research project
NOT to be used for any future research that is unrelated to this study.
___________________________
Participant’s Signature

__________________
Date
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